permit
unrestrict
use
distribut
reproduct
medium
provid
give
appropri
credit
origin
author
sourc
provid
link
creativ
common
licens
indic
chang
made
oral
commun
oral
commun
physiotherapist
romain
lachal
speaker
de
la
croixrouss
introduct
studi
show
high
incid
invas
pulmonari
aspergillosi
ipa
patient
sever
influenza
suggest
assess
benefit
antifung
prophylaxi
howev
studi
come
area
lack
extern
valid
aim
measur
incid
invas
pulmonari
aspergillosi
ipa
aspergillosi
colon
patient
sever
influenza
admit
intens
care
unit
icu
patient
method
retrospect
multicent
cohort
studi
recruit
patient
influenza
admit
four
icu
three
french
tertiari
hospit
septemb
april
patient
adult
confirm
influenza
infect
base
posit
airway
pcr
test
patient
aspergillusposit
lower
respiratori
tract
specimen
cultur
patient
aspergillu
diagnos
aspergillu
colon
invas
pulmonari
aspergillosi
put
proven
accord
aspicu
criteria
multivari
logist
regress
perform
determin
factor
associ
invas
pulmonari
aspergillosi
ipa
aspergillosi
colon
result
four
hundr
ninetyon
patient
includ
three
hundr
fiftythre
patient
infect
influenza
patient
influenza
b
mean
simplifi
acut
physiolog
score
ii
sd
patient
die
icu
three
hundr
fiftysix
patient
invas
mechan
ventil
patient
underw
extracorpor
membran
oxygen
twentysix
patient
aspergillusposit
lower
respiratori
tract
specimen
cultur
includ
patient
diagnos
ipa
accord
aspicu
criteria
multivari
analysi
factor
associ
aspergillosisposit
lower
respiratori
tract
specimen
cultur
liver
cirrhosi
haematolog
malign
use
vasopressor
influenza
tabl
mortal
rate
significantli
differ
patient
without
aspergillu
p
conclus
larg
french
cohort
studi
patient
sever
influenza
ipa
diagnos
critic
ill
patient
influenza
infect
prospect
research
warrant
confirm
find
identifi
patient
increas
static
complianc
ml
h
prone
result
thirteen
studiedpati
consid
pp
respond
ecmo
pp
respond
greater
bodi
mass
index
frequent
viral
pneumonia
shorter
ecmo
durat
compar
pp
nonrespond
p
group
tidal
volum
eeli
redistribut
ventral
dorsal
region
pp
howev
optim
peep
significantli
lower
pp
supin
posit
vs
pp
respond
pp
nonrespond
respect
figur
lastli
baselin
center
graviti
index
lower
pp
respond
p
conclus
eit
allow
monitor
pp
impact
ventil
seem
relev
tool
identifi
patient
like
respond
pp
ecmo
respiratori
muscl
contract
success
ventil
liber
trial
predict
extub
failur
martin
dre
speaker
introduct
even
patient
success
pass
ventil
liber
trial
period
extub
risk
complic
present
studi
investig
whether
assess
respiratori
muscl
contract
within
h
extub
could
predict
extub
failur
acut
respiratori
failur
reintub
death
period
follow
extub
patient
method
patient
two
intens
care
unit
intub
sinc
least
h
success
pass
ventil
liber
trial
enrol
studi
within
two
hour
follow
extub
right
hemidiaphragm
tfdi
right
upper
intercost
muscl
thicken
fraction
tfci
obtain
ultrasound
tfdi
tfic
compar
patient
without
extub
failur
unpair
test
receiv
oper
characterist
roc
curv
construct
predict
risk
extub
failur
indic
result
patient
particip
studi
extub
failur
respect
patient
without
extub
failur
tfdi
p
tfic
p
auc
roc
curv
tfdi
tfic
respect
p
valu
tfdi
lower
predict
extub
failur
sensit
specif
valu
tfic
greater
predict
extub
failur
sensit
specif
eventu
tfdi
tfic
ratio
patient
without
extub
failur
respect
p
auc
roc
curv
tfdi
tfic
provid
sensit
specif
predict
extub
failur
cutoff
conclus
assess
respiratori
muscl
contract
within
two
hour
extub
could
use
identifi
patient
risk
extub
failur
potenti
interest
cutoff
could
use
time
consid
prevent
post
extub
ventil
strategi
effect
empir
aminoglycosid
combin
therapi
mortal
patient
septic
shocka
propensitybas
analysi
llitjo
speaker
introduct
current
guidelin
recommend
combin
antibiot
therapi
patient
septic
shock
howev
support
evid
scarc
aim
studi
address
impact
aminoglycosid
combin
therapi
mortal
septic
shock
patient
method
monocent
retrospect
studi
adult
patient
diagnos
septic
shock
within
first
h
includ
septic
shock
defin
microbiolog
proven
clinic
suspect
infect
associ
acut
circulatori
failur
requir
vasopressor
empir
combin
therapi
defin
addit
aminoglycosid
within
h
diagnosi
septic
shock
propens
score
aminoglycosid
administr
built
use
day
demograph
clinic
characterist
determin
mortal
assess
use
propensityadjust
cox
proport
hazard
compet
risk
analysi
result
studi
period
patient
admit
septic
shock
among
male
median
age
year
old
crude
inicu
mortal
rate
antibiot
regimen
base
beta
lactam
therapi
almost
patient
combin
aminoglycosid
patient
firstlin
aminoglycosid
distribut
amikacin
gentamicin
tobramycin
total
includ
organ
panel
introduct
outofhospit
cardiac
arrest
ohca
geograph
dispar
outcom
may
reflect
baselin
variat
patient
characterist
may
also
result
differ
number
ambul
provid
basic
life
support
bl
advanc
life
support
al
aim
assess
influenc
alloc
ambul
resourc
outcom
ohca
patient
larg
urban
commun
patient
method
may
januari
analyz
prospect
collect
utstein
databas
ohca
adult
case
geocod
accord
neighborhood
number
bl
firefight
perform
cardiopulmonari
resuscit
appli
autom
extern
defibril
al
ambul
medic
team
provid
advanc
care
drug
endotrach
intub
collect
assess
respect
influenc
utstein
paramet
socioeconom
characterist
ambul
resourc
neighborhood
use
mixedeffect
model
success
return
spontan
circul
rosc
primari
endpoint
surviv
hospit
discharg
secondari
endpoint
introduct
use
spectrum
studi
aim
evalu
whether
hypoxemia
icu
among
obes
patient
differ
caus
manag
compar
nonobes
patient
patient
method
subgroup
analysi
prevalencepointday
conduct
frenchspeak
icu
aim
report
pattern
outcom
hypoxem
patient
defin
p
f
mmhg
obes
defin
bodi
mass
index
bmi
kg
result
among
patient
hospit
icu
day
studi
bmi
data
obes
hypoxem
compar
nonobes
patient
p
exhibit
frequent
obesityhypoventil
syndrom
versu
p
sleep
apnea
versu
p
less
frequent
nonobstruct
chronic
respiratori
diseas
versu
p
interstiti
pulmonari
diseas
versu
p
frequent
home
noninvas
ventil
niv
versu
p
hypoxemia
mild
moder
sever
similar
nonobes
patient
ard
criteria
fulfil
versu
nonobes
patient
requir
high
flow
oxygen
niv
invas
ventil
respect
case
differ
nonobes
patient
peep
higher
iqr
versu
iqr
p
tidal
volum
intub
patient
ml
kg
iqr
obes
patient
versu
p
plateau
pressur
differ
group
versu
cm
well
ph
diagnosi
atelectasi
frequent
group
versu
differ
use
prone
posit
versu
p
icu
mortal
obes
patient
versu
p
multivari
cox
model
confirm
neg
independ
associ
obes
icu
mortal
introduct
highflow
oxygen
therapi
hfnc
shown
benefit
prognosi
patient
hypoxem
acut
respiratori
failur
arf
noninvas
ventil
niv
remain
debat
indic
evalu
effect
hfnc
alveolar
recruit
lung
volum
hypoxem
arf
compar
niv
facial
mask
fm
patient
method
prospect
crossov
physiolog
studi
conduct
elig
patient
present
hypoxem
arf
due
pneumonia
requir
hfnc
niv
accord
icu
physician
cardiogen
pulmonari
oedema
underli
respiratori
diseas
exclud
patient
investig
pulmovista
germani
devic
underw
min
period
hfnc
niv
random
order
interspers
min
period
fm
use
refer
primari
endpoint
comparison
global
region
endexpiratori
electr
lung
imped
eeli
niv
hfnc
secondari
endpoint
comparison
techniqu
lung
volum
global
region
tidal
variat
tv
respiratori
paramet
hemodynam
toler
dyspnea
comfort
result
niv
global
region
tv
increas
niv
compar
hfnc
p
fm
p
hfnc
modifi
tv
fm
niv
significantli
improv
ratio
compar
hfnc
p
fig
hfnc
significantli
reduc
respiratori
rate
vs
fm
p
niv
differ
found
dyspnea
score
techniqu
patient
comfort
similar
hfnc
fm
decreas
niv
conclus
studi
demonstr
similar
benefit
hfnc
niv
alveolar
recruit
set
use
compar
fm
contrast
hfnc
despit
better
oxygen
niv
also
increas
lung
volum
may
contribut
potenti
deleteri
effect
hypoxem
arf
lead
recent
concept
patient
self
inflict
lung
injuri
psili
brochard
l
et
al
ajrccm
introduct
ventilatori
acquir
pneumonia
vap
one
main
nosocomi
infect
adult
icu
one
prospect
multicent
studi
perform
six
month
picu
us
prospect
describ
pediatr
vap
design
incipav
studi
report
occurr
vap
european
picu
focus
patient
risk
factor
rf
microorgan
involv
diagnost
tool
antibiot
use
first
aim
studi
calcul
incid
vap
patient
method
multicent
prospect
cohort
studi
includ
patient
mechan
ventil
mv
least
eight
picu
one
netherland
seven
franc
vap
defin
use
cdc
criteria
appli
picu
stay
exclud
h
preceed
follow
picu
patient
describ
admiss
main
rf
ever
test
medic
litteratur
daili
includ
pediatr
intensivist
picu
electron
databas
secur
dedic
websit
ethic
committe
french
societi
intens
care
approv
studi
declar
cnil
record
clinicaltrialsorg
parent
individu
inform
dedic
sheet
descript
data
report
number
median
firstthird
quartil
incid
calcul
number
vap
day
mv
result
result
base
declar
inform
report
incipav
databas
first
open
septemb
clean
one
year
episod
mv
includ
patient
month
male
main
reason
admiss
picu
postop
care
respiratori
neurolog
circulatori
failur
score
observ
mortal
score
patient
ventil
via
uncuf
tube
case
tracheostomi
total
vap
declar
day
mv
incid
vap
day
mv
conclus
incid
vap
incipav
studi
higher
incid
report
recent
gupta
day
mv
new
analys
plan
clean
databas
includ
special
read
case
vap
sever
sepsi
septic
shock
hematolog
pediatr
patient
admit
picu
bicentr
retrospect
studi
alimi
speaker
introduct
pediatr
sepsi
remain
burdensom
public
health
problem
especi
patient
immunodefici
adher
surviv
sepsi
campaign
ssc
would
associ
lower
mortal
howev
correl
never
evalu
children
hematolog
malign
patient
method
retrospect
bicentr
cohort
studi
children
identifi
hematolog
malign
hematopoiet
stem
cell
transplant
requir
intens
care
sever
sepsi
januari
august
detail
descript
sepsi
resuscit
within
six
hour
diagnosi
sepsi
evalu
adher
ssc
recommand
admiss
pediatr
intens
care
unit
picu
accur
analysi
microbiolog
etiolog
assess
mortal
month
sepsi
result
patient
includ
screen
admiss
icu
receiv
oxygen
patient
show
low
blood
pressur
age
without
continu
infus
inotrop
lactic
acid
measur
patient
within
h
picu
admiss
receiv
oxygen
patient
continu
infus
inotrop
ventil
lactic
acid
central
venou
oxygen
satur
measur
obtain
one
third
patient
infecti
organ
isol
patient
common
primari
site
infect
central
venou
cathet
patient
show
fungic
infect
mortal
within
month
evalu
introduct
hfnc
emerg
promis
method
provid
respiratori
support
bronchiol
two
rct
evalu
hfnc
less
sever
bronchiol
admit
gener
ward
fail
demonstr
reduct
length
oxygen
therapi
proport
patient
transfer
picu
kepreot
franklin
therefor
perform
superior
trial
test
hypothesi
hfnc
could
reduc
proport
treatment
failur
requir
noninvas
ventil
among
infant
set
patient
method
inclusionfirst
episod
bronchiol
infant
less
monthsold
room
air
mwca
score
exclus
urgent
need
niv
mwca
lack
consent
random
standard
oxygen
therapi
l
min
control
hfnc
l
kg
min
experiment
crossov
nt
allow
failur
nasal
flow
oxygen
min
maintain
target
increas
mwca
score
refractori
apnea
increas
primari
endpointproport
patient
treatment
failur
requir
noninvas
within
follow
random
secondari
endpointpercentag
admit
icu
assess
short
term
respiratori
statu
gener
ward
unit
lo
oxygen
nutrit
support
free
day
result
month
studi
period
patient
admit
bronchiol
ped
network
screen
underw
random
intentiontotreat
analysi
tabl
hfnc
nt
improv
primari
outcom
failur
occur
patient
hfnc
group
control
group
ic
p
hfnc
nt
reduc
risk
admiss
icu
hfnc
group
versu
control
ic
p
patient
intub
main
reason
treatment
failur
worsen
mwca
score
mean
lo
gener
ward
unit
lower
control
group
day
versu
day
p
shortterm
assess
respiratori
statu
nt
shown
differ
except
mwca
score
rr
favor
hfnc
three
pneumothorax
report
hfnc
group
conclus
neither
evid
lower
rate
noninvas
ventil
support
among
patient
receiv
hfnc
therapi
differ
rate
icu
admiss
introduct
patient
septic
shock
may
develop
sever
myocardi
dysfunct
refractori
medic
treatment
sever
cohort
casereport
studi
report
salvag
therapi
venoarteri
extracorpor
membran
oxygen
vaecmo
patient
aim
studi
assess
use
vaecmo
rescu
therapi
refractori
myocardi
dysfunct
associ
septic
shock
patient
method
multicent
intern
retrospect
studi
patient
ecmo
center
implant
vaecmo
rescu
therapi
refractori
septic
shock
sever
myocardi
dysfunct
cardiac
index
l
min
left
ventricular
eject
fraction
includ
control
patient
exhibit
sever
myocardi
dysfunct
period
time
receiv
ecmo
isol
larg
septic
shock
databas
includ
first
day
met
criteria
sever
myocardi
dysfunct
ecmo
nonecmo
patient
outcom
compar
match
diseas
sever
primari
end
point
mortal
day
result
mean
sd
n
shown
eightytwo
patient
rescu
vaecmo
includ
patient
exhibit
extrem
sever
myocardi
dysfunct
mean
cardiac
index
l
min
left
ventricular
eject
fraction
despit
high
dose
catecholamin
mean
inotrop
score
kg
min
also
profound
lactic
acidemia
ph
lactatemia
mmoll
sever
multipl
organ
failur
sofa
score
sapsii
score
seventyeight
could
match
nonecmo
patient
base
propens
score
diseas
sever
lactatemia
cardiac
index
sofa
score
mortal
day
dramat
reduc
match
ecmo
patient
compar
control
vs
p
sensit
analysi
patient
cardiac
index
monitor
weight
use
match
weight
ponder
inotrop
score
lactatemia
sofa
score
age
cardiac
index
inclus
mortal
day
remain
significantli
reduc
weight
ecmo
patient
final
survivor
ecmo
group
report
accept
evalu
healthrel
qualiti
life
month
follow
icu
discharg
conclus
retrospect
propensitymatch
studi
rescu
therapi
vaecmo
associ
dramat
reduct
day
mortal
patient
refractori
septic
shock
sever
myocardi
dysfunct
beringu
speaker
introduct
fluid
expans
first
therapeut
option
patient
present
acut
circulatori
failur
hemodynam
effect
persist
time
maxim
increas
cardiac
output
unknown
sought
describ
time
cours
cardiac
output
period
fluid
expans
object
identifi
pattern
fluid
respons
determin
time
maxim
increas
cardiac
output
fluid
expans
patient
method
prospect
multicentr
observ
studi
conduct
four
intens
care
unit
includ
mechan
ventil
patient
acut
circulatori
failur
infus
norepinephrin
equip
transpulmonari
thermodilut
devic
picco
decis
fluid
expans
ml
salin
standard
period
made
calibr
achiev
two
hour
fluid
expans
transpulmonari
thermodilut
deriv
indic
collect
twohour
period
observ
fluid
respons
defin
increas
cardiac
index
start
fluid
expans
four
pattern
fluid
respons
predefinednev
respond
ultrafast
respond
end
fluid
expans
shortterm
respond
end
fluid
expans
persist
respond
observ
period
chang
drug
dosag
ventilatori
set
allow
studi
result
fiftyeight
patient
case
includ
septic
shock
main
reason
acut
circulatori
failur
pattern
fluid
respons
followingsnonrespond
ultrafast
respond
shortterm
respond
persist
respond
addit
patient
hemodynam
instabl
requir
second
fluid
expans
protocol
signific
differ
found
pattern
term
baselin
hemodynam
characterist
drug
administr
increas
cardiac
output
maxim
second
never
respond
second
ultrafast
respond
second
shortterm
respond
second
persist
respond
conclus
persist
fluid
respons
occur
minor
patient
present
acut
circulatori
failur
maxim
increas
cardiac
output
could
observ
fluid
expans
min
introduct
fluid
compos
molar
sodium
lactat
recent
identifi
benefici
endotoxin
anim
object
work
evalu
effect
molar
sodium
lactat
microand
macrocircul
capillari
leakag
differ
biolog
paramet
sepsi
rat
model
caecal
ligat
punctur
clp
patient
method
realiz
clp
rat
random
group
n
per
group
sham
clpnacl
clplactat
immedi
clp
fluid
infus
intraven
ml
kg
h
h
evalu
mesenter
microcircul
laser
speckl
imag
cardiac
function
echocardiographi
inflamm
uremia
albuminemia
vegfa
assay
capillari
leakag
use
blue
evan
extravas
lung
gut
realiz
addit
rat
n
group
result
express
median
interquartil
comparison
versu
clpnacl
realiz
use
kruskallw
anova
test
pg
ml
p
differ
observ
syndecan
plasma
level
conclus
demonstr
first
time
molar
lactat
fluid
perfus
protect
clpinduc
cardiovascular
dysfunct
mesenter
microvascular
alter
capillari
leakag
associ
signific
reduct
inflammatori
process
result
suggest
molar
lactat
fluid
perfus
may
attract
target
treatment
sepsi
introduct
invas
candidiasi
ic
associ
high
incid
mortal
intens
care
unit
icu
delay
antifung
therapi
ic
contribut
poor
outcom
icu
none
predict
publish
risk
score
abl
accur
predict
ic
therefor
new
score
introduc
previou
antiinfect
therapi
elaps
time
admiss
risk
evalu
differenti
candidemia
invas
candidiasi
develop
patient
method
retrospect
analysi
data
outcomerea
prospect
multicent
cohort
critic
ill
patient
icu
length
stay
least
day
includ
multivari
subdistribut
surviv
model
compet
risk
use
day
day
day
use
landmark
method
slide
window
horizon
day
impact
everi
identifi
risk
analys
candidemia
invas
viscer
candidiasi
ivccandida
periton
pleural
candidiasi
separ
compet
risk
icudeath
icudischarg
predict
probabl
infect
next
day
calcul
day
base
cumul
incid
function
everi
combin
risk
result
patient
includ
candidemia
occur
patient
ivc
patient
antifung
therapi
use
patient
multivari
analysi
risk
factor
candidemia
ivc
identifi
figur
confirm
impact
previous
describ
risk
factor
ie
septic
shock
multifoc
colon
sofa
score
hospit
stay
icu
parenter
nutrit
corticosteroid
blood
transfus
mechan
ventil
surgeri
risk
differ
associ
candidemia
ivc
variabl
corticosteroid
therapi
blood
transfus
mechan
ventil
associ
candidemia
risk
time
depend
impact
earli
state
landmark
time
late
onset
landmark
time
day
antibiotherapi
broad
spectrum
piperacillintazobactam
number
ppi
day
use
medic
histori
cancer
associ
ivc
landmark
time
predict
model
found
maximum
predict
probabl
landmark
respect
candidemia
ivc
shini
app
develop
comput
predict
risk
candidemia
ivc
depend
risk
factor
combin
conclus
risk
factor
candida
infect
differ
candidemia
ivc
must
analys
distinct
diseas
moreov
risk
highli
timerel
earli
late
pattern
icu
stay
introduct
adult
onset
still
diseas
aosd
rare
complex
autoinflammatori
disord
sever
system
lifethreaten
manifest
empir
treatment
object
describ
clinic
featur
manag
outcom
aosd
patient
requir
intens
care
support
patient
method
undertook
retrospect
multicent
cohort
studi
french
academ
icu
januari
june
includ
case
icu
admiss
relat
lifethreaten
aosd
patient
older
year
consid
inclus
met
follow
criteria
admiss
icu
relat
system
aosd
flare
accord
yamaguchi
fautrel
criteria
studi
methodolog
data
privaci
polici
french
methodolog
refer
approv
institut
ethic
committe
applic
regist
clinicaltrialsgov
result
fortyf
patient
includ
median
age
quartil
year
men
affect
women
first
aosd
flare
popul
median
sap
ii
cardiocirculatori
shock
pericard
respiratori
acut
respiratori
distress
syndrom
hematolog
reactiv
hemophagocyt
syndrom
disord
frequent
lifethreaten
manifest
multipl
organ
failur
frequent
associ
bad
prognosi
present
admiss
p
nine
patient
die
median
age
year
among
previous
diagnos
aosd
versu
without
previou
diagnosi
p
comparison
survivor
nonsurvivor
icu
stay
shown
tabl
corticosteroid
cs
use
first
line
therapi
patient
efficaci
cs
monotherapi
three
patient
success
treat
anakinra
global
efficaci
four
patient
sever
organ
failur
admiss
die
despit
treatment
anakinra
introduc
sever
line
immunosuppress
agent
cyclosporin
etoposid
intraven
immunoglobulin
ann
intens
care
suppl
conclus
herein
report
largest
cohort
patient
admit
icu
lifethreaten
aosd
lead
lifethreaten
present
miscellan
present
clinic
spectrum
high
mortal
rate
among
young
peopl
previou
diagnosi
aosd
lack
specif
clinic
biolog
sign
frequent
cardiovascular
collaps
key
point
quickli
elimin
septic
diagnosi
add
immunosuppress
treatment
empir
antibiotherapi
septic
shock
among
patient
system
lupu
erythematosusshort
longterm
outcom
associ
cost
analysi
french
nationwid
databas
arthur
mageau
speaker
karim
sacr
ann
perozziello
ruckli
clairedupui
lila
bouadma
thoma
papo
timsit
introduct
plasma
exchang
pe
often
lead
advers
effect
sepsi
result
impair
immun
caus
remov
antibodi
relat
catheterassoci
infect
repres
sever
complic
studi
evalu
infecti
risk
associ
current
use
pe
identifi
predict
factor
patient
method
major
patient
admit
tertiari
icu
receiv
pe
therapi
includ
patient
develop
secondari
infect
compar
use
univari
multivari
analysi
result
eightyeight
patient
underw
pe
procedur
patient
mechan
ventil
receiv
constrict
drug
renal
replac
therapi
indic
thrombot
thrombocytopen
purpura
neurolog
diseas
vascul
autoimmun
diseas
indic
advers
effect
perprocedur
observ
patient
witch
half
lifethreathen
peassoci
infect
occur
patient
median
time
elaps
icu
admiss
ep
initi
infect
diagnosi
respect
day
infecti
complic
includ
ventilationassoci
pneumonia
nosocomi
pneumonia
viral
reactiv
bacteremia
catheterassoci
infect
urinari
infect
sever
septic
shock
patient
patient
deceas
comparison
univari
analysi
show
patient
associ
infect
significantli
higher
age
need
frequent
mechan
ventil
vasoact
drug
number
pe
icu
inhospit
length
stay
significantli
higher
infecti
group
signific
differ
observ
infecti
infecti
group
regard
sever
score
admiss
corticoid
immunosuppress
therapi
type
substitut
liquid
pe
volum
multivari
analysi
age
p
number
session
ci
p
requir
mechan
ventil
p
predict
infect
occurr
icu
mortal
higher
infecti
group
versu
p
conclus
pe
associ
infect
particular
pneumonia
patient
lead
lifethreaten
condit
age
number
pe
session
requir
mechan
ventil
predict
occurr
infect
romar
larcher
speaker
introduct
lung
fibroprolifer
ard
patient
associ
mortal
alveolar
procollagen
iii
ntpcpiii
biomark
lung
fibroprolifer
chest
ct
scan
could
use
diagnosi
fibroprolif
radiolog
lesion
main
object
present
studi
therefor
quantifi
chest
ct
scan
lesion
ard
patient
high
alveolar
level
ntpcpiii
indic
activ
fibroprolifer
patient
method
retrospect
cohort
studi
year
januari
includ
ard
least
one
dosag
alveolar
ntpcpiii
obtain
perform
bronchoalveolar
lavag
bal
chest
ct
scan
within
day
bal
accord
previou
studi
alveolar
level
ntpcpiii
l
indic
histolog
lung
fibroprolifer
ct
scan
score
interstiti
honeycomb
alveolar
groundglass
abnorm
crude
score
correct
score
relat
number
score
lobe
case
import
lobar
condens
use
result
one
hundr
ninetytwo
patient
includ
either
coupl
alveolar
ntpcpiii
ct
scan
use
threshold
ntpcpiii
l
crude
correct
fibrosi
score
highest
lung
fibroprolifer
present
valu
lung
fibroprolifer
ct
scan
score
accord
alveolar
ntpcpiii
level
appear
tabl
median
delay
onset
ard
ct
scan
day
onset
ard
day
bal
ct
scan
day
conclus
alveolar
ntpcpiii
use
surrog
lung
fibroprolifer
ct
scan
fibrosi
score
significantli
higher
patient
activ
pulmonari
fibroprolifer
introduct
ultraprotect
ventil
tidal
volum
vt
reduct
ml
kg
predict
bodi
weight
pbw
sever
ard
may
reduc
alveolar
strain
drive
pressur
henc
ventilatorinduc
lung
injuri
main
drawback
worsen
respiratori
acidosi
hypothes
vt
could
reduc
ml
kg
clinic
signific
decreas
drive
pressur
deltap
without
need
extracorpor
remov
maintain
ph
rang
target
recent
ard
trial
patient
method
conduct
nonexperiment
beforeandaft
multicent
studi
ard
patient
mm
hg
within
h
ard
diagnosi
inclus
vt
reduc
ml
kg
pbw
adjust
maintain
ph
respiratori
rate
increas
min
peep
set
use
tabl
favor
high
peep
strategi
appli
posit
peep
wean
trial
primari
judgment
criterion
deltap
day
compar
studi
inclus
result
patient
age
year
sap
ii
amount
patient
pneumonia
ard
risk
factor
sofa
inclus
inclus
mm
hg
peep
inclus
day
deltap
decreas
significantli
vt
decreas
ml
kg
day
studi
tabl
vt
ml
kg
patient
ml
kg
patient
time
vt
ml
kg
averag
day
sedat
drug
significantli
modifi
two
patient
develop
acut
cor
pulmonal
inclus
right
ventricl
left
ventricl
ratio
increas
nonsignificantli
day
eleven
patient
present
sever
respiratori
acidosi
ph
fourteen
patient
die
day
conclus
ultraprotect
ventil
may
appli
approxim
moder
sever
sever
ard
patient
mean
reduct
deltap
approxim
price
sever
respiratori
acidosi
patient
vasopressor
introduct
earli
prolong
repeat
session
prone
posit
pp
proven
substanti
outcom
benefit
ard
patient
sever
form
ard
veno
venou
extracorpor
membran
oxygen
vvecmo
consid
therapeut
option
perform
case
case
patient
treat
vvecmo
previous
turn
prone
howev
studi
evalu
interest
maintain
pp
ecmo
therefor
object
studi
compar
surviv
rate
patient
support
vvecmo
concomit
pp
prone
ecmo
group
turn
prone
ecmo
period
ecmo
alon
group
includ
adult
treat
vvecmo
ard
januari
april
univers
teach
hospit
marseil
franc
patient
either
cannul
icu
refer
hospit
transport
ecmo
mobil
team
consid
patient
ecmo
pp
session
systemat
perform
center
feasibl
strongli
encourag
patient
referr
center
criteria
vvecmo
previous
publish
ecmo
patient
consid
prone
posit
case
persist
hypoxemia
defin
mmhg
despit
maxim
ecmo
blood
flow
failur
attempt
wean
ecmo
least
day
ecmo
presenc
lung
consolid
chest
xray
ultrasound
echographi
accord
physician
charg
technic
issu
previous
describ
compar
prone
ecmo
group
ecmo
alon
group
perform
kaplanmei
surviv
curv
coxmodel
mortal
result
patient
includ
analysi
prone
group
ecmo
alon
group
prone
group
surviv
rate
compar
surviv
rate
ecmo
alon
group
p
hr
introduct
emphasi
regard
import
earli
cardiopulmonari
resuscit
cpr
defibril
led
improv
outcom
cardiac
arrest
ca
meanwhil
recent
data
rais
concern
regard
benefit
target
temperatur
manag
ttm
comatos
cardiac
arrest
survivor
may
result
loss
interest
ttm
patient
uncertain
consequ
outcom
use
data
sudden
death
expertis
center
sdec
great
pari
area
assess
relationship
chang
time
use
ttm
patient
outcom
adjust
potenti
confound
patient
method
use
data
prospect
collect
sdec
registri
may
decemb
variabl
collect
accord
utstein
style
nontraumat
ohca
patient
stabl
return
spontan
circul
rosc
includ
analysi
compar
patient
characterist
outcom
accord
ttm
use
perform
multivari
logist
regress
use
surviv
icu
discharg
main
endpoint
result
studi
period
patient
retain
analysi
receiv
ttm
compar
control
patient
ttm
significantli
frequent
male
younger
ca
occur
frequent
public
place
shockabl
rhythm
frequent
proport
patient
short
noflow
min
greater
p
regard
time
trend
gender
age
locat
ca
chang
accord
year
inclus
registri
bystand
cpr
increas
patient
p
rate
shockabl
rhythm
increas
p
rate
patient
noflow
min
decreas
p
figur
ttm
use
decreas
time
p
meanwhil
surviv
rate
icu
discharg
increas
significantli
patient
p
figur
multivari
analysi
year
ca
occurr
associ
outcom
icu
discharg
ttm
use
decreas
year
driven
particular
utstein
criteria
conclus
report
improv
time
icu
surviv
postca
patient
appear
mostli
associ
increas
bystand
cpr
higher
rate
shockabl
rhythm
ttm
use
declin
year
subgroup
ca
patient
evid
consequ
regard
outcom
marin
paul
speaker
introduct
postresuscit
shock
high
incid
cardiac
arrest
ca
due
wholebodi
ischemiareperfus
may
complic
multipl
organ
failur
mof
death
mesenter
ischemia
mi
may
occur
set
incid
outcom
poorli
document
perform
retrospect
monocentr
studi
aim
describ
characterist
outcom
mi
ca
consecut
patient
admit
tertiari
ca
center
confirm
mi
icu
stay
studi
mi
confirm
endoscopi
abdomin
ctscan
surgic
laparotomi
result
among
ca
postca
patient
mi
clinic
suspect
patient
confirm
patient
median
age
year
median
time
ca
cardiopulmonari
resuscit
cpr
min
time
cpr
return
spontan
circul
min
patient
initi
shockabl
rhythm
receiv
epinephrin
cpr
patient
develop
postresuscit
shock
median
initi
blood
lactat
mmoll
delay
ca
diagnosi
mi
day
mostli
clinic
abdomin
symptom
includ
hemorrhag
feed
intoler
confirm
ct
scan
abnorm
lower
digest
endoscopi
despit
surgic
intestin
resect
perform
patient
icu
mortal
patient
surviv
good
neurolog
outcom
caus
death
mof
postanox
brain
injuri
despit
recoveri
initi
shock
cohort
observ
mi
ca
uncommon
complic
associ
poor
outcom
effort
made
order
obtain
earlier
recognit
mi
patient
preserv
brain
function
preliminari
result
need
confirm
multicentr
studi
introduct
botul
rare
potenti
sever
neuroparalyt
diseas
caus
neurotoxin
produc
case
clostridium
botulinum
treatment
mainli
consist
life
support
techniqu
specif
medic
antitoxin
franc
guidelin
regard
use
antitoxin
avail
temporari
author
use
primari
goal
studi
describ
evalu
morbid
mortal
sever
adult
botul
icu
franc
secondari
goal
evalu
current
patient
care
french
icu
especi
concern
administr
antitoxin
patient
method
conduct
retrospect
observ
multicent
studi
french
icu
among
adult
icu
unit
agre
particip
patient
data
collect
standardis
crf
includ
patient
age
year
age
admit
icu
januari
june
acut
botul
studi
protocol
approv
srlf
ethic
committe
data
collect
conduct
accord
french
law
cnil
recommend
result
among
particip
unit
nt
identifi
botul
case
unabl
collect
patient
data
twentyeight
icu
identifi
patient
admiss
median
iqr
age
year
patient
male
patient
foodborn
botul
median
sap
ii
clinic
present
ocular
symptom
especi
diplopia
ptosi
oropharyng
symptom
especi
swallow
impair
frequent
usual
first
describ
patient
intub
median
durat
mechan
ventil
day
maximum
day
tracheotomi
perform
patient
median
icu
hospitalis
durat
day
current
botul
episod
associ
sequela
evalu
modifi
rankin
scale
icu
discharg
hospit
discharg
last
followup
patient
respect
score
two
patient
die
hospitalis
icu
stay
twentyf
patient
treat
botul
antitoxin
unabl
show
signific
differ
outcom
patient
treat
treat
antitoxin
conclus
although
botul
rare
caus
death
nowaday
potenti
sever
diseas
high
morbid
possibl
extend
hospitalis
mechan
ventil
recent
studi
favour
use
antitoxin
clear
recommend
need
introduct
nangibotid
peptid
specif
inhibitor
preclin
septic
shock
model
nangibotid
abl
restor
appropri
inflammatori
respons
vascular
function
improv
surviv
phase
nangibotid
found
safe
well
toler
highest
dose
patient
method
intern
multicent
phase
iia
random
doubleblind
twostag
placebocontrol
studi
main
inclus
criteria
septic
shock
accord
sepsi
definit
nangibotid
initi
within
h
shock
onset
patient
random
receiv
either
placebo
mg
kg
h
nangibotid
studi
drug
infus
end
vasopressor
h
day
safeti
data
review
independ
data
safeti
monitor
board
dsmb
primari
endpoint
safeti
toler
patient
followup
period
day
result
patient
random
treat
patient
die
dose
group
well
balanc
term
baselin
characterist
except
apach
ii
score
tend
nonsignificantli
lower
placebo
group
primari
infect
sourc
abdomin
pulmonari
urinari
nangibotid
safe
well
toler
group
dsmb
rais
safeti
concern
number
sae
ae
number
patient
sae
ae
compar
group
frequent
ae
atrial
fibril
anemia
pleural
effus
thrombocytopenia
trend
toward
decreas
circul
level
pharmacodynam
marker
observ
nangibotidetr
patient
allcaus
mortal
pool
nangibotid
group
placebo
group
subgroup
level
median
mortal
calcul
placebo
nangibotid
group
respect
group
high
level
trend
toward
increas
organ
support
free
day
aliv
seen
nangibotidetr
patient
versu
placebo
conclus
nangibotid
shown
safe
well
toler
septic
shock
patient
although
small
exploratori
studi
power
conclud
efficaci
non
signific
lower
mortal
observ
nangibotid
group
result
support
need
larger
studi
demonstr
role
nangibotid
treatment
septic
shock
explor
potenti
efficaci
predict
biomark
nangibotid
anxieti
depress
patient
admit
icu
hresult
multicentr
observ
prospect
moodicu
studi
camil
vissac
speaker
introduct
sever
studi
publish
psychiatr
disord
intens
unit
icu
risk
factor
associ
disord
studi
evalu
frequenc
anxieti
depress
disord
icu
stay
patient
method
main
object
prospect
multicentr
observ
studi
assess
rate
patient
anxieti
depress
icu
secondari
object
assess
rate
patient
anxiolyt
antidepress
drug
identifi
factor
associ
anxieti
depress
icu
patient
hospit
sinc
h
icu
studi
day
elig
evalu
patient
anxieti
depress
symptom
perform
bedsid
physician
nurs
care
patient
day
studi
p
read
book
cargiv
rel
icu
stay
ci
p
organ
failur
independ
associ
less
anxieti
depress
ci
p
conclus
anxieti
depress
symptom
common
critic
ill
patient
icu
stay
histori
anxieti
depress
announc
sever
ill
loss
autonomi
tracheostomi
antipsychot
medic
read
book
caregiv
associ
increas
risk
anxieti
depress
disord
icu
howev
sever
critic
ill
associ
decreas
risk
anxieti
depress
futur
studi
requir
assess
relationship
anxieti
depress
disord
icu
stay
introduct
increas
number
death
occur
icu
set
research
focus
describ
understand
improv
endoflif
care
well
improv
patient
famili
experi
aim
studi
describ
evalu
experi
physician
nurs
involv
endoflif
situat
icu
describ
factor
associ
poor
good
score
patient
method
questionnair
valid
multicent
prospect
studi
conduct
juli
juli
french
icu
icu
consecut
adult
die
least
h
admiss
icu
includ
physician
nurs
charg
patient
time
death
ask
complet
questionnair
within
h
death
psychometr
valid
conduct
use
two
datasetsa
learn
cohort
valid
cohort
result
among
patient
nurs
score
physician
score
analyz
median
global
caesar
score
nurs
physician
lower
nurs
score
significantli
associ
follow
factorsconflict
physician
pain
manag
nurs
alon
rather
physician
death
disclos
famili
phone
upon
arriv
rather
bedsid
use
invas
treatment
end
life
higher
physician
score
significantli
associ
follow
factorsavail
dedic
inform
room
joint
famili
inform
nurs
total
rather
partial
famili
inform
joint
implement
nurs
decis
withdraw
withhold
therapi
open
visit
polici
higher
score
also
associ
patient
characteristicsmccab
immunocompromis
dementia
liver
failur
haematolog
diseas
use
psychotrop
medic
last
higher
score
associ
end
life
conditionsdecis
withdraw
withhold
therapi
cardiopulmonari
resuscit
death
disclos
famili
bedsid
rather
phone
upon
arriv
icu
conclus
describ
valid
new
instrument
assess
experi
physician
nurs
involv
endoflif
situat
icu
studi
show
import
area
improv
practic
includ
adapt
level
intens
care
qualiti
teamwork
qualiti
commun
implic
famili
member
effici
combin
geriatr
intensivist
evalu
identifi
cluster
elderli
patient
admit
intens
care
unit
seniorea
studi
julien
demisel
speaker
introduct
improv
care
older
patient
icu
challeng
term
surviv
qualiti
life
qol
set
prospect
observ
assess
effect
combin
geriatr
intensivist
initi
evalu
determin
cluster
older
patient
oneyear
outcom
cluster
patient
method
patient
age
year
older
admit
icu
western
franc
requir
mechan
ventil
septemb
decemb
includ
proxi
member
consult
icu
admiss
use
predefin
comprehens
geriatr
assess
surviv
assess
one
year
comprehens
geriatr
assess
perform
place
live
survivor
cluster
perform
base
baselin
characterist
icu
admiss
paramet
use
jaccard
similar
measur
result
five
hundr
one
patient
includ
analysi
age
year
male
ninetytwo
percent
patient
live
home
icu
admiss
mean
comorbid
burden
assess
cirsg
score
patient
adl
score
sofa
icu
admiss
cluster
result
three
group
group
n
character
older
age
lower
comorbid
burden
intermedi
acut
sever
group
n
character
lower
age
intermedi
comorbid
higher
acut
sever
group
n
higher
age
higher
comorbid
lower
acut
sever
patient
could
cluster
due
incomplet
data
cluster
experienc
differ
trajectori
throughout
icu
stay
higher
icu
mortal
group
highest
amount
organ
support
moreov
cluster
evolut
differ
hospit
discharg
overal
oneyear
surviv
mortal
higher
group
compar
group
p
see
figur
patient
survivor
underw
oneyear
athom
evalu
moder
decreas
independ
observ
perceiv
qol
remain
satisfactori
patient
indic
happi
happi
differ
oneyear
geriatr
evalu
observ
cluster
conclus
comprehens
geriatr
assess
acut
sever
paramet
use
identifi
three
differ
pattern
patient
differ
outcom
pattern
may
use
design
futur
intervent
studi
long
term
surviv
older
patient
icu
stay
improv
compar
previou
studi
uniqu
blood
cultur
icu
associ
dramat
reduct
blood
cultur
contamin
rate
interrupt
timeseri
studi
rafael
mahieu
speaker
sensibl
depend
volum
collect
blood
falseposit
bc
may
aris
blood
contamin
venipunctur
object
assess
effect
uniqu
highvolum
blood
cultur
ubc
strategi
rate
bc
contamin
pathogen
detect
patient
method
interrupt
timeseri
studi
conduct
medic
icu
januari
decemb
ubc
protocol
implement
januari
patient
suspect
bacteri
infect
ml
blood
collect
singl
phlebotomi
ten
millilit
blood
inocul
two
bact
alert
fa
aerob
bottl
two
bact
alert
fn
anaerob
bottl
perform
addit
blood
cultur
within
h
strongli
discourag
unless
new
bloodstream
infect
suspect
nurs
physician
knowledg
bc
collect
practic
skill
reinforc
educ
program
decemb
protocol
adher
evalu
month
monitor
bc
volum
result
studi
period
icu
stay
least
one
bc
differ
observ
two
period
regard
sever
sofa
admiss
inicu
death
educ
program
median
volum
blood
cultur
per
bottl
increas
ml
confid
interv
ci
ml
month
decreas
ml
introduct
extend
followup
icu
survivor
shown
mani
patient
suffer
longterm
physic
psycholog
sequala
ptsd
increasingli
psychiatr
disord
report
icu
survivor
aim
determin
frequenc
ptsd
predictor
patient
method
mix
method
studi
conduct
medic
icu
januari
januari
data
obtain
medic
record
month
posticu
discharg
patient
contact
phone
complet
impact
event
scalerevis
questionnair
iesr
univari
logist
regress
analys
use
identifi
variabl
independ
associ
iesr
result
patient
admit
studi
period
discharg
aliv
never
success
contact
die
within
month
period
patient
fulfil
inclus
criteria
patient
characterist
mean
age
year
male
median
charlson
comorbid
index
mean
sapsii
invas
mechan
ventil
imv
vasopressor
use
median
durat
imv
length
stay
respect
day
day
patient
met
diagnost
criteria
ptsd
univari
analysi
risk
factor
ptsd
respect
ptsd
group
control
age
vs
p
femal
sex
vs
p
alcohol
vs
p
imv
vs
p
sed
use
vs
p
polyneuromyopathi
vs
p
delirium
vs
p
catheter
vs
p
durat
imv
vs
p
physic
restraint
vs
p
multivari
logist
regress
age
ci
p
femal
sex
ci
p
physic
restraint
ci
p
polyneuromythi
ci
p
identifi
risk
factor
independ
associ
ptsd
conclus
ptsd
common
icu
survivor
physic
restraint
femal
sex
polyneuromyopathi
younger
age
factor
independ
associ
ptsd
guh
fire
caus
total
evacu
unpreced
event
franc
report
factual
element
first
day
disast
involv
intens
care
unit
icu
activ
specif
propos
impos
respons
sole
icu
guadeloup
island
near
half
million
peopl
patient
method
data
extract
icu
medic
file
experi
report
emerg
depart
softwar
result
fire
start
around
floor
build
icu
floor
oper
room
floor
icu
occupi
bed
includ
ventil
patient
invad
thick
smoke
trigger
fire
alarm
evacu
icu
decid
doctor
activ
offici
evacu
plan
h
absenc
administr
instruct
ventil
patient
reloc
radiolog
level
access
medic
gase
nonventil
patient
evacu
outdoor
car
park
patient
servic
patient
extract
icu
patient
evacu
ventil
patient
bass
terr
public
hospit
post
anesthesia
care
unit
ventil
patient
nonventil
patient
privat
hospit
locat
km
unit
ambulatori
surgeri
bed
thu
day
reaffect
icu
patient
per
room
icu
patient
evacu
guh
patient
priorit
medic
evacu
martiniqu
univers
hospit
muh
thank
militari
vector
patient
simultan
casa
militari
aircraft
medic
helicopt
samu
wors
initi
progress
note
except
patient
septic
shock
need
intub
norepinephrin
radiolog
level
icu
activ
heavili
impact
period
difficulti
relat
emerg
servic
medicosurg
servic
support
structur
laboratori
radiolog
pharmaci
rearrang
conclus
disastr
never
experienc
situat
limit
immedi
impact
death
due
fast
manag
patient
transfer
relat
icu
doctor
initi
region
support
muh
militari
vector
help
propos
immedi
respons
sever
icu
patient
midand
longterm
consequ
signific
evacu
patient
well
guadeloup
care
provis
term
icu
hospit
compon
relat
distanc
away
franc
evalu
descript
alarm
intens
care
unit
improv
profession
practicesoptim
monitor
reduc
nois
pollut
pierreyv
delannoy
speaker
lydi
martel
nicola
boussekey
damien
thellier
hugu
georg
olivi
robineau
olivi
leroy
ch
marcq
en
baroeul
franc
ch
tourco
franc
correspond
pierreyv
delannoy
pydelannoy
chtourcoingfr
annal
intens
care
suppl
introduct
excess
alarm
intens
care
multipl
consequencesth
nois
gener
alter
qualiti
patient
stay
particip
genesi
phenomenon
call
alarm
fatigu
alter
qualiti
surveil
directli
impact
patient
safeti
pejor
term
object
project
improv
qualiti
care
work
condit
intens
care
unit
tourco
optim
monitor
patient
collabor
medic
team
compani
provid
monitor
product
patient
method
analysi
alarm
philip
intelivu
monitor
one
month
perform
correct
measur
reduc
number
implement
collabor
dmaic
approach
defin
measur
analyz
improv
control
correct
measur
includ
person
monitor
medic
reflect
alarm
threshold
creation
specif
profil
patient
train
caregiv
good
use
monitor
creation
alarm
cultur
via
train
creation
commun
tool
action
ad
technic
intervent
intens
care
ventil
monitor
impact
alarm
caregiv
patient
present
analysi
period
evalu
use
questionnair
second
alarm
analysi
assess
evalu
effect
implement
measur
result
alarm
equival
alarm
day
patient
includ
vital
alarm
critic
techniqu
found
first
period
analysi
patient
questionnair
contribut
usabl
questionnair
among
respond
major
feel
signific
discomfort
stay
health
questionnair
respons
rate
n
respond
believ
decreas
attent
increas
reaction
time
due
fals
alarm
also
believ
irrelev
alarm
disrupt
qualiti
patient
stay
better
alarm
manag
could
prevent
incid
nearli
caregiv
say
alarm
could
heard
miss
second
period
reduct
total
number
alarm
alarm
equival
alarm
day
patient
p
obtain
conclus
creat
implement
target
correct
measur
dmaic
approach
reduct
number
alarm
achiev
reduct
probabl
enhanc
patient
safeti
improv
healthcar
environ
patient
caregiv
routin
use
electron
medic
data
manag
system
drive
prescript
red
blood
cell
transfus
canadian
british
pediatr
intens
care
unit
camil
jutra
speaker
introduct
physician
know
follow
patient
wish
unabl
express
assess
impact
advanc
direct
ad
written
physician
decis
patient
method
multicentr
prospect
intervent
simul
studi
carri
eight
patient
recruit
wrote
ad
receiv
clear
complet
inform
video
interview
one
icu
physician
two
simul
scenario
includ
ten
question
icu
admiss
situat
withhold
withdraw
therapi
use
patient
characterist
submit
icu
physician
french
icu
three
round
r
simul
without
knowledg
patient
ad
ad
ad
knowledg
carri
result
qualit
analysi
ad
highlight
form
live
endoflif
formal
guidelin
medic
care
result
perform
complet
data
physician
figur
variabl
physician
highamong
question
question
agreement
respect
ad
significantli
decreas
number
question
agreement
increas
number
question
agreement
p
differ
round
p
physician
characterist
associ
interindividu
variabl
intraindividu
variabl
high
question
kappa
coeffici
k
ad
significantli
associ
variabl
adjust
characterist
physician
patient
p
relev
notic
knowledg
ad
carri
low
impact
physician
decis
discuss
expect
find
help
ad
patient
diminish
variabl
among
physician
respect
patient
autonomi
variabl
physician
increas
studi
assum
variabl
reflect
differ
interpret
ad
among
physician
ad
major
impact
physician
decis
admiss
withhold
withdraw
therapi
decis
increas
interindividu
variabl
knowledg
ad
written
might
limit
autonom
model
among
patient
whose
known
express
opposit
therapeut
relentless
patient
gener
practition
interview
meet
made
patient
frequent
therapeut
limit
cardiac
arrest
resuscit
renal
replac
therapi
invas
mechan
ventil
limit
case
nutrit
hydrat
never
limit
conclus
ten
year
set
wwt
procedur
icu
limit
frequent
appear
earlier
concern
younger
patient
often
paramed
initi
reflect
stronger
involv
caregiv
end
life
issu
introduct
patient
refer
intens
care
unit
icu
refus
intensivist
consid
well
ill
benefit
intens
care
treatment
studi
aim
evalu
factor
associ
decis
refus
icu
admiss
assess
outcom
exclud
patient
patient
method
inpati
refer
icu
februari
august
includ
analysi
patient
evalu
emerg
unit
hospit
area
senior
intensivist
refus
patient
consid
well
inappropri
referr
ir
ill
futil
icu
admiss
main
outcom
surviv
day
first
referr
icu
patient
characterist
number
bed
avail
time
referr
qualiti
life
day
icu
referr
also
assess
result
patient
admit
refus
reason
refus
futil
ill
n
ir
well
n
median
mortal
probabl
model
mpmii
score
ir
group
futil
group
day
admiss
request
came
emerg
unit
n
medic
depart
n
surgeri
depart
n
main
outcom
futil
ir
group
respect
futil
group
modifi
rankin
score
increas
inclus
final
evalu
lack
autonomi
elderli
peopl
dementia
main
caus
refus
futil
group
n
respect
conclus
refus
icu
admiss
occur
case
refus
futil
strongli
invari
associ
death
wherea
patient
consid
well
intens
care
treatment
rare
die
strategi
develop
creat
admiss
criteria
patient
antibiot
consumpt
differ
two
period
discuss
statist
signific
impact
antibiot
consumpt
fluoroquinolon
amoxicillinclanulan
acid
known
induc
resist
decreas
second
period
prescript
antibiot
improv
cefepim
enterobact
ceftazidim
ciprofloxacin
pseudomona
thu
save
colimycin
imipenem
cilastatin
nonsignific
trend
lower
multiresist
broadspectrum
betalactamaseproduc
bacteria
cephalosorinas
carbapenemas
screen
test
intervent
infectiologist
servic
allow
effect
adapt
strategi
antibiot
therapi
hope
come
year
select
bmr
decreas
inclus
postimplement
period
associ
increas
surviv
univari
analysi
vs
p
logrank
analysi
figur
yet
associ
statist
signific
adjust
patient
comorbid
sever
multivari
cox
model
adjust
hazard
ratio
ci
p
implement
multidisciplinari
multimod
care
bundl
nsti
associ
higher
patient
recruit
better
censor
surviv
univari
multivari
analysi
prior
home
ventil
associ
lower
rate
niv
failur
suggest
failur
technic
reason
highli
preval
seri
niv
failur
riskfactor
disclos
pertain
clinic
sever
decompens
caus
introduct
definit
septic
shock
includ
vasopressor
treatment
maintain
mean
arteri
pressur
mmhg
lactat
concentr
mmoll
impact
hyperoxia
patient
fulfil
criteria
unknown
patient
method
conduct
post
hoc
analysi
trial
includ
patient
requir
vasopressor
therapi
avail
plasma
lactat
valu
studi
inclus
compar
effect
hyperoxia
normoxia
treatment
mortal
patient
hyperlactatemia
mmoll
patient
requir
vasopressor
hypotens
without
hyperlactatemia
result
patient
enrol
analysi
lactat
mmoll
lactat
lower
equal
mmoll
among
patient
lactat
mmoll
hyperoxia
normoxia
treat
respect
patient
lactat
mmoll
significantli
less
coronari
arteri
diseas
cirrhosi
requir
surgeri
frequent
also
higher
ill
sever
sofa
vs
p
requir
renal
replac
therapi
rrt
receiv
vasopressor
mechan
ventil
longer
time
mortal
rate
day
higher
hyperoxia
treat
patient
lactat
mmoll
compar
normoxia
treat
patient
vs
p
despit
similar
rrt
requir
well
vasopressor
mechan
ventilationfre
day
multivari
analysi
show
independ
associ
hyperoxia
mortal
day
patient
lactat
mmoll
hyperoxia
effect
mortal
outcom
studi
suggest
hyperoxia
may
associ
higher
mortal
rate
patient
septic
shock
use
criteria
patient
hypotens
requir
vasopressor
without
hyperlactatemia
acut
respiratori
failur
obesityhypoventil
syndrom
manag
intens
care
unit
nader
chebib
speaker
introduct
critic
illnessrel
corticosteroid
insuffici
circi
common
critic
ill
usual
associ
poor
outcom
prolong
durat
mechan
ventil
mv
higher
mortal
circi
may
alter
cardiac
vascular
function
weaninginduc
pulmonari
oedema
wipo
major
mechan
wean
failur
aim
studi
evalu
role
circi
patient
difficult
ventil
wean
possibl
relat
wipo
patient
method
prospect
studi
conduct
intens
care
univers
hospit
franc
patient
mv
h
meet
wean
criteria
fail
first
spontan
breath
trial
sbt
underw
corticotropin
stimul
test
assess
total
blood
cortisol
level
immedi
mg
iv
tetracosactrin
min
afterward
defin
differ
maxim
valu
test
circi
defin
nmoll
nmoll
inadequ
adren
reserv
biomark
natriuret
peptid
protidemia
sampl
echocardiogram
perform
second
sbt
use
diagnos
wipo
defin
accord
two
definit
one
liber
one
conserv
deriv
figur
compar
counterpart
associ
persist
adjust
sever
sofa
score
first
sbt
wipo
occur
patient
accord
liber
conserv
definit
respect
wipo
associ
circi
inadequ
adren
reserv
influenc
wean
outcom
whatev
definit
use
conclus
circi
common
difficult
wean
associ
prolong
find
signific
associ
circi
wipo
introduct
highflow
nasal
cannula
oxygen
therapi
hfnc
recent
techniqu
provid
high
decreas
work
breath
recruit
lung
despit
promis
clinic
result
wean
never
investig
object
describ
factor
associ
success
wean
hfnc
patient
method
retrospect
monocent
studi
period
patient
admit
icu
treat
hfnc
acut
respiratori
failur
includ
patient
never
wean
hfnc
icu
stay
treat
hfnc
associ
niv
receiv
prevent
postextub
hfnc
exclud
primari
outcom
compar
patient
accord
outcom
first
hfnc
wean
attempt
secondari
outcom
compar
evolut
patient
fail
hfnc
wean
first
attempt
success
wean
hfnc
result
patient
includ
success
wean
hfnc
first
attempt
time
first
attempt
success
wean
lower
vs
p
like
correspond
mm
hg
vs
p
higher
rox
index
fail
p
patient
fail
first
attempt
significantli
increas
rox
index
time
success
wean
p
conclus
confirm
studi
rox
index
could
use
noninvas
predictor
success
hfnc
wean
avail
bedsid
introduct
recent
european
american
clinic
practic
guidelin
recommend
firstlin
noninvas
ventil
niv
manag
acut
hypoxem
respiratori
failur
immunocompromis
patient
contrast
nonimmunocompromis
patient
expert
unabl
offer
recommend
given
uncertainti
evid
immunocompromis
patient
particularli
high
mortal
rate
requir
invas
ventil
howev
clear
whether
immunosuppress
statu
risk
factor
niv
failur
aim
assess
influenc
immunosuppress
statu
outcom
patient
treat
niv
acut
respiratori
failur
patient
method
perform
post
hoc
analysi
pool
prospect
studi
acut
hypoxem
respiratori
failur
patient
treat
niv
includ
cardiogen
pulmonari
edema
acuteonchron
respiratori
failur
hypercapnia
exclud
result
among
patient
analyz
immunocompromis
whose
main
reason
cancer
n
immunocompromis
patient
higher
sever
score
upon
icu
admiss
like
bilater
lung
infiltr
receiv
higher
pressuresupport
level
niv
nonimmunocompromis
patient
intub
inicu
mortal
rate
higher
immunocompromis
patient
patient
vs
p
patient
vs
p
respect
use
multivari
analysi
immunosuppress
independ
associ
intub
adjust
ci
p
icu
mortal
ci
p
conclus
immunosuppress
statu
influenc
outcom
patient
acut
hypoxem
respiratori
failur
treat
niv
studi
specif
popul
mandatori
stephan
dauger
speaker
introduct
ventilatori
acquir
pneumonia
vap
one
main
nosocomi
infect
adult
icu
date
one
prospect
multicent
studi
perform
six
month
picu
us
prospect
describ
pediatr
vap
design
incipav
studi
report
occurr
vap
european
picu
one
aim
incipav
studi
precis
describ
diagnost
tool
use
pathogen
involv
pediatr
vap
patient
method
multicent
prospect
cohort
studi
includ
patient
mechan
ventil
mv
least
eight
picu
one
netherland
seven
franc
vap
defin
use
cdc
criteria
appli
picu
stay
exclud
h
preceed
follow
picu
patient
describ
admiss
main
risk
factor
ever
test
medic
litteratur
daili
includ
pediatr
intensivist
picu
electron
databas
secur
dedic
websit
ethic
committe
french
societi
intens
care
approv
studi
declar
cnil
record
clinicaltri
parent
legal
repres
individu
inform
dedic
sheet
descript
data
report
number
median
firstthird
quartil
result
base
declar
inform
report
incipav
databas
first
open
septemb
clean
total
vap
accord
cdc
criteria
declar
day
mv
least
one
pathogen
identifi
case
vap
one
diagnosi
made
tracheal
aspir
without
quantit
cultur
respect
blind
protect
specimen
brush
without
quantit
cultur
respect
identifi
pathogen
pseudomona
aeruginosa
pa
haemophilu
influenza
hi
staphylococcu
aureu
sa
streptococcu
pneumonia
sp
stenotrophomona
maltophilia
sm
hi
sp
involv
earli
vap
day
pa
sm
sa
report
late
onset
vap
conclus
tracheal
aspir
quantit
cultur
still
method
choic
diagnos
vap
picu
nosocomi
pathogen
mainli
involv
day
mv
precis
analysi
plan
clean
databas
includ
special
read
case
vap
introduct
parapneumon
effus
pleural
empyema
common
complic
communityacquir
bacteri
pneumonia
children
yet
consensu
concern
manag
patholog
expert
recommend
scarc
object
studi
compar
whether
evolut
patient
benefit
drainag
procedur
patient
method
retrospect
singlecent
studi
collect
data
children
treat
pleural
infect
strasbourg
univers
hospit
may
may
group
children
compar
concenr
medic
invas
treatment
receiv
thoracentesi
chest
drain
insert
without
instil
fibrinolyt
agent
surgic
techniqu
result
children
benefit
invas
treatment
strategi
antibiot
alon
aa
epidemiolog
data
group
compar
comorbid
vaccin
statu
signific
differ
durat
oxygen
day
aa
group
versu
day
group
p
time
elaps
obtain
day
aa
group
versu
day
group
p
overal
hospit
stay
durat
intens
care
initi
creactiv
protein
level
measur
mgl
aa
group
versu
mgl
group
p
propos
predict
score
invas
procedur
base
initi
crp
pleural
ultrasound
data
introduct
protect
mechan
ventil
adjuv
therapi
sever
ard
welldefin
adult
pediatr
popul
howev
clearli
identifi
recommend
avail
perform
protect
ventil
pediatr
vv
ecmo
aim
studi
first
describ
potenti
associ
ventilatori
set
ecmo
outcom
ard
patient
secondari
goal
compar
three
period
interest
identifi
signific
modif
potenti
consequ
surviv
rate
patient
method
perform
observ
monocentr
retrospect
studi
januari
decemb
patient
treat
ecmo
vv
refractori
ard
includ
collect
data
day
day
day
day
ecmo
three
period
interest
defin
retrospect
collect
data
local
databas
approv
french
data
protect
author
result
patient
treat
extracorpor
membran
oxygen
includ
identifi
increas
number
ecmo
vv
pediatr
refractori
ard
associ
higher
surviv
rate
throughout
three
period
osi
oxygen
satur
index
preecmo
paramet
significantli
associ
higher
mortal
identifi
signific
modif
adjuv
therapi
illustr
sharp
increas
use
neuromuscular
blocker
prone
posit
ecmo
also
show
evid
strong
modif
ventilatori
paramet
ecmo
exampl
tidal
volum
significantli
lower
throughout
period
cckg
vs
cckg
drive
pressur
vs
cm
contrari
peep
higher
recent
period
final
identifi
improv
surviv
rate
three
period
conclus
recent
modif
ventilatori
paramet
vv
ecmo
pediatr
ard
aim
implement
better
lung
protect
modif
associ
better
surviv
howev
correl
surviv
ventil
set
remain
unclear
multicentr
studi
help
physician
identifi
prognosi
factor
introduct
septic
shock
ss
recent
redefin
adult
lifethreaten
organ
dysfunct
caus
dysregul
host
respons
infect
due
pediatr
specif
adult
definit
transpos
children
toxic
shock
syndrom
tss
particular
entiti
infecti
shock
larg
pediatr
preval
toxin
specif
streptococcu
staphylococcu
aureu
lead
superantigen
activ
tlymphocyt
respons
major
cytokin
storm
multiorgan
failur
immunosuppress
induc
ss
demonstr
adult
children
investig
whether
similar
immun
disord
aris
tss
patient
method
singlecent
prospect
studi
includ
children
yearsold
consecut
admit
pediatr
intens
care
unit
ss
surviv
sepsi
campaign
goldstein
criteria
tss
center
diseas
control
septemb
juli
control
recruit
outpati
admit
elect
benign
surgeri
without
criteria
infect
immun
monitor
realiz
flow
cytometri
includ
hladr
express
monocyt
mhladr
total
lymphocyt
count
lymphocyt
subpopul
proport
cell
regulatori
cell
nk
cell
b
cell
sampl
analyz
day
shock
onset
clinic
data
collect
prospect
well
sever
score
secondari
nosocomi
infect
occurr
result
fortysix
ss
tss
control
recruit
time
point
mhladr
ss
tss
group
decreas
compar
control
fig
moreov
mhladr
significantli
higher
tss
day
ss
lymphocyt
time
cours
also
differ
ss
tssmore
profound
lymphopenia
occur
day
tss
ss
correct
faster
tss
day
day
ss
differ
observ
concern
regulatori
cell
thirteen
patient
ss
present
secondari
infect
compar
one
tss
group
conclus
studi
show
despit
similar
initi
shock
immun
respons
significantli
differ
ss
tss
tss
nt
induc
persist
immunesuppress
seen
sshighlight
differ
time
cours
mhladr
lymphocyt
secondari
infect
occurr
one
type
septic
shock
differ
infecti
shock
differ
immun
respons
clinic
outcom
result
reinforc
object
better
character
immun
state
patient
intens
care
order
propos
person
medicin
adapt
immunemodulatori
therapi
introduct
septic
shock
common
patholog
intens
care
unit
respons
high
mortal
rate
extracorpor
life
support
ecl
use
patient
longer
respond
standard
treatment
includ
inotrop
recent
multicent
studi
involv
children
septic
shock
septic
shock
score
sss
prove
highli
reliabl
identifi
patient
risk
death
abl
defin
refractori
septic
shock
object
studi
evalu
two
version
sss
bedsid
sss
bsss
comput
csss
group
patient
hospit
septic
shock
receiv
ecl
support
patient
method
retrospect
studi
includ
patient
age
month
year
hospit
intens
care
unit
necker
enfant
malad
trousseau
hospit
septic
shock
requir
ecl
assist
januari
march
five
data
collect
time
chosensepsi
time
ecl
decis
time
ecl
start
time
end
hospit
time
first
collect
clinic
biolog
criteria
collect
calcul
differ
predict
score
septic
shock
group
deceas
patient
group
live
patient
compar
differ
time
result
patient
includ
studi
die
hospit
time
studi
bsss
csss
poor
reliabl
identifi
deceas
children
vasoactiveinotrop
score
significantli
higher
ecl
start
time
deceas
patient
decreas
ecl
decis
time
ecl
start
time
live
patient
conclus
pilot
studi
test
databas
children
septic
shock
receiv
ecl
aphp
intens
care
unit
continu
studi
carri
part
collabor
project
european
societi
pediatr
neonat
intens
care
espnic
extend
pediatr
intens
care
unit
clarifi
ecl
success
criteria
character
evolut
organ
failur
thu
better
defin
ecl
use
children
septic
shock
aim
identifi
earli
predictor
co
defin
icu
stay
day
need
vital
support
death
children
scd
patient
method
retrospect
observ
cohort
studi
scd
patient
period
conduc
french
territori
america
teach
hospit
scd
referr
center
result
infant
admiss
carabdrepa
cohort
co
death
use
multivari
analysi
found
signific
predictor
coan
episod
dactyl
defin
pain
tender
hand
feet
age
one
year
ic
hemoglobin
level
less
g
per
decilit
ic
ic
leukocytosi
ic
respiratori
rate
equal
cycl
min
ic
delay
first
symptom
medic
contact
ic
admiss
sepsi
ic
model
demonstr
good
predict
perform
term
discrimin
calibr
conclus
sicklecel
diseas
children
high
risk
life
threaten
complic
episod
dactyl
sustain
drop
hemoglobin
associ
sepsi
context
delay
medic
care
strong
predictor
complic
outcom
introduct
traumatolog
lead
caus
death
young
adult
children
hemorrhag
shock
major
aggrav
factor
trauma
howev
data
avail
pediatr
popul
triss
method
offer
standard
approach
evalu
outcom
trauma
care
enabl
determin
individu
probabl
surviv
ps
patient
accord
trauma
injuri
sever
score
aim
studi
identifi
multipl
trauma
children
admit
hemorrhag
shock
pediatr
trauma
center
analyz
factor
could
influenc
outcom
use
triss
method
patient
method
perform
monocentr
observ
descript
retrospect
studi
medic
record
includ
patient
children
year
age
admit
multipl
trauma
present
hemorrhag
shock
upon
arriv
patient
includ
identifi
mean
computer
databas
intern
servic
primari
outcom
death
result
januari
april
multipl
trauma
children
admit
servic
among
hemorrhag
shock
upon
admiss
includ
studi
median
interquartil
age
weight
year
kg
respect
trauma
profil
similar
polytraumat
children
head
trauma
global
principl
damag
control
resuscit
met
includ
applic
massiv
transfus
protocol
howev
children
actual
correspond
usual
definit
massiv
blood
transfus
ml
kg
h
requir
surgic
hemostasi
procedur
overal
mortal
averag
triss
unexpect
survivor
unexpect
death
accord
triss
method
popul
conclus
studi
multipl
trauma
children
admit
hemorrhag
shock
center
children
heavili
traumat
overal
mortal
rate
howev
triss
method
reveal
observ
mortal
lower
predict
mortal
excess
survivor
check
medic
record
unexpect
survivor
seem
benefici
aggress
prehospit
resuscit
care
introduct
due
collaps
cardiopulmonari
resuscit
cpr
maneuv
major
traumat
injuri
may
complic
cours
resuscit
outofhospit
cardiac
arrest
patient
ohca
goal
assess
preval
injuri
describ
characterist
identifi
predict
factor
conduct
observ
studi
period
french
cardiac
arrest
ca
center
nontraumat
ohca
patient
admit
aliv
icu
studi
major
injuri
identifi
rank
use
function
twolevel
scale
sever
lifethreaten
consequenti
classifi
cprrelat
injuri
collapserel
injuri
depend
predomin
mechan
factor
associ
occurr
cprrelat
injuri
icu
surviv
identifi
use
multivari
logist
regress
introduct
object
studi
observ
practic
procedur
sedat
analgesia
psa
emerg
depart
ed
evalu
effect
patient
method
januari
juli
conduct
prospect
multicentr
studi
ed
prehospit
set
enrol
adult
patient
need
pain
procedur
would
requir
psa
procedur
divid
group
adisloc
bdisplac
fractur
cother
procedur
abscess
drainag
foreign
bodi
psa
drug
divid
group
drug
propofol
ketamin
midazolam
drug
oxygen
nitrousoxyd
premix
use
composit
primari
outcom
defin
success
psasuccess
procedur
ep
feel
suffici
sedat
patient
absenc
pain
memori
procedur
result
patient
enrol
psa
success
accord
primari
outcom
criteria
point
reach
point
pain
decreas
measur
numer
rate
scale
nr
median
iqr
number
patient
procedur
group
followgroup
group
b
n
group
c
n
drug
group
predomin
n
success
rate
higher
compar
group
group
respect
p
multivari
analysi
psa
success
independ
associ
factor
ramsay
sedat
scale
p
protect
factor
morphin
group
psa
success
p
advers
event
rate
studi
compar
rate
intern
studi
advers
event
easili
treat
seriou
consequ
conclus
prospect
multicentr
studi
patient
show
effici
perfect
case
satisfactori
result
global
effici
posit
link
use
sed
drug
neg
cutan
procedur
abscess
drainag
result
studi
period
patient
posit
diagnosi
pe
includ
accord
analysi
case
patient
present
pe
within
h
trauma
eventsth
patient
earli
pe
group
older
late
pe
group
p
bodymassindex
bmi
thirti
p
high
sequanti
organ
failur
score
sofa
admiss
p
day
pe
diagnosi
earli
group
also
present
higher
sofa
score
p
higher
infect
rate
p
biolog
assess
reveal
lower
platelet
level
p
lower
p
f
ratio
earli
group
p
studi
show
earli
pe
associ
transfus
p
surgic
treatment
measur
p
incid
long
bone
fractur
lower
extrem
higher
earli
pe
compar
patient
p
introduct
bag
mask
ventil
spread
technic
ventil
cardio
pulmonari
resuscit
cpr
despit
sever
advers
effect
gastric
ga
insuffl
may
favor
lung
regurgit
result
occurr
aspir
pneumonia
hypothes
continu
chest
compress
cc
may
limit
risk
high
tidal
volum
gastric
inflat
compar
interrupt
cc
strategi
aim
experiment
studi
assess
impact
differ
cc
ventil
strategi
gastric
inflat
ventil
min
prolong
simul
cpr
patient
method
thiel
embalm
cadav
tec
donat
program
du
quebec
troisrivier
ventil
min
recruit
lung
flow
airway
pressur
measur
airway
open
acqknowledg
softwar
surgic
gastrostomi
perform
cm
midlin
laparotomi
introduc
cuf
tracheal
tube
size
stomach
caviti
tube
connect
wright
spiromet
measur
cumul
gastric
inflat
volum
experiment
strategi
randomli
appli
min
cadav
interrupt
chest
compress
icc
two
success
bag
insuffl
interrupt
cc
everi
cc
continu
chest
compress
ccc
cc
ventil
ratio
first
strategi
without
interrupt
cc
continu
cc
bag
insuffl
everi
ccc
min
strategi
stomach
complet
empti
gastrostomi
tube
order
strategi
experi
random
cadav
result
cadav
analyz
mean
age
year
femal
pbw
kg
expir
bag
tidal
volum
averag
min
long
period
ml
icc
ml
ccc
ml
ccc
min
cumul
gastric
inflat
volum
significantli
higher
icc
compar
ccc
strategi
fig
min
icc
min
ccc
min
ccc
min
p
conclus
compar
recommend
icc
strategi
continu
chest
compress
significantli
reduc
cumul
gastric
inflat
interestingli
ccc
affect
ventil
actual
deliv
cpr
optim
ratio
chest
compress
en
ventil
continu
chest
compress
remain
open
discuss
introduct
cardiac
event
often
seen
acut
cerebr
palsi
would
indic
poor
prognosi
purpos
studi
clarifi
heartbrain
interact
term
incid
repercuss
morbid
mortal
cerebr
palsi
patient
patient
method
prospect
studi
month
includ
consecut
acut
cerebr
palsi
patient
initi
admit
vital
emerg
room
benefit
systemat
cardiac
assess
name
ecg
echocardiogram
troponin
assay
h
patient
transfer
anoth
hospit
cardiac
checkup
h
exclud
epidemiolog
clinic
paraclin
therapeut
evolutionari
paramet
studi
univari
statist
studi
carri
deduc
prognost
factor
earli
mortal
h
among
cardiac
assess
compon
p
result
patient
includ
averag
age
year
sex
ratio
diagnos
relat
cerebroles
wereischem
stroke
case
sever
head
trauma
case
hemorrhag
stroke
case
sever
mening
case
cardiac
event
observ
werean
electr
anomali
patient
increas
troponin
patient
echocardiograph
anomali
patient
distribut
cardiac
event
type
brain
injuri
shown
tabl
earli
mortal
rate
h
death
hemorrhag
stroke
ischem
stroke
sever
head
trauma
sever
mening
prognost
valu
variou
cardiac
event
cerebr
palsi
patient
type
aggress
shown
tabl
discuss
studi
show
statist
signific
differ
term
earli
mortal
accord
presenc
absenc
one
cardiac
incid
hand
import
npv
note
brain
lesion
combin
conclus
absenc
cardiac
event
cerebr
palsi
patient
would
favor
better
earli
evolut
find
confirm
broader
studi
recommend
perform
cardiac
checkup
cerebr
palsi
patient
first
h
introduct
dopplerbas
resist
index
ri
semiquantit
evalu
renal
perfus
use
colourdoppl
sqp
suggest
potenti
predictor
aki
occurr
icu
patient
without
renal
dysfunct
result
howev
limit
preliminari
data
studi
aim
evalu
perform
ri
sqp
predict
aki
within
day
criticallyil
patient
without
overt
aki
patient
method
posthoc
analysi
multicentr
prospect
collect
dataset
adult
patient
without
cardiac
arrhythmia
requir
mechan
ventil
includ
patient
sever
chronic
renal
dysfunct
known
renal
arteri
stenosi
exclud
aki
defin
accord
urinari
output
serum
creatinin
criteria
kdigo
definit
renal
doppler
perform
studi
inclus
result
report
n
median
iqr
adjust
factor
associ
aki
develop
assess
use
mix
logist
regress
model
take
centr
random
effect
result
overal
patient
includ
studi
aki
studi
inclus
ultim
includ
post
hoc
analysi
half
patient
male
gender
n
median
age
iqr
addit
mechan
ventil
patient
requir
vasopressor
sepsi
inclus
median
lod
score
iqr
overal
patient
develop
aki
first
day
icu
stay
semiquantit
perfus
score
rang
perfus
perfus
respect
patient
without
aki
day
p
dopplerbas
resist
index
respect
patient
without
aki
day
p
figur
area
roc
curv
predict
aki
within
day
sqp
ri
adjust
confound
neither
sqp
ci
dopplerbas
ri
ci
associ
aki
day
result
suggest
neither
dopplerbas
resist
index
semiquantit
renal
perfus
accur
predict
occurr
aki
icu
patient
requir
mechan
ventil
perform
urinari
tissu
inhibitor
insulinlik
growth
factor
bind
predict
renal
recoveri
poorli
studi
preliminari
studi
dopplerbas
renal
resist
index
ri
might
help
differenti
transient
persist
acut
kidney
injuri
aki
aim
studi
compar
perform
ri
predict
shortterm
revers
aki
critic
ill
patient
patient
method
prospect
monocentr
studi
includ
consecut
critic
ill
patient
aki
ri
measur
within
h
admiss
urinari
measur
renal
recoveri
evalu
day
receiveroper
characterist
curv
roc
plot
evalu
diagnost
perform
ri
predict
persist
aki
result
patient
includ
transient
aki
persist
aki
ri
transient
aki
group
persist
aki
group
p
significantli
differ
time
group
perform
poor
respect
area
roc
curv
ci
ci
ci
ci
area
roc
curv
ri
ci
ri
predict
persist
aki
ci
sensit
ci
specif
ri
neither
correl
age
rho
p
mean
arteri
pressur
rho
p
quantiti
fluid
rho
p
logist
regress
found
ri
odd
ratio
step
p
sepsisrel
organ
failur
assess
score
p
predict
persist
aki
conclus
dopplerbas
renal
resist
index
better
perform
predict
revers
aki
critic
ill
patient
urinari
unabl
differenti
transient
persist
aki
studi
need
precis
adequ
factor
influenc
ri
introduct
acut
kidney
injuri
aki
intens
care
unit
icu
carri
high
mortal
morbid
potenti
activ
reninangiotensinaldosteron
system
aki
may
play
role
profibrot
pathway
reninangiotensinaldosteron
blocker
acei
arb
well
known
benefit
chronic
kidney
diseas
may
potenti
nephrotox
aki
nevertheless
ancillari
studi
frogicu
cohort
icm
may
recent
shown
lower
mortal
year
followup
patient
receiv
acei
arb
episod
aki
kdigo
icu
discharg
vs
p
present
studi
analyz
use
acei
arb
kdigo
aki
potenti
effect
longterm
mortal
patient
method
ancillari
akiki
studi
nejm
patient
discharg
aliv
icu
includ
longterm
prognosi
mortal
assess
accord
treatment
acei
arb
icu
discharg
use
univari
multivari
analys
adjust
potenti
confound
factor
result
among
patient
discharg
aliv
receiv
acei
arb
icu
discharg
tabl
detail
patient
characterist
patient
without
acei
arb
sever
attest
higher
sap
p
higher
rate
catecholamin
infus
p
aki
howev
mortal
significantli
differ
two
group
acei
arb
vs
p
mortal
risk
associ
nonprescript
acei
arb
adjust
prognost
variabl
p
discuss
substanti
proport
patient
receiv
acei
arb
icu
discharg
episod
sever
aki
find
differ
mortal
favor
reninangiotensinaldosteron
system
blocker
observ
ancillari
studi
frogicu
includ
patient
acei
arb
wherea
present
studi
includ
could
explain
differ
popul
less
sever
aki
frogicu
lack
power
studi
conclus
studi
confirm
posit
effect
longterm
mortal
random
control
trial
acei
arb
icu
discharg
episod
sever
aki
warrant
introduct
chronic
kidney
diseas
ckd
associ
high
mortal
relat
sepsi
studi
alreadi
shown
urem
toxin
action
vascular
immun
disord
ckd
potenti
role
acut
kidney
injuri
aki
undetermin
kinet
urem
toxin
concentr
consequ
aki
disserv
address
aim
studi
evalu
kinet
three
urem
toxin
concentr
indoxyl
sulfat
sulfat
pc
first
week
kidney
failur
urem
mice
model
consequ
endotoxemia
patient
method
studi
explor
vivo
kinet
three
urem
toxin
concentr
day
control
sham
kidney
injuri
induct
ki
ki
obtain
electrocauter
follow
contralater
nephrectomi
two
week
later
urem
toxin
concentr
determin
sera
sacrific
day
ki
induct
lp
challeng
perform
mg
kg
ip
sham
ki
group
day
surviv
follow
two
group
ki
mice
fed
arabinoxylanoligosaccharid
chelat
pc
group
axo
sevelam
chelat
phosphat
known
decreas
fgf
group
sevelam
expos
lp
day
ki
follow
surviv
result
pc
fgf
concentr
increas
rapidli
kidney
injuri
day
last
ki
group
compar
group
sham
figur
associ
elev
cytokin
concentr
serum
day
ki
mice
expos
lp
die
wherea
sham
lp
anim
surviv
fig
treatment
axo
sevelam
day
preced
lp
challeng
decreas
respect
pc
concentr
axo
group
fgf
concentr
sevelam
group
improv
surviv
ki
anim
conclus
experiment
studi
accumul
urem
toxin
appear
earli
cours
kidney
failur
associ
local
express
proinflammatori
molecul
accumul
toxin
associ
higher
mortal
endotoxemia
decreas
pc
fgf
concentr
associ
improv
surviv
lp
challeng
earli
accumul
urem
toxin
potenti
role
sepsi
mortal
need
confirm
aki
human
introduct
aki
dread
complic
patient
hematolog
malign
associ
increas
morbid
mortal
moreov
aki
may
preclud
abil
receiv
chemotherapi
howev
current
knowledg
kinet
renal
recoveri
persist
renal
dysfunct
limit
patient
method
conduct
retrospect
singlecent
studi
includ
patient
hematolog
malign
admit
intens
care
unit
icu
nant
univers
hospit
januari
decemb
purpos
studi
epidemiolog
aki
occurr
major
advers
kidney
event
make
result
one
hundr
three
patient
includ
among
aki
median
age
year
old
male
common
malign
lymphoma
acut
myeloblast
leukemia
myeloma
patient
newli
diagnos
malign
relaps
diseas
chemotherapi
administ
day
icu
admiss
simplifi
acut
physiolog
score
ii
sap
day
icu
stay
patient
receiv
vasopressor
requir
invas
mechan
ventil
icu
hospit
mortal
respect
accord
kdigo
criteria
aki
stage
aki
stage
aki
stage
requir
renal
replac
therapi
rrt
icu
mortal
rrt
patient
overal
median
durat
aki
day
increas
day
kdigo
stage
patient
day
kdigo
stage
patient
day
kdigo
stage
patient
among
survivor
renal
recoveri
occur
patient
icu
discharg
patient
patient
make
report
patient
icu
discharg
patient
hospit
discharg
day
discharg
conclus
criticallyil
patient
hematolog
malign
high
incid
aki
although
almost
patient
discharg
aliv
icu
make
account
roughli
everi
patient
research
need
identifi
predictor
make
develop
new
therapeut
strategi
might
translat
better
longterm
outcom
show
delay
rrt
strategi
absenc
lifethreaten
condit
affect
mortal
allow
nearli
patient
escap
rrt
compar
earli
rrt
strategi
patient
aki
obviou
econom
counterpart
evalu
studi
patient
method
financi
cost
rrt
continu
intermitt
assess
patient
seven
french
icu
septemb
august
take
account
cathet
circuit
dialyz
membran
dialys
replac
fluid
price
medic
nurs
work
time
includ
time
venou
catheter
rrt
durat
includ
circuit
prepar
restitut
time
also
record
cost
comput
extrapol
figur
akiki
popul
order
estim
cost
differ
two
strategi
earli
delay
analysi
restrict
first
h
inclus
result
mean
work
time
minut
intermitt
rrt
minut
continu
rrt
mean
financi
cost
first
h
rrt
initi
euro
intermitt
rrt
euro
continu
rrt
p
extrapol
figur
patient
includ
akiki
reveal
earli
strategi
associ
cost
euro
delay
one
cost
euro
first
h
random
conclus
studi
highlight
consider
save
safe
obtain
delay
rrt
strategi
icu
patient
sever
aki
introduct
unhealthi
use
alcohol
acut
kidney
aki
injuri
major
public
health
problem
chronic
alcohol
exposur
may
directli
indirectli
associ
kidney
damag
littl
known
impact
current
excess
alcohol
consumpt
kidney
function
nontrauma
critic
ill
patient
aim
determin
whether
unhealthi
use
alcohol
independ
associ
aki
intens
care
unit
icu
worst
kidney
function
hospit
discharg
patient
method
prospect
cohort
studi
noncirrhot
nonliv
transplant
recipi
nonchron
dialyz
patient
admit
polyval
icu
univers
hospit
studi
design
power
detect
differ
incid
aki
atrisk
drinker
atrisk
drinker
twosid
alpha
error
atrisk
dink
defin
accord
nation
institut
alcohol
abus
alcohol
criteria
aki
accord
kidney
diseas
improv
global
outcom
kdigo
criteria
patient
follow
hospit
discharg
day
result
period
calcul
cumul
incid
stage
aki
atrisk
drinker
atrisk
drinker
stage
aki
significantli
frequent
admiss
icu
atrisk
drinker
atrisk
drinker
versu
p
cumul
incid
stage
aki
significantli
higher
atrisk
atrisk
drinker
figur
p
logrank
test
adjust
suscept
predispos
factor
aki
atrisk
drink
significantli
associ
aki
hazard
ratio
hr
p
proport
patient
stage
aki
hospit
discharg
among
survivor
significantli
higher
atrisk
atrisk
drinker
versu
respect
p
atrisk
drink
remain
independ
associ
stage
aki
subgroup
patient
without
stage
aki
admiss
icu
hr
p
conclus
result
suggest
kidney
dysfunct
significantli
frequent
atrisk
atrisk
drinker
believ
systemat
accur
identif
patient
prior
alcohol
misus
may
allow
prevent
aki
alexandr
elabbadi
speaker
addit
respiratori
failur
present
shock
clinic
pictur
includ
fever
patient
cough
wherea
extrapulmonari
symptom
less
common
ctscan
pattern
includ
alveolar
consolid
patient
ground
glass
opac
septa
thicken
one
patient
present
anoth
pathogenbacteri
infect
patient
viral
infect
fungal
infect
one
invas
aspergillosi
icu
admiss
score
iqr
mechan
ventil
requir
patient
vasopressor
renal
replac
therapi
hospit
mortal
rate
found
associ
hemodynam
failur
renal
replac
therapi
neutropenia
conclus
hmpv
found
respiratori
tract
immunocompromis
patient
acut
respiratori
failur
case
anoth
pathogen
also
identifi
ct
pattern
noth
uniqu
could
ascrib
second
pathogen
whether
posit
hmpv
relev
result
unclear
remain
unaddress
set
data
compar
clinic
radiograph
pictur
outcom
patient
posit
hmpv
match
patient
document
influenza
infect
ongo
display
confer
helmi
amri
speaker
introduct
critic
ill
influenza
patient
mortal
rate
coinfect
especi
invas
aspergillosi
recent
document
amongst
patient
thought
play
major
role
prognosi
patient
nevertheless
need
systemat
microbiolog
document
still
wide
accept
icu
health
worker
moreov
high
incid
cardiovascular
event
acut
coronari
syndrom
stroke
within
first
day
influenza
ill
describ
year
aim
studi
assess
daili
practic
regard
microbiolog
investig
coinfect
assess
cardiovascular
event
rate
proport
patient
hematolog
malign
iqr
proport
allogen
stem
cell
transplant
iqr
lrti
preval
ci
icu
admiss
requir
patient
ci
last
hospit
mortal
factor
associ
heterogen
assess
use
metaregress
heterogen
result
partli
explain
studi
design
proport
patient
hematolog
malign
proport
patient
coinfect
systemat
review
two
third
immunocompromis
patient
hmpv
detect
lrti
mani
requir
icu
admiss
high
heterogen
note
may
explain
studi
design
underli
immun
statu
underli
diseas
rate
coinfect
includ
studi
howev
high
risk
bia
justifi
need
addit
studi
field
pichon
speaker
analysi
mortal
perform
kaplanmei
curv
mortal
accord
age
main
risk
factor
comput
result
patient
includ
age
categori
accord
quintil
repartit
year
old
n
n
n
n
n
next
two
age
group
separatedyoung
group
age
older
group
age
median
age
iqr
respect
older
age
significantli
associ
higher
mortal
rate
univari
analysi
hr
p
multivari
cox
analysi
main
risk
factor
mortal
age
hr
p
ps
hr
p
sever
inclus
assess
sequenti
organ
failur
assess
sofa
score
admiss
icu
per
one
unit
increas
hr
p
howev
haematolog
malign
charlson
comorbid
score
index
without
age
reason
icu
admiss
significantli
associ
mortal
figur
show
kaplanmei
surviv
analysi
relat
age
ps
mortal
p
conclus
older
age
significantli
associ
higher
mortal
threshold
found
accur
discrimin
dead
aliv
patient
despit
prognost
impact
surviv
meaning
subgroup
oldest
patient
moder
limit
autonomi
studi
may
allow
better
select
oldest
patient
like
benefit
icu
admiss
accord
three
simpl
variablesag
ps
sofa
score
introduct
hemophagocyt
syndrom
hs
rare
lifethreaten
condit
lead
multi
organ
failur
includ
shock
sever
hs
symptomat
treatment
reli
etoposid
infus
hemodynam
instabl
hs
poorli
studi
object
studi
describ
characterist
hs
patient
shock
prognost
factor
impact
etoposid
inject
hemodynam
paramet
patient
method
adult
critic
ill
patient
hs
manag
multidisciplinari
nation
refer
center
retrospect
includ
patient
without
vasopressor
requir
etoposid
infus
exclud
result
forti
patient
includ
twothird
n
male
gender
median
age
iqr
shock
n
acut
respiratori
failur
n
monitor
n
main
reason
icu
admiss
common
hstrigger
underli
hematolog
diseas
malign
diseas
patient
infecti
diseas
system
rheumat
diseas
median
sofa
score
patient
requir
mechan
ventil
n
median
lactat
level
mmoll
hospit
mortal
n
associ
sever
assess
need
mechan
ventil
vs
p
male
gender
vs
survivor
p
etoposid
infus
follow
increas
norepinephrin
dose
p
trend
toward
higher
lactat
level
p
figur
statist
signific
chang
observ
regard
mean
arteri
pressur
heart
rate
renal
function
assess
serum
creatinin
oliguria
conclus
result
suggest
high
sever
hs
patient
acut
circulatori
failur
high
hospit
mortal
hemodynam
worsen
h
follow
etoposid
infus
chang
hemodynam
icu
stay
comparison
patient
cytopenia
shock
absenc
hs
current
ongo
present
congress
longterm
prognosi
highgrad
glioma
admit
intens
care
unit
maxen
speaker
introduct
limit
data
avail
concern
prognosi
primari
malign
brain
tumor
intens
care
unit
icu
among
highgrad
glioma
hgg
frequent
associ
poorest
surviv
wherea
longterm
prognosi
icu
admiss
patient
malign
better
known
data
exist
regard
patient
hgg
aim
studi
analyz
factor
associ
mortal
patient
hgg
admit
icu
assess
function
statu
anticanc
therapi
cours
icu
survivor
eightyear
bicentr
retrospect
cohort
studi
consecut
patient
hgg
admit
icu
includ
function
statu
assess
karnofski
perform
statu
kp
mutat
isocitr
dehydrogenas
idh
also
collect
anticanc
therapi
cours
icu
discharg
classifi
continu
without
chang
chang
modifi
stop
icu
discharg
initi
icu
discharg
hgg
diagnos
icu
stay
introduct
thrombocytopenia
common
disord
intens
care
unit
icu
associ
increas
risk
bleed
data
platelet
transfus
icu
obtain
gener
cohort
peripher
thrombocytopenia
ongo
activ
bleed
subject
invas
procedur
patient
hypoprolif
thrombocytopenia
manag
platelet
transfus
remain
somewhat
empir
deriv
studi
perform
hematolog
patient
stabl
clinic
condit
herein
describ
analys
determin
posttransfus
platelet
increment
cancer
patient
hypoprolif
thrombocytopenia
icu
singlecent
retrospect
observ
studi
period
patient
malign
hypoprolif
thrombocytopenia
receiv
least
one
platelet
transfus
icu
includ
transfus
episod
poor
platelet
yield
defin
bodi
surfac
areaadjust
correct
count
increment
cci
altern
weightadjust
platelet
transfus
yield
rtp
patient
consid
refractori
platelet
transfus
experienc
poor
platelet
increment
cci
rtp
follow
two
consecut
abocompat
transfus
contain
least
platelet
per
kg
bodyweight
result
patient
receiv
total
platelet
transfus
analyz
indic
platelet
transfus
distribut
prophylact
secur
invas
procedur
therapeut
activ
bleed
transfus
threshold
lower
prophylact
indic
secur
invas
procedur
therapeut
indic
introduct
trauma
spine
common
patholog
constantli
increas
algeria
mainli
road
accid
potenti
seriou
associ
spinal
cord
injuri
lifethreaten
treat
traumat
cervic
thoracolumbar
spine
patient
spine
unit
chu
oran
patient
method
depart
orthoped
traumatolog
surgeryspin
unit
chu
oran
month
especi
summer
season
secondari
support
ua
middl
year
year
result
quadripleg
patient
men
women
age
year
patient
year
old
year
old
year
old
main
caus
traumat
quadriplegia
mainli
due
avp
fall
sport
accid
judo
gymnast
repres
histopatholog
lesion
level
patient
patient
clinic
patient
alreadi
complet
quadriplegia
admiss
patient
incomplet
tetraplegia
neurolog
involv
classifi
accord
frankel
classif
practic
conduct
decompress
arthrodesi
graft
screw
plate
patient
benefit
conserv
treatment
reduct
cranial
traction
cours
mark
recoveri
patient
incomplet
tetraplegia
patient
die
result
complic
discuss
traumat
quadriplegia
major
public
health
problem
injuri
devast
affect
spinal
cord
adult
youth
adolesc
men
highest
preval
suffer
time
perman
deficit
quickli
quadripleg
parapleg
becom
awar
deficit
consequ
hospit
rehabilit
cost
repres
huge
invest
emot
damag
patient
famili
measur
sever
week
treatment
surgeri
resuscit
rehabilit
found
advers
result
treatment
failur
complic
insert
care
famili
conclus
traumat
quadriplegia
especi
aggrav
transport
goal
surgeri
decompress
marrow
stabil
spine
introduct
despit
daili
interrupt
sed
infus
delay
awaken
frequent
observ
critic
ill
patient
requir
invas
mechan
ventil
aim
identifi
prognost
signific
standard
electroencephalographi
find
adult
patient
delay
awaken
intens
care
unit
patient
method
retrospect
studi
includ
consecut
patient
invas
mechan
ventil
intens
care
unit
underw
standard
eeg
delay
awaken
delay
awaken
classifi
groupscoma
hypoact
delirium
hyperact
delirium
accord
rass
inclus
primari
endpoint
good
neurolog
outcom
defin
proport
patient
aliv
awak
ie
respond
simpl
command
consecut
day
day
eeg
secondari
endpoint
includ
preval
differ
etiolog
delay
awaken
defin
categori
hypox
metabol
septic
antibiot
sedat
acut
brain
injuri
proport
patient
aliv
awak
icu
discharg
day
data
present
median
interquartil
rang
number
percentag
causespecif
preval
model
use
identifi
independ
paramet
associ
awaken
death
respect
tabl
contrast
background
frequenc
hz
associ
preserv
reactiv
protect
etiolog
delay
awaken
sepsi
hypoxia
sedat
neurotox
antibiot
metabol
caus
patient
multifactori
origin
hypox
encephalopathi
associ
shortterm
mortal
end
icu
stay
patient
awak
aliv
awak
dead
day
awak
awak
dead
conclus
delay
awaken
icu
like
multifactori
origin
character
favor
outcom
case
background
eeg
abnorm
frequenc
continu
reactiv
provid
major
prognost
inform
shortterm
mortal
popul
assess
characterist
longterm
surviv
function
outcom
object
retrospect
studi
identifi
earli
factor
associ
ca
adult
manag
cse
admit
intens
care
unit
icu
introduct
postcardiac
arrest
coma
common
caus
brain
injuri
icu
predict
neurolog
outcom
crucial
import
provid
object
inform
love
one
opt
best
therapeut
option
includ
withhold
withdraw
treatment
deem
hopeless
among
prognost
tool
avail
somatosensori
evok
potenti
proven
efficiencyund
certain
condit
absenc
cortic
wave
associ
unfavor
neurolog
prognosi
specif
close
tradit
test
requir
expertis
avail
neurophysiologist
assum
techniqu
also
perform
train
intensivist
patient
method
two
physician
icu
receiv
two
day
specif
train
univers
neurophysiolog
laboratori
specialist
interpret
evok
potenti
patient
concern
prolong
postcardiac
arrest
coma
cessat
sedat
record
interpret
sent
neurophysiolog
referr
center
review
specialist
within
h
feasibl
reliabl
test
evalu
retrospect
introduct
sodium
disturb
common
probabl
poorli
understood
electrolyt
disord
neurolog
diseas
complic
minim
better
recognit
diagnosi
treatment
sodium
disord
studi
aim
analyz
incid
etiolog
impact
dysnatremia
brain
damag
popul
hypothes
chang
sodium
level
could
indic
recent
neurolog
deterior
patient
method
conduct
six
month
long
prospect
cohort
includ
brain
damag
patient
admit
icu
march
august
minimum
length
stay
lo
day
patient
includ
screen
sodium
disord
first
week
icu
stay
outcom
measur
incid
death
glasgow
outcom
scale
go
discharg
lo
patient
also
monitor
neurolog
deterior
includ
cognit
declin
convuls
seizur
increas
cerebr
edema
brain
herniat
contemporari
sodium
disord
univari
multivari
analysi
use
determin
level
signific
result
studi
period
one
hundr
patient
admit
icu
neurointens
care
among
includ
studi
patient
admit
traumat
brain
injuri
tbi
case
accord
analysi
patient
present
hyponatremia
among
diagnos
syndrom
inappropri
antidiuret
hormon
secret
siadh
corticosteroid
defici
one
case
cerebr
salt
wast
syndrom
siadh
attribut
convuls
seizur
case
mening
case
tbi
case
hyponatremia
found
predict
factor
mortal
icu
p
lo
p
sign
neurolog
deterior
p
day
diagnosi
studi
result
show
incid
hypernatremia
case
among
case
attribut
central
diabet
insipidu
hypernatremia
found
predict
factor
mortal
icu
p
go
p
sign
neurolog
deterior
p
day
diagnosi
conclus
summari
studi
demonstr
sodium
disturb
common
neurointens
care
unit
associ
increas
icu
mortal
besid
indic
chang
sodium
level
could
reveal
seriou
neurolog
complic
guillaum
geri
speaker
introduct
cardiogen
shock
cs
remain
sever
poorli
understood
patholog
mani
predict
death
score
previous
describ
focus
ischem
cs
took
account
data
relat
manag
patient
urgent
need
simpl
object
criteria
assess
shortterm
cs
mortal
regardless
initi
etiolog
patient
method
frenshock
registri
larg
prospect
multicent
registri
cs
patient
admit
intens
cardiac
gener
critic
care
unit
april
octob
franc
patient
prospect
includ
regardless
cs
etiolog
met
least
one
criterion
low
cardiac
output
systol
blood
pressur
sbp
mmhg
need
amin
low
cardiac
index
min
echocardiographi
right
heart
catheter
clinic
radiolog
biolog
ntprobnp
bnp
echocardiograph
invas
hemodynam
overload
sign
clinic
oliguria
marbl
confus
biolog
hypoperfus
lactat
mmoll
hepat
renal
failur
studi
factor
relat
mortal
use
kaplanmei
analys
cox
proport
hazard
model
result
patient
includ
male
median
age
nonischem
cs
predomin
n
although
type
infarct
infrequ
n
mortal
n
non
survivor
older
previou
renal
failur
marbl
atrial
fibril
admiss
lower
sbp
dbp
diagnost
test
reveal
higher
arteri
lactat
crp
natriuret
peptid
kaliemia
lower
ph
prothrombin
timehemoglobin
egfr
also
lvef
multivari
analysi
retain
age
especi
low
systol
blood
pressur
especi
mmhg
high
arteri
lactat
especi
mmoll
low
egfr
especi
mlminm
low
lvef
especi
signific
predictor
mortal
ischem
etiolog
type
infarct
predict
conclus
multicentr
prospect
design
confirm
heterogen
cs
term
present
prognosi
five
simpl
practic
easi
find
sign
found
signific
predictor
short
term
mortal
could
use
provid
accur
stratifi
definit
cs
patient
order
tailor
addit
therapi
left
ventricular
eject
fraction
increas
p
aortic
velocitytim
integr
increas
cm
cm
p
match
propens
score
levosimendan
remain
factor
associ
signific
reduct
vaecmo
wean
failur
hazard
ratio
confid
p
kaplanmei
surviv
curv
show
surviv
rate
day
levosimendan
group
nonlevosimendan
group
p
howev
signific
differ
found
levosimendan
nonlevosimendan
group
regard
day
mortal
propens
score
analysi
hazard
ratio
confid
p
studi
suggest
levosimendan
could
associ
benefici
effect
vaecmo
wean
icu
patient
howev
use
levosimendan
tend
decreas
day
mortal
propens
match
analysi
p
introduct
cardiogen
shock
patient
treat
venoarteri
ecmo
vaecmo
may
develop
brain
injuri
ecmo
support
aim
assess
predict
valu
serial
measur
neuron
specif
enolas
nse
identifi
poor
neurolog
outcom
ctdefin
acut
brain
injuri
set
patient
method
conduct
prospect
cohort
studi
consecut
adult
patient
cannul
vaecmo
refractori
cardiogen
shock
medic
icu
univers
hospit
pari
franc
plasma
sampl
predefin
time
point
day
day
day
vaecmo
cannul
ecmo
remov
death
plasma
sampl
collect
store
primari
endpoint
poor
outcom
composit
endpoint
ctdefin
brain
injuri
death
day
vaecmo
cannul
secondari
endpoint
ctdefin
brain
injuri
plasma
nse
level
measur
end
studi
data
present
median
interquartil
rang
number
percentag
associ
nse
level
outcom
explor
multivari
logist
regress
analysi
nse
level
dichotom
accord
median
valu
day
day
result
total
patient
male
n
sofa
score
admiss
includ
underw
cardiopulmonari
resuscit
vaecmo
cannul
vaecmo
cannul
patient
mechan
ventil
sedat
receiv
vasopressor
plasma
nse
level
l
day
l
day
l
day
poor
outcom
occur
patient
ctdefin
brain
injuri
observ
patient
plasma
nse
level
day
day
associ
poor
outcom
crude
analys
multivari
analysi
nse
level
day
remain
independ
associ
poor
outcom
tabl
patient
underw
brain
ct
vaecmo
support
nse
level
day
day
associ
ctdefin
brain
injuri
conclus
cardiogen
shock
patient
treat
vaecmo
plasma
nse
level
measur
day
vaecmo
initi
independ
associ
short
term
acut
brain
injuri
death
irrespect
preecmo
characterist
patient
persist
elev
nse
level
day
vaecmo
initi
may
benefit
advanc
neuromonitor
ecmo
support
patient
hypoxemia
caus
often
chronic
respiratori
heart
renal
failur
higher
often
vasopressor
p
patient
caus
hypoxemia
invas
ventil
p
number
caus
associ
hypoxemia
sever
p
multivari
linear
regress
number
caus
hypoxemia
neg
associ
pf
coeff
ci
p
icumort
across
group
p
multivari
logist
regress
show
addit
age
chronic
heart
failur
admiss
diagnosi
pf
ard
caus
hypoxemia
associ
icumort
wherea
obes
protect
conclus
hypoxem
patient
caus
hypoxemia
number
caus
hypoxemia
independ
associ
lower
pf
ratio
caus
hypoxemia
independ
associ
icumort
prevent
patient
acquir
supplementar
condit
induc
hypoxemia
may
improv
prognosi
introduct
patient
sever
acut
respiratori
distress
syndrom
ard
extracorpor
membran
oxygen
ecmo
ventil
low
tidal
volum
optim
posit
endexpiratori
pressur
peep
combin
best
alveolar
recruit
minim
overdistens
electr
imped
tomographi
eit
provid
noninvas
realtim
bedsid
imag
lung
aim
studi
assess
eit
abil
choos
best
peep
patient
ecmo
receiv
ultraprotect
mechan
ventil
patient
method
ard
patient
venoven
ecmo
includ
written
inform
given
patient
rel
inclus
recruit
maneuv
decrement
peep
trial
step
monitor
eit
lung
imag
divid
four
ventraltodors
horizont
region
interest
drive
pressur
maintain
constant
patient
four
eitbas
peep
definedpeep
odclmin
pressur
lowest
eitassess
collaps
lung
cl
overdistens
od
peep
lowest
pressur
abl
limit
eitassess
collaps
least
overdistens
peep
comp
peep
eitbas
complianc
maximum
peep
gi
peep
eitbas
global
inhomogen
gi
index
minimum
concord
four
eitbas
peep
refer
pulmonari
peep
p
defin
accord
respiratori
clinic
ultrasound
usual
paramet
evalu
cohen
kappa
coeffici
result
fourteen
patient
decrement
peep
trial
induc
decreas
tidal
imped
variat
tiv
depend
region
increas
tiv
nondepend
lung
region
figur
studi
aim
evalu
impact
serum
pulmonari
marker
biotrauma
transit
ultraprotect
ventil
set
follow
initi
vvecmo
b
differ
mechan
ventil
strategi
vvecmo
patient
method
monocentr
random
clinic
trial
conduct
period
patient
receiv
vvecmo
refractori
sever
ard
vvecmo
start
patient
switch
aprv
mode
one
second
high
pressur
phigh
low
pressur
plow
h
patient
random
assign
follow
three
experiment
step
accord
computergener
alloc
sequencephigh
plow
high
peepveri
low
drive
pressur
vhpeepvldp
step
phigh
plow
low
peephigh
drive
pressur
lpeephdp
step
phigh
plow
low
peep
low
drive
pressur
lpeepldp
step
plasma
bronchoalveolar
solubl
receptor
advanc
glycat
endproduct
srage
serum
cytokin
dose
vvecmo
h
mechan
ventil
strategi
result
sixteen
patient
vvecmo
day
mechan
ventil
includ
ultraprotect
mechan
ventil
set
follow
ecmo
init
associ
signific
reduct
plasma
srage
plasma
cytokin
howev
plasma
srage
cytokin
similar
within
experiment
step
ecmo
nevertheless
bronchoalveolar
level
srage
lowest
drive
pressur
minim
conclus
vvecmo
allow
ultraprotect
ventil
combin
signific
reduct
tidal
volum
drive
pressur
ventil
strategi
significantli
reduc
pulmonari
biotrauma
could
therefor
decreas
ventil
induc
lung
injuri
howev
optim
ultraprotect
ventil
strategi
vvecmo
initi
remain
undetermin
warrant
investig
univari
analysi
qsofa
lactat
ig
ii
score
use
mechan
ventil
ed
signific
multivari
analysi
ig
ii
score
use
mechan
ventil
ed
significantli
associ
mortal
icu
discuss
lo
ed
associ
mortal
icu
studi
dead
group
often
associ
high
comorbid
alter
qsofa
admiss
ed
use
mechan
ventil
ed
associ
poor
prognosi
whatev
origin
septic
shock
import
confirm
result
larg
prospect
studi
introduct
microcirculatori
alter
frequent
observ
patient
sepsi
vivo
microdialysi
md
bedsid
techniqu
monitor
tissu
metabol
chang
conduct
studi
aim
assess
perform
muscl
lactat
lactat
pyruv
l
p
ratio
clearanc
predict
mortal
septic
shock
patient
use
microdialysi
patient
method
studi
design
prospect
control
clinic
trial
perform
multidisciplinari
intens
care
unit
septic
shock
patient
enrol
interstiti
tissu
concentr
lactat
pyruv
glucos
glycerol
obtain
baselin
everi
h
day
use
muscl
microdialysi
clearanc
muscl
lactat
l
p
ratio
defin
percentag
chang
muscl
lactat
level
l
p
ratio
compar
baselin
valu
posit
valu
clearanc
mean
decreas
rate
paramet
studi
found
associ
muscl
lactat
clearanc
hospit
mortal
statist
signific
differ
p
p
studi
p
also
found
associ
clearanc
muscl
lactat
pyruv
ratio
hospit
mortal
statist
signific
differ
p
p
studi
p
introduct
mortal
septic
shock
remain
high
undernutrit
septic
shock
respons
signific
morbid
mortalityth
object
studi
evalu
interest
muscl
mass
loss
ultrasound
measur
quadricep
thick
patient
admit
intens
care
septic
shock
prognost
factor
mortal
prospect
observ
studi
conduct
medic
intens
care
unit
centr
hospitali
universitair
rouenth
inclus
period
extend
april
octob
main
object
evalu
relationship
variabl
muscl
thick
measur
ultrasound
mortal
secondari
object
assess
differ
variabl
mean
quadricep
thick
live
deceas
patient
result
patient
admit
septic
shock
includedth
median
quadricep
thick
variabl
defin
threshold
valuew
observ
higher
mortal
group
whose
quadricep
thick
decreas
p
final
parent
could
interview
recal
four
parent
accept
interview
one
mother
describ
chang
skin
colour
bleed
shock
parent
infant
describ
weird
movement
said
help
recogn
death
one
mother
notic
sign
grate
inform
possibl
symptom
call
three
father
wive
refus
interview
coupl
bad
time
discuss
difficulti
encount
expect
parent
refus
inclus
lack
parent
involv
interview
main
problem
partial
due
strong
apprehens
recal
feel
guilt
overtak
benefit
expect
studi
parent
particip
alway
motivationa
countergift
caregiv
suffer
desir
avoid
bereav
parent
ifireap
main
hypothesi
better
inform
parent
percept
endoflif
sign
could
help
live
better
situat
literatur
studi
topic
picu
therefor
first
step
observ
die
children
determin
sign
worsen
appear
endoflif
period
studi
ongo
french
picu
patient
like
die
short
term
picu
includ
inform
parent
studi
obtain
nonopposit
caregiv
observ
die
child
death
child
exclud
death
nt
occur
five
next
day
nonexhaust
list
percept
sign
propos
caregiv
fulfil
presenc
absenc
worsen
sign
die
process
result
april
august
patient
includ
exclud
unpredict
death
nonfrench
speaker
parent
oversight
brain
death
median
age
year
chronic
diseas
main
caus
death
respiratori
neurolog
failur
death
follow
limit
withdraw
treatment
patient
frequent
percept
sign
appear
worsen
die
process
concern
child
appear
cyanosi
pallor
marbl
petechia
sometim
respiratori
sign
percept
patient
still
invas
mechan
ventil
time
death
detail
tabl
unsurprisingli
physiolog
paramet
present
die
process
bradycardia
hypotens
desatur
could
notic
parent
monitor
gasp
note
patient
patient
present
digest
neurolog
sign
patient
except
one
receiv
sedoanalgesia
conclus
ifireap
first
prospect
studi
tri
determin
percept
sign
endof
life
picu
frequent
sign
gasp
concern
chang
skin
color
appear
sign
could
hurt
parent
could
easier
support
receiv
inform
onset
next
step
studi
determin
sign
notic
parent
need
explan
impact
inform
experi
introduct
sedationanalgesia
part
manag
ventil
pediatr
patient
must
adjust
patient
object
evalu
implement
nursingdriven
protocol
sedationanalgesia
durat
mechan
ventil
patient
method
beforeandaft
prospect
observ
studi
pediatr
intens
care
unit
includ
children
age
day
year
receiv
mechan
ventil
longer
h
observ
period
sedationanalgesia
administr
accord
medic
prescript
intervent
period
sedationanalgesia
adjust
nurs
accord
protocolbas
sedationanalgesia
guidelin
includ
evalu
comfortb
scale
result
total
children
includ
protocol
decreas
durat
mechan
ventil
protocol
statist
signific
median
durat
day
vs
day
protocol
p
protocol
mean
comfortb
optim
object
fix
protocol
monitor
comfortb
significantli
frequent
decreas
total
dose
hypnot
opioid
complianc
protocol
nurs
insuffici
median
appear
increas
complic
relat
insuffici
sedationanalgesia
autoextub
low
number
medic
alert
procedur
implement
nursingdriven
protocol
sedationanalgesia
children
reduc
durat
mechan
ventil
total
dose
sedationanalgesia
protocol
insuffici
appli
howev
ensur
comfort
ventil
children
safe
result
thirteen
case
aluminum
phosphid
poison
identifi
women
men
averag
age
year
extrem
year
poison
accident
inhal
patient
voluntari
ingest
part
suicid
attempt
patient
delay
intox
admiss
averag
h
glasgow
coma
score
averag
respiratori
sign
forefront
inhal
dyspnea
irrit
cough
wherea
patient
ingest
toxic
shock
stage
abdomin
pain
vomit
present
patient
electr
abnorm
present
patient
conduct
disturb
n
repolar
disord
n
increas
troponin
observ
four
patient
ingest
toxic
mechan
ventil
necessari
case
use
vasoact
amin
patient
use
extraren
cleans
ecmo
perform
one
patient
four
patient
die
highest
mortal
observ
ingest
aluminum
phosphid
factor
significantli
relat
mortal
univari
analysi
wereor
poison
p
cardiogen
shock
p
elev
troponin
p
use
ventilatori
support
p
conclus
acut
aluminum
phosphid
poison
remain
graft
heavi
mortal
especi
develop
countri
absenc
antidot
treatment
rapid
hemodynam
manag
may
help
improv
prognosi
includ
use
circulatori
assist
result
seven
hundr
sixtytwo
patient
includ
studi
averag
age
year
clear
femal
predomin
sex
ratio
two
hundr
fortythre
addict
psychiatr
histori
alreadi
histori
attempt
suicid
averag
time
treatment
h
four
hundr
seventyon
patient
admit
camu
emerg
intox
voluntari
case
secondari
oral
ingest
toxicolog
analysi
show
drug
rank
first
n
pesticid
second
n
carbon
monoxid
third
n
drugspsychotrop
drug
anticonvuls
cardiotrop
antidiabet
paracetamol
common
caus
drug
poison
frequenc
respect
wherea
pesticid
rodenticid
predomin
n
follow
chloralos
n
organophosphoru
n
illeg
drug
crimin
patient
predomin
toxidrom
respect
anticholinerg
serotoninerg
cholinerg
toxidrom
lactic
acidosi
common
biolog
abnorm
follow
biolog
inflammatori
syndrom
rhabdomyolysi
mechan
ventil
requir
case
use
vasoact
amin
case
antidot
prescrib
case
transit
acceler
patient
evolut
benefici
patient
descript
retrospect
studi
case
acut
intox
pesticid
admit
icu
resuscit
care
result
one
hundr
seventynin
case
pesticid
intox
admit
studi
period
repres
acut
intox
case
admit
intens
care
averag
age
addict
year
sex
ratio
poison
occur
home
case
public
space
poison
voluntari
case
accident
patient
came
directli
emerg
case
transfer
hospit
case
rodenticid
implic
type
pesticid
n
chloralos
leader
n
follow
organophosphoru
n
carbam
n
neurolog
sign
tremor
loss
conscious
predomin
n
follow
tachycardia
n
digest
sign
n
respiratori
distress
present
patient
hemodynam
failur
three
inhal
pneumonia
complic
poison
case
use
mechan
ventil
necessari
case
use
vasoact
drug
use
antibiot
therapi
gastric
lavag
perform
patient
atropin
administ
patient
median
length
stay
day
overal
mortal
n
conclus
pesticid
poison
realiti
tunisia
character
variabl
toxic
substanc
avail
countri
neurolog
sign
foreground
origin
major
fatal
complic
taken
care
due
time
appropri
place
camil
jutra
speaker
mainli
hospit
south
countri
studi
molecular
profil
isol
carbapenemas
show
predomin
posit
result
blavim
blandm
gene
case
ie
case
posit
blandm
gene
case
posit
blavim
gene
case
blavim
blandm
gene
geneposit
case
blavim
gene
blandm
gene
parallel
bmr
research
use
convent
bacteriolog
confirm
presenc
carbapenemresist
bgn
pcrposit
specimen
conclus
patient
explor
carrier
carbapenemas
patient
transfer
anoth
hospit
tunisia
highlight
one
hand
need
isol
polici
care
transfer
patient
hand
need
set
control
strategi
spread
mdr
seventythre
patient
requir
mechan
ventil
median
durat
one
day
site
method
screen
mdrb
realis
case
site
method
practic
case
ninetyf
episod
infect
detect
frequent
site
infect
pulmonari
vascular
urinari
multivari
studi
reavel
two
site
method
led
adapt
antibiotherapi
case
versu
five
site
method
p
conclud
two
site
mdrb
screen
method
effici
detect
nosocomi
infect
adjust
emper
antibiotherapi
help
reduc
manag
cost
threaten
watera
potenti
sourc
outbreak
stenotrophomona
maltophilia
french
intens
care
unit
flora
delamair
speaker
introduct
stenotrophomona
maltophilia
sm
nonfer
gramneg
bacterium
nfgnb
caus
seriou
opportunist
infect
repres
major
threat
intens
care
unit
icu
due
multidrug
resist
mdr
outbreak
sm
occur
septemb
januari
icu
gener
hospit
outbreak
control
team
conven
investig
time
epidemiolog
survey
conduct
correct
measur
initi
patient
method
outbreak
investig
combin
clinic
environment
sampl
molecular
type
use
pulsefield
gel
electrophoresi
pfge
patient
infect
colon
sm
period
includ
clinic
data
analyz
result
sixteen
patient
contamin
sm
includ
among
pulmonari
contamin
one
bacteraemia
two
death
probabl
relat
sm
infect
report
admiss
screen
show
outbreak
strain
acquir
icu
median
time
sm
contamin
day
rang
day
thirteen
patient
intub
median
length
day
intub
rang
day
patient
receiv
multiantibiot
treatment
includ
broadspectrum
antibiot
tabl
sm
clinic
strain
genotyp
found
sm
genotyp
patient
environment
sampl
reveal
contamin
almost
sink
sink
icu
contamin
sm
includ
sink
among
patient
room
environment
screen
show
earli
recontamin
siphon
plughol
replac
infect
control
measur
includ
evict
tap
water
patient
care
strengthen
prevent
hygien
measur
made
possibl
control
outbreak
januari
discuss
pfge
result
suggest
outbreak
relat
uniqu
clone
sm
polyclon
colon
icu
water
system
sm
caus
sever
infect
debilit
patient
sourc
inappropri
antibiotherapi
antism
antibiot
integr
probabilist
antibiotherapi
within
icu
contamin
sm
conclus
outbreak
report
highlight
risk
mdr
gramneg
bacterium
contamin
water
system
icu
patient
although
complet
evict
environment
pathogen
imposs
discontinu
outbreak
obtain
infect
control
procedur
pedagogi
reason
evict
result
sampl
taken
surfac
posit
fungal
presenc
divid
mould
yeast
identifi
strain
belong
genera
frequent
aspergillu
candida
mucor
cladosporium
penicillium
trichosporon
predomin
fungi
encount
aspergillusnig
conclus
achiev
profession
servic
provid
safe
environ
patient
punctual
fungal
monitor
need
done
consist
introduct
carbapenemaseproduc
enterobacteriacea
cpe
repres
grow
problem
worldwid
pathogen
resist
avail
antibiot
therefor
challeng
treat
new
delhi
ndm
hydrolyz
penicillin
cephalosporin
first
isol
patient
travel
india
describ
around
world
intens
care
unit
erasm
hospit
brussel
belgium
epidem
case
month
occur
aim
studi
describ
characterist
evolut
colon
infect
patient
screen
patient
colon
infect
cpeproduc
klebsiella
pneumonia
kp
within
rang
month
around
identif
first
case
includ
patient
confirm
ndmkp
genotyp
describ
patient
profil
previou
antibiot
use
infect
type
treatment
outcom
result
five
patient
least
one
sampl
posit
ndmkp
icu
novemb
march
strain
suscept
fosfomycin
also
colistin
chloramphenicol
nt
perform
genotyp
detail
featur
list
tabl
patient
young
mean
year
suffer
sever
medic
condit
patient
stay
icu
subunit
patient
present
infect
relat
ndmkp
mediantim
colon
infect
day
patient
receiv
previou
broadspectrum
antibiotherapi
infect
treat
rare
use
antibiot
highli
toxic
observ
microbiolog
success
patient
relaps
infect
patient
die
caus
death
untrackt
infect
comorbid
colon
patient
surviv
mortal
conclus
ndmproduc
enterobacteriacea
emerg
knowledg
seri
first
describ
locallyacquir
case
belgium
worri
reason
first
colon
infect
ratio
high
attest
high
pathogen
power
pathogen
host
frailti
second
infect
patient
die
despit
earli
target
antimicrobi
therapi
well
known
gene
encod
cpe
usual
plasmidtransmit
fact
patient
previou
broadspectrum
antibiot
therapi
support
statement
howev
speci
found
kp
patient
stay
unit
time
proxim
clear
plead
contact
compon
transmiss
hygien
rule
addit
antibiot
stewardship
therefor
crucial
eric
thebault
speaker
express
supar
protein
significantli
predict
worsen
septic
patient
within
h
admiss
ed
biomark
could
enhanc
earli
identif
sever
patient
appropri
rapid
manag
abl
decreas
risk
poor
outcom
assess
prognost
valu
blood
marker
panel
predict
earli
clinic
worsen
patient
admit
ed
suspect
sepsi
patient
method
triag
prospect
multicent
site
franc
belgium
studi
biolog
sampl
adult
patient
admit
ed
suspect
confirm
communityacquir
infect
least
sir
criteria
includ
protocol
includ
clinic
biolog
time
point
main
outcom
subsequ
deterior
defin
followingdeath
intens
care
admiss
increas
sofa
score
within
h
patient
divid
group
depend
worsen
evolut
criteria
central
evalu
independ
adjud
committe
sepsi
expert
emerg
physician
intensivist
accuraci
prognost
perform
biomark
assess
patient
follow
day
mortal
studi
durat
year
patient
includ
wrongli
includ
n
secondari
exclud
n
patient
analyz
mean
age
charlson
adjud
patient
classifi
worsen
patient
without
deterior
admiss
differ
group
sir
criteria
count
wbc
crp
lactat
cf
tabl
central
analysi
progress
select
combin
biomark
best
prognost
perform
conclus
vital
sign
biolog
marker
paramet
predict
worsen
patient
prognost
valu
panel
blood
marker
ed
could
help
identif
septic
patient
risk
worsen
time
admiss
develop
specif
manag
day
septic
shock
settl
differ
two
group
mean
plasma
concentr
neither
schea
pct
crp
howev
comparison
mean
plasma
concentr
schea
pct
crp
show
signific
differ
survivor
nonsurvivor
tabl
studi
suggest
group
critic
ill
patient
sever
septic
shock
fall
procalcitonin
crp
level
rise
schea
associ
favor
outcom
studi
need
subject
introduct
recent
randomis
clinic
trial
fail
demonstr
non
inferior
procalcitonin
pct
guid
antibiot
therapi
respect
month
mortal
among
patient
sever
acut
exacerb
chronic
obstruct
pulmonari
diseas
aecopd
need
mechan
ventil
explain
result
assess
capac
pct
distinguish
infecti
non
infecti
caus
sever
aecopd
pct
level
patient
time
inclus
h
day
measur
use
sensit
immunoassay
result
regard
cohort
n
time
pct
level
higher
patient
bacteri
infect
n
viral
infect
n
patient
without
document
infect
fig
interestingli
whether
pct
level
tend
higher
patient
bacteri
infect
n
patient
viral
infect
n
pneumon
group
patient
pct
fail
distinguish
bacteri
infect
n
viral
infect
n
non
pneumon
group
patient
conclus
result
underlin
interest
pct
biomark
distinguish
infecti
non
infecti
caus
sever
aecopd
howev
pct
could
fail
distinguish
bacteri
viral
infect
set
rosman
speaker
independ
factor
associ
icu
admiss
within
follow
week
element
differenti
count
elimin
model
sever
eosinopenia
also
significantli
associ
longer
length
stay
bacteremia
vs
septic
shock
within
day
vs
mortal
vs
p
outcom
conclus
sever
eosinopenia
reflect
system
inflamm
independ
factor
associ
icu
admiss
within
day
also
associ
longer
length
stay
bacteremia
septic
shock
mortal
thoma
lafon
speaker
introduct
emerg
depart
ed
earli
appropri
recognit
infect
crucial
start
antibiot
treatment
time
fashion
tradit
biomark
remain
specif
enough
infect
patient
lymphopenia
known
associ
sepsi
icu
yet
evalu
potenti
infect
biomark
ed
contrari
white
blood
cell
wbc
count
routin
wide
perform
part
admiss
assess
investig
whether
isol
clinic
associ
sever
lymphopenia
ed
could
marker
infect
conduct
retrospect
singlecent
studi
yearperiod
adult
patient
admit
ed
sever
lymphopenia
lymphocyt
count
g
l
analyz
patient
hematolog
oncolog
diseas
hiv
infect
hepatocellular
defici
immunosuppress
year
old
exclud
diagnosi
infect
confirm
independ
adjud
committe
correl
lymphopenia
infect
assess
use
univari
analysi
multivari
logist
regress
result
januari
decemb
patient
admit
ed
sever
lymphopenia
elig
men
mean
age
year
infect
confirm
patient
initi
patient
refer
ed
suspect
infect
among
biolog
marker
crp
differ
infect
uninfect
group
vs
p
depth
lymphopenia
associ
higher
preval
infect
bacteremia
microbiolog
identif
figur
multivari
analysi
clinic
criteria
independ
associ
infect
sir
criteriaor
p
feveror
p
contrari
classic
biolog
biomark
appear
associ
infect
wbc
countor
p
crpor
p
preval
infect
high
patient
sever
lymphopenia
regardless
reason
admiss
ed
tradit
biomark
result
easi
measur
marker
could
use
routin
emerg
physician
assist
earli
diagnosi
infect
introduct
prognosi
infect
acut
chronic
liver
failur
aoclf
depend
rapid
diagnosi
may
difficult
absenc
classic
sign
fever
found
neutrophillymphocyt
ratio
nlr
plateletlymphocyt
ratio
plr
regard
cheap
simpl
promis
paramet
predict
sepsi
sever
sever
diseas
aim
evalu
role
nlr
plr
diagnosi
infect
aoclf
retrospect
followup
studi
case
diagnosi
decompens
cirrhosi
januari
decemb
result
total
case
decompens
cirrhosi
enrol
studi
mean
age
year
gender
diagnosi
sepsi
identifi
case
multivari
logist
regress
analys
show
signific
posit
correl
creactiv
protein
crp
p
procalcitonin
p
plr
p
nlr
p
infect
evalu
abil
nlr
crp
procalcitonin
plr
predict
infect
roc
curv
obtain
evalu
paramet
nlr
show
strong
statist
signific
correl
high
concord
correl
coeffici
conclus
infect
one
lead
caus
hospit
patient
decompens
cirrhosi
associ
consider
mortal
clinician
seek
use
easili
obtain
biomark
studi
shown
plr
nlr
good
marker
predict
infect
aoclf
result
among
patient
studi
ci
anxieti
ci
depress
symptom
ci
ptsd
anxieti
depress
ptsd
defin
had
score
predict
factor
age
anxieti
p
risk
factor
psychiatr
comorbid
signific
memori
disord
seem
favor
ptsd
well
sepsi
presenc
favor
anxieti
noninvas
ventil
favor
anxieti
depress
signific
chang
preval
due
profession
practic
evolut
conclus
anxieti
depress
ptsd
critic
ill
common
detect
predictor
allow
earli
multidisciplinari
manag
patient
order
reduc
preval
introduct
postintens
care
syndrom
sum
cognit
psychiatr
physic
sequela
hospit
intens
care
unit
frequent
sequela
seriou
impact
qualiti
life
autonomi
morbid
mortal
patient
last
sever
year
initi
hospit
although
consensu
intens
care
unit
team
frequent
schedul
visit
assess
physic
mental
statu
patient
discharg
ward
clinic
interest
practic
evidenc
yet
patient
method
sinc
followup
visit
intens
care
unit
discharg
set
intens
ward
tour
univers
hospit
centr
order
detect
potenti
occurr
postintens
care
syndrom
patient
patient
admit
acut
respiratori
distress
syndrom
septic
shock
elig
conduct
descript
studi
cohort
assess
evolut
patient
inform
studi
could
declin
particip
result
thirtyeight
patient
summon
reevalu
followup
visit
month
discharg
among
admit
icu
acut
respiratori
distress
syndrom
septic
shock
acut
respiratori
distress
syndrom
septic
shock
anoth
diagnosi
acut
respiratori
failur
sever
intox
thirteen
patient
still
hospit
rehabilit
followup
visit
day
among
remain
patient
consult
gener
practition
yet
fourteen
patient
present
cognit
alter
patient
psychiatr
troubl
patient
physic
sequela
respiratori
one
patient
two
sequela
least
domain
post
intens
care
syndrom
patient
sequela
figur
fifteen
patient
reevalu
month
discharg
show
global
improv
statu
persist
defici
overal
refer
specialist
modif
treatment
followup
visit
conclus
observ
studi
confirm
frailti
patient
discharg
intens
care
unit
patient
present
troubl
belong
field
post
intens
care
syndrom
highlight
potenti
interest
earli
reevalu
introduct
congress
place
exchang
updat
medic
knowledg
howev
cost
neglig
profit
train
particip
remain
unclear
studi
purpos
studi
identifi
young
intensivit
fund
particip
congress
selfquestionnair
french
sent
young
doctor
specialti
mail
list
intern
peopl
survey
characterist
attend
confer
fund
staff
total
contribut
rel
data
anonym
questionnair
regist
cnil
result
period
studi
patient
admit
burn
icu
patient
includ
mean
age
year
ratio
sex
averag
tbsa
total
bodi
surfac
area
earli
icu
mortal
n
patient
assign
n
survivor
n
compar
studi
group
follow
tabl
tabl
compar
studi
group
conclus
optim
initi
fluid
resuscit
burn
patient
associ
lower
fluid
overload
first
h
improv
earli
outcom
lower
earli
mortal
introduct
static
marker
cardiac
preload
central
venou
pressur
cvp
remain
help
variabl
bedsid
guid
hemodynam
manag
criticallyil
patient
sinc
transthorac
echocardiographi
tte
current
firstlin
tool
evalu
hemodynam
condit
criticallyil
patient
aim
assess
abil
tte
estim
track
chang
cvp
patient
mechan
ventil
four
atrial
fibril
concomit
cvp
measur
intern
jugular
cathet
tte
examin
perform
passiv
leg
rais
test
infus
salin
calcul
tricuspid
e
wave
ratio
tricuspid
e
e
wave
ratio
right
ventricular
isovolum
time
ivrt
e
ivrt
ratio
wave
ratio
suprahepat
vein
flow
vtisystol
fill
fraction
peak
velocitiessystol
fill
fraction
suprahepat
vein
flow
endexpiratori
diamet
inferior
vena
cava
ivc
respiratori
variat
ivc
diamet
statist
analysi
consid
cvp
threshold
valu
mmhg
clinic
relev
result
chang
cvp
induc
passiv
leg
rais
test
patient
fluid
administr
patient
pool
valu
endexpiratori
ivc
diamet
respiratori
variat
ivc
diamet
correl
cvp
r
r
respect
p
baselin
endexpiratori
ivc
diamet
mm
predict
cvp
mmhg
specif
sensit
endexpiratori
ivc
diamet
mm
predict
cvp
mmhg
specif
sensit
baselin
respiratori
variat
ivc
diamet
could
predict
neither
cvp
mmhg
cvp
mmhg
auc
p
rel
chang
ratio
vtisystol
fill
fraction
correl
rel
chang
cvp
r
r
respect
p
concord
rate
chang
ratio
cvp
concord
rate
chang
vtisystol
fill
fraction
cvp
conclus
criticallyil
patient
tte
reliabl
estim
cvp
track
chang
cvp
induc
chang
cardiac
preload
nevertheless
endexpiratori
ivc
diamet
ou
mm
mm
detect
cvp
ou
mmhg
mmhg
respect
specif
sebastian
knudsen
speaker
introduct
arteri
elast
ea
ventricular
end
systol
elast
ee
shown
link
way
may
optim
effici
convert
left
ventricular
power
forward
flow
relationship
may
disrupt
sepsi
devis
pilot
studi
investig
feasibl
use
speckl
track
echocardiographi
ste
examin
ea
surrog
convent
equat
base
blood
pressur
stroke
volum
icu
patient
chose
group
septic
patient
group
nonsept
patient
attempt
demonstr
decoupl
ea
ee
use
convent
equat
use
ste
patient
method
septic
nonsept
patient
underw
echocardiograph
carotid
arteri
examin
invas
blood
pressur
measur
echocardiograph
measur
stroke
volum
eject
fraction
use
calcul
ea
ee
convent
mean
carotid
ste
perform
analyz
circumferenti
strain
strainrat
result
studi
ea
feasibl
use
ste
patient
ea
correl
circumferenti
strain
r
p
strainrat
r
p
use
convent
method
demonstr
relationship
ea
ee
r
p
ee
circumferenti
strain
r
p
circumferenti
strain
rate
p
differ
septic
nonsept
patient
regard
ste
ea
ea
ee
conclus
speckl
track
echocardiographi
ste
feasibl
way
examin
elast
great
arteri
icu
patient
differ
observ
septic
nonsept
patient
regard
arteri
elast
assess
use
convent
method
ste
associ
fluid
overload
sofa
score
kinet
admiss
day
septic
shockresult
epigo
studi
xavier
chapalain
speaker
introduct
fluid
infus
one
cornerston
sepsi
resuscit
therapi
howev
paradigm
shift
current
occur
concern
rais
potenti
advers
effect
fluid
therapi
one
major
advers
effect
report
fluid
overload
fo
fo
defin
fluid
accumul
baselin
bodi
weight
object
studi
assess
influenc
fo
sofa
score
chang
day
day
studi
retrospect
multicent
epidemiolog
data
analysi
adult
patient
admit
septic
shock
caus
periton
pneumonia
mechan
ventil
enrol
studi
delta
sofa
score
defin
sofa
score
measur
admiss
minu
sofa
score
measur
day
bivari
analysi
perform
parametr
test
nonparametr
test
multivari
analysi
perform
studi
associ
fo
delta
sofa
score
result
patient
met
inclus
criteria
studi
cumul
fluid
balanc
day
greater
fo
group
betweengroup
differ
ml
pvalu
delta
sofa
score
twofold
higher
fo
group
fo
group
differ
two
group
pvalu
patient
without
fo
rapidli
discharg
icu
compar
patient
fo
one
week
less
mechan
ventil
compar
fo
patient
pvalu
stepwis
decreas
delta
sofa
score
durat
fluid
overload
greater
pvalu
linear
model
associ
fluid
overload
statu
delta
sofa
score
confirm
adjust
relativerisk
pvalu
studi
report
exposit
fluid
overload
frequent
event
occur
patient
cohort
fluid
overload
patient
prolong
multiorgan
failur
septic
shock
introduct
comatos
patient
antiepilept
drug
a
usual
administ
nasogastr
tube
ngt
popul
often
residu
plasma
concentr
a
outsid
therapeut
rang
object
studi
estim
modal
administr
a
ngt
variou
intens
care
unit
tuni
studi
consist
investig
modal
administr
a
ngt
resid
intens
care
four
month
prepar
question
includ
demograph
inform
particip
voluntari
anonym
questionnari
distribut
seven
intens
care
depart
author
head
depart
resid
includ
result
resid
sexratio
mean
age
year
period
ngt
replac
perform
averag
respons
day
resid
thought
a
administ
time
food
account
total
popul
accord
resid
dosag
form
administ
ngt
use
intens
care
unit
tablet
think
crush
administr
introduc
drug
ngt
resid
thought
mix
tap
water
resid
respond
treatment
introduc
dri
ngt
accord
resid
use
a
resuscit
servic
phenobarbit
resid
respond
detect
possibl
overdos
therapeut
drug
monitor
best
way
a
adjust
particular
popul
among
resid
express
need
train
modal
administr
treatment
ngt
improv
knowledg
manag
comatos
a
requir
control
method
administr
ngt
thu
action
strategi
put
place
improv
knowledg
medic
sector
subject
bacteri
coinfect
occur
patient
detect
virus
influenza
n
parainfluenza
n
respiratori
syncyti
viru
rsv
n
upper
respiratori
airway
infect
frequent
caus
myasthenia
gravi
exacerb
despit
popul
immunosuppress
olivi
carelli
speaker
test
prove
feasibl
fast
univers
hospit
univers
affili
teach
hospit
would
high
valu
confirm
nonunivers
icu
main
outcom
studi
predict
abil
epredelir
diagnos
delirium
therefor
correl
posit
epredelir
score
icdsc
score
intens
care
delirium
screen
checklist
search
subsequ
analysi
perform
epredeler
use
cardiac
surgeri
vs
patient
also
compar
abil
epredeler
apach
ii
score
predict
delirium
patient
method
studi
approv
medic
ethic
committe
patient
sign
inform
consent
data
patient
collect
secur
electron
system
consecut
patient
age
includ
period
patient
exclud
cognit
dysfunct
known
admiss
chronic
alcohol
epredeler
score
calcul
physician
h
admiss
presenc
delirium
screen
nurs
period
five
day
icdsc
scale
nic
nurs
instrument
commun
sedat
score
result
patient
elig
analysi
overal
incid
delirium
highest
incid
newonset
delirium
day
result
roc
analysi
figur
show
epredelir
score
highli
discrimin
seen
studi
higher
incid
delirium
post
cardiac
surgeri
group
patient
three
time
delirium
group
compar
gener
popul
e
predeler
score
threshold
one
combin
maxim
sensit
specif
maximum
youden
index
apach
ii
score
threshold
would
epredelir
score
discrimin
power
apach
ii
score
auc
epredelir
delirium
predict
model
reliabl
remain
fast
easi
gener
nonunivers
icu
character
great
turnov
patient
caregiv
rather
low
nursetopati
ratio
allow
earli
prevent
measur
aim
reduc
delirium
incid
high
risk
patient
abil
epredeler
score
predict
delirium
roc
curv
analysi
omar
ben
hadj
salem
speaker
two
a
associ
patient
a
associ
drug
case
polymed
drug
note
case
a
subtherapeut
case
vpa
subtherapeut
case
among
sampl
correspond
valu
dp
lower
recommand
one
sampl
present
least
one
drug
associ
concern
a
case
drug
associ
nonrespect
ngt
modal
a
administr
patient
conclus
tdm
use
tool
assess
drugdrug
interact
control
modal
a
administr
comatos
patient
diagnost
pitfal
treatment
issu
larg
seri
patient
select
prospect
populationbas
registri
final
diagnosi
ohca
neurolog
caus
ohcanc
furthermor
also
aim
identifi
factor
associ
use
icag
first
line
investig
initi
diagnost
checkup
figur
pmuscalcl
calcul
peak
inspiratori
flow
correl
actual
peak
pmu
r
p
addit
seem
better
correl
pmu
r
p
pmuscalcl
definit
result
includ
eit
assess
present
meet
conclus
preliminari
data
suggest
potenti
interest
analyz
vt
valu
evolut
psl
titrat
furthermor
new
calcul
tool
pmuscalc
may
help
clinician
assess
respiratori
effort
bedsid
person
level
assist
immunocompromis
intens
care
unit
icu
popul
associ
prognosi
bodi
mass
index
bmi
never
assess
object
studi
influenc
bmi
icu
immunocompromis
patient
mortal
risk
factor
icu
mortal
accord
bmi
patient
method
post
hoc
analysi
prospect
multin
cohort
studi
perform
countri
immunocompromis
acuterespiratoryfailur
arf
patient
conduct
primari
endpoint
icumort
rate
impact
bmi
icumort
risk
factor
accord
bmi
analys
use
multivari
cox
analysi
best
threshold
separ
dead
aliv
patient
determin
use
youden
index
result
patient
bmi
avail
overal
icumort
rate
ninetyon
patient
underweight
icumort
normal
weight
icumort
overweight
icumort
obes
grade
icumort
obes
grade
icumort
obes
grade
icumort
multivari
cox
analysi
includ
initi
oxygen
strategi
sequenti
organ
failur
assess
sofa
score
without
respiratori
item
ratio
icu
admiss
invas
mechan
ventil
pattern
chest
x
ray
etiolog
arf
higher
bmi
significantli
associ
lower
mortal
rate
adjust
hr
ahr
p
centr
effect
observ
two
bmi
group
separatedlow
high
bmi
adjust
risk
die
lower
high
bmi
group
compar
low
bmi
group
ahr
p
multivari
cox
analysi
risk
factor
mortal
common
groupssofa
score
without
respiratori
item
niv
use
invas
mechan
ventil
found
low
bmi
ratio
mmhg
alveolarinterstiti
radiolog
pattern
figur
immunocompromis
arf
patient
higher
bmi
associ
lower
mortal
contrari
low
bmi
group
ratio
radiolog
pattern
associ
mortal
high
bmi
group
result
suggest
ratio
radiolog
pattern
reliabl
predict
prognosi
obes
arf
patient
might
one
explan
invers
adjust
associ
observ
icu
mortal
bmi
introduct
critic
ill
patient
intens
care
unit
icu
acquir
weak
complic
commonli
observ
associ
poor
outcom
increas
length
stay
assess
skelet
muscl
diaphragm
icuassoci
morpholog
chang
usual
appreci
ultrasonographi
shear
wave
elastographi
swe
novel
techniqu
allow
measur
absolut
elast
valu
kpa
soft
tissu
quantifi
mechan
properti
therefor
aim
determin
reliabl
reproduc
ultrasonograph
swe
measur
critic
ill
patient
patient
method
first
phase
two
oper
test
healthi
subject
variou
probe
posit
order
select
reproduc
among
best
probe
posit
use
examin
intra
interoper
reliabl
healthi
subject
second
phase
intra
interoper
reliabl
elastographi
evalu
critic
ill
patient
introduct
acquir
von
willebrand
syndrom
avw
hemostasi
disord
wide
describ
differ
extracorpor
circulatori
assist
convers
data
avail
field
extracorpor
remov
report
result
prospect
monocentr
studi
focus
von
willebrand
disord
induc
devic
patient
method
prospect
studi
perform
consecut
patient
treat
either
hemolung
ila
activv
devic
biolog
test
includedplatelet
function
analyzeradenosin
diphosph
pfaadp
epinephrin
pfaepi
von
willebrand
factor
antigen
vwf
ag
activ
vwf
rco
multimer
profil
hydrasi
system
measur
perform
prior
initi
min
daili
h
stop
bleed
thrombot
event
record
result
hemolung
use
patient
ila
activv
januari
juli
indic
acut
exacerb
chronic
obstruct
pulmonari
diseas
n
acut
respiratori
distress
syndrom
n
sever
acut
asthma
n
signific
prolong
pfaadp
median
time
versu
p
pfaepi
versu
p
observ
patient
one
patient
miss
data
normal
respect
among
patient
test
h
stop
vwf
rco
vwf
ag
ratio
decreas
patient
min
median
ratio
versu
figur
ratio
normal
h
cessat
patient
test
loss
high
molecular
weight
multim
occur
patient
test
n
earli
min
median
ratio
versu
associ
increas
low
molecular
weight
multim
figur
fourteen
bleed
event
report
nine
thrombot
event
report
right
intern
jugular
cannul
site
devic
thrombosi
trend
pronounc
decreas
high
molecular
weight
multim
patient
bleed
event
conclus
von
willebrand
disord
observ
patient
may
contribut
least
part
frequenc
sever
bleed
complic
observ
popul
introduct
aim
identifi
characterist
patient
sever
acut
exacerb
chronic
obstruct
pulmonari
diseas
copd
evalu
prognost
copd
patient
patient
method
retrospect
studi
perform
period
icu
habib
bourguiba
univers
hospit
sfax
tunisia
patient
sever
acut
exacerb
copd
includ
studi
period
patient
acut
exacerb
copd
admit
icu
emphysema
patient
mean
age
sd
year
sex
ratio
common
comorbid
hypertens
patient
cardiac
failur
situat
diabet
case
mean
sapsii
score
icu
admiss
patient
acut
circulatori
failur
patient
requir
mechan
ventil
mortal
rate
studi
around
length
stay
lo
length
invas
ventil
median
icu
stay
evolut
mark
death
patient
mortal
significantli
higher
patient
cardiac
failur
vs
p
necessit
introduct
catecholamin
admiss
vs
p
high
plasma
urea
plasma
creatinin
concentr
significantli
associ
mortal
p
p
respect
conclus
copd
exacerb
frequent
caus
hospit
icu
sever
form
requir
mechan
ventil
associ
poor
outcom
develop
shock
acut
kidney
injuri
significantli
associ
mortal
eighti
nine
patient
enrol
mean
age
year
male
femal
ratio
seventi
nine
percent
smoker
classifi
gold
stage
histori
noninvas
ventil
niv
invas
ventil
iv
found
case
respect
mean
progress
copd
year
mean
exacerb
frequenc
per
year
mean
durat
symptom
hospit
dsbh
day
mean
sap
ii
apach
ii
respect
mean
ph
mmhg
respect
mean
gc
less
case
predomin
precipit
factor
acut
exacerb
ae
respiratori
tract
infect
case
thirti
two
percent
patient
septic
choc
admiss
symptomat
treatment
base
inhal
bronchodil
corticosteroid
mechan
ventilationniv
iv
case
twenti
two
patient
intub
immedi
hospit
niv
failur
mortal
durat
copd
progress
p
exacerb
frequenc
per
year
p
prior
iv
p
dsbh
p
sap
ii
p
gc
p
ph
p
septic
choc
admiss
p
predict
iv
univari
analysi
gc
p
signific
multivari
analysi
conclus
requir
iv
aecopd
depend
sever
underli
respiratori
ill
graviti
ae
qualiti
earli
manag
thu
basic
treatment
improv
earli
appropri
treatment
ae
might
reduc
sever
need
iv
jeanloup
augi
speaker
monocentr
observ
ancillari
studi
rexecor
studi
patient
present
sever
exacerb
copd
implant
hemolung
alung
technolog
pittsburgh
usa
assess
transthorac
echocardiographi
tte
baselin
one
hour
start
imv
ventil
paramet
kept
unmodifi
two
hour
one
hour
begin
tte
data
imv
paramet
arteri
blood
ga
simultan
collect
result
seven
patient
women
median
age
year
median
bodi
mass
index
kg
includ
novemb
februari
median
admiss
respiratori
sofa
regard
tte
find
patient
rv
hypertrophi
rv
free
wall
superior
mm
mm
rv
dysfunct
report
mean
st
cm
mean
taps
mm
induc
signific
variat
mmhg
mmhg
p
ph
p
figur
show
evolut
echo
paramet
differ
wave
valu
signific
reduct
p
wherea
systol
pulmonari
arteri
pressur
spap
decreas
significantli
mmhg
mmhg
p
pulmonari
vascular
resist
pvr
also
significantli
decreas
vs
p
note
paramet
assess
lv
function
chang
flow
variat
conclus
physiolog
studi
decreas
induc
flow
variat
lead
decreas
spap
without
modifi
systol
rv
function
paramet
introduct
comorbidom
correspond
comorbid
frequent
associ
copd
cardiovascular
diseas
diabet
oetoporosi
sarcopenia
carri
signific
impact
mortal
distribut
type
comorbid
vari
studi
agreement
exist
five
phenotyp
comorbiditiesth
current
studi
conduct
determin
associ
specif
comorbid
icu
surviv
acut
exacerb
copd
patient
method
consecut
patient
admit
icu
hypercapn
exacerb
copd
classifi
accord
associ
comorbid
five
clustersclust
includ
cardiac
profil
cluster
includ
less
comorbid
cluster
includ
metabol
syndrom
apnea
anxietydepress
cluster
includ
denutrit
sarcopenia
cluster
includ
bronchiectasi
patient
standard
ventilatori
niv
standard
mv
pharmacolog
nebul
agonist
steroid
anticholinerg
manag
discharg
statu
dead
aliv
compar
identifi
comorbid
cluster
result
studi
period
patient
mean
age
year
male
consecut
admit
icu
definit
diagnosi
aecopd
niv
use
primari
ventil
modal
remain
convent
invas
ventil
icu
mortal
occur
follow
mean
icu
ventilatori
support
durat
day
day
respect
figur
depict
rel
mortal
comorbid
cluster
differ
observ
mortal
rate
cluster
statist
signific
current
studi
show
comorbid
phenotyp
copd
associ
short
term
outcom
icu
mortal
follow
exacerb
nosolog
framework
carri
prognost
inform
potenti
impact
clinic
decis
could
made
manag
patient
aim
studi
assess
frequenc
patient
admit
hypercapn
respiratori
failur
without
prior
pulmonari
diagnosi
assign
final
diagnosi
emphasi
morbid
overlap
patient
method
consecut
patient
admit
icu
hypercapn
respiratori
failur
demograph
clinic
data
pertain
current
prior
hospitalis
record
patient
manag
acut
episod
consid
icu
discharg
follow
performedpulmonari
ct
scan
particular
emphasi
emphysema
fibrosi
pattern
spirometri
diagnosi
obstruct
lung
diseas
transthorac
cardiac
echographi
nocturn
polygraphi
diagnosi
sleep
apnea
syndrom
ahi
result
studi
period
patient
mean
age
year
male
consecut
admit
sever
hypercapn
respiratori
failur
requir
ventilatori
support
niv
start
patient
failur
rate
tabl
report
pulmonari
diseas
eventu
adjud
admiss
icu
discharg
conclus
reliabl
inform
actual
lung
diseas
patient
admit
hypercapn
respiratori
failur
often
lack
icu
admiss
studi
highlight
frequenc
copd
bronchiectasi
obesityhypoventil
syndrom
patient
overlap
frequent
present
patient
need
character
evolutionari
geniu
short
long
term
introduct
despit
wide
spread
use
home
mechan
ventil
hmv
treat
chronic
hypercapn
respiratori
failur
complianc
hmv
among
patient
seldom
systemat
studi
evalu
outcom
icu
survivor
requir
home
mechan
ventil
also
interest
aim
determin
patient
complianc
home
mechan
ventil
indic
discharg
determin
patient
outcom
qualiti
life
within
three
month
discharg
patient
method
retro
pectiv
observ
studi
conduct
medic
icu
consecut
patient
discharg
icu
home
mechan
ventil
januari
decemb
includ
data
collect
involv
patient
demograph
past
histori
underli
diseas
function
state
clinic
paraclin
therapeut
icu
stay
cours
characterist
discharg
data
type
mode
indic
home
mechan
ventil
gather
complianc
report
obtain
provid
one
three
month
use
vital
statu
qualiti
life
assess
st
georg
hospit
respiratori
problem
sgrq
estim
via
phone
call
three
month
discharg
result
among
tal
icu
admit
patient
requir
mechan
ventil
patient
discharg
hmv
via
noninvas
ventil
tracheostomi
tppv
mean
age
predominantli
chronic
respiratori
failur
copd
mmrc
score
iii
iv
alreadi
hmv
patient
least
two
comorbid
charlson
comorbid
index
admiss
mean
sapsii
median
icu
stay
day
discharg
complianc
report
obtain
patient
respect
mean
percentag
daili
use
home
niv
tppv
h
per
day
respect
twelv
patient
readmit
mortal
three
month
estim
health
relat
qualiti
life
assess
sgqr
show
signific
impair
mean
total
score
symptom
score
activ
score
impact
score
compar
popul
norm
total
score
symptom
score
activ
score
impact
score
conclus
present
studi
show
rather
poor
vital
function
outcom
three
month
discharg
hmv
albeit
satisfi
hmv
complianc
introduct
simul
intens
care
innov
method
teach
respiratori
set
respons
asynchroni
may
increas
mortal
patient
reason
develop
simul
spontan
artifici
ventil
simva
virtual
breath
patient
mathemat
model
resolv
differenti
equat
chest
lung
movement
accord
inspiratori
effort
order
match
clinic
databas
goal
studi
evalu
asynchroni
index
ai
virtual
copd
patient
accord
pressur
support
ps
level
inspiratori
time
ti
compar
result
studi
thill
et
al
patient
method
virtual
case
copd
defin
thorac
pulmonar
complianc
total
resist
lung
volum
inspiratori
adapt
muscl
pressur
asynchroni
index
patient
ineffect
effort
ie
ie
ventil
respiratori
rate
ventilatori
protocol
baselinep
optimalp
optimalti
optim
meant
decreas
ps
ti
order
reduc
ai
describ
thill
et
al
virtual
case
titrat
protocol
ai
record
compar
result
thill
et
al
optim
protocol
titrat
ps
ti
order
reduc
ai
softwar
simul
correspond
valu
tidal
volum
respiratori
frequenc
effect
intrins
peep
ga
trap
differ
set
respiratori
mechan
virtual
case
patient
signific
tabl
conclus
ai
abl
chang
accord
ps
ti
set
within
rang
studi
thill
et
al
simul
softwar
simva
realist
may
help
teach
interact
ventilatori
set
asynchroni
copd
patient
pressur
support
ventil
anywher
without
risk
patient
introduct
aim
determin
incid
prognost
impact
mortal
length
intens
care
unit
icu
stay
lo
pulmonari
embol
pe
critic
ill
patient
sever
acut
exacerb
chronic
obstruct
pulmonari
diseas
copd
patient
method
retrospect
studi
perform
period
icu
habib
bourguiba
univers
hospit
sfax
tunisia
patient
sever
acut
exacerb
copd
includ
diagnosi
pe
confirm
spiral
comput
tomographi
scan
show
one
fill
defect
obstruct
pulmonari
arteri
branch
result
studi
period
patient
acut
exacerb
copd
admit
icu
mean
age
standard
deviat
year
icu
stay
patient
develop
pe
diagnosi
confirm
within
h
icu
admiss
case
comparison
two
group
without
pe
show
baselin
characterist
howev
patient
pe
group
develop
shock
icu
admiss
icu
stay
icu
mortal
significantli
higher
pe
group
vs
p
addit
icu
lo
significantli
higher
pe
group
pefre
group
p
conclus
studi
show
pe
common
patient
sever
copd
exacerb
requir
icu
admiss
moreov
pe
significantli
associ
higher
mortal
icu
lo
critic
ill
patient
sever
copd
exacerb
introduct
impact
home
ventil
surviv
patient
chronic
respiratori
failur
still
debat
studi
includ
patient
chronic
hypercapnia
away
hospitalis
show
posit
effect
frequenc
exacerb
impact
home
ventil
surviv
patient
discharg
icu
well
proven
current
studi
report
long
term
surviv
accord
use
home
ventil
patient
method
patient
surviv
icu
stay
hypercapn
respiratori
failur
consid
home
ventil
follow
basisfrequ
exacerb
longterm
oxygenotherapi
obstruct
lung
diseas
sign
nocturn
hypoventil
restrict
lung
diseas
vital
statu
check
januari
kaplanmei
surviv
curv
drawn
log
rank
statist
test
result
studyperiod
patient
fulfil
inclus
criteria
includ
studi
mean
age
year
male
major
copd
home
ventil
administ
patient
remain
mean
followup
month
patient
home
ventil
significantli
longer
surviv
patient
without
home
ventil
log
rank
figur
conclus
home
ventil
associ
prolong
surviv
icu
patient
surviv
hypercapn
respiratori
failur
fragil
reliabl
conclus
anesthesia
critic
care
random
trial
statist
signific
findingsa
systemat
review
grolleau
speaker
introduct
fragil
index
fi
repres
number
patient
respons
statist
signific
find
suggest
aid
interpret
robust
result
clinic
trial
small
fi
indic
statist
signific
trial
depend
event
object
calcul
fi
statist
signific
result
random
control
trial
rct
anesthesia
critic
care
intervent
determin
frequenc
distort
present
result
spin
patient
method
systemat
search
medlin
januari
februari
identifi
rct
explor
effect
critic
care
medicin
anesthesia
intervent
studi
includ
random
patient
two
parallel
arm
report
least
one
statist
signific
p
binari
outcom
primari
secondari
two
review
independ
assess
elig
extract
data
fi
determin
chosen
outcom
assess
level
spin
neg
trial
presenc
recommend
clinic
practic
posit
trial
result
identifi
elig
rct
median
sampl
size
patient
interquartil
rang
iqr
median
fi
iqr
mean
ad
three
event
one
trial
treatment
arm
elimin
statist
signific
trial
fi
zero
statist
signific
outcom
found
nonsignific
recalcul
pvalu
use
fisher
exact
test
high
spin
identifi
n
neg
rct
n
posit
rct
provid
recommend
lower
level
spin
recommend
associ
public
journal
high
impact
factor
p
conclus
statist
signific
result
anesthesia
critic
care
rct
often
fragil
studi
conclus
frequent
affect
spin
routin
calcul
fi
medic
literatur
may
allow
better
understand
trial
therefor
enhanc
qualiti
report
introduct
risk
admit
icu
patient
end
life
increas
age
popul
yet
usual
easi
discern
priori
hospit
presag
fatal
outcom
signific
potenti
recoveri
limit
lifesupport
therapi
llst
becom
current
practic
icu
mani
countri
includ
tunisia
lack
legal
framework
practic
aim
studi
evalu
magnitud
llst
among
intensivist
practic
differ
healthcar
facil
patient
method
questionnair
address
icu
physician
practic
univers
nonunivers
hospit
tunisia
invit
particip
respond
anonym
questionnair
limit
activ
cessat
care
questionnair
includ
descript
particip
workplac
characterist
frequenc
end
life
situat
daili
practic
insight
way
handl
situat
without
extern
help
health
worker
result
intensivist
year
experi
practic
princip
icu
belong
univers
hospit
answer
questionnair
particip
found
limit
lifesupport
therapi
ethic
accept
activ
shorten
die
process
major
comfort
withhold
withdraw
lifesupport
therapi
declar
practic
llst
addit
said
awar
practic
icu
estim
icu
death
preced
llst
around
formal
written
llst
polici
present
unwritten
polici
declar
polici
one
senior
icu
doctor
usual
take
part
decisionmak
regard
llst
singl
senior
icu
doctor
icu
nurs
care
patient
consid
request
limit
lifesustain
therapi
patient
famili
surrog
rare
comfort
talk
llst
famili
strongli
agre
principl
give
analges
painkil
llst
ensur
absenc
pain
termin
stage
even
death
may
hasten
use
regret
lack
ethic
consult
committe
conclus
limit
lifesupport
therapi
frequent
practic
tunisian
icu
although
formal
legisl
academ
frame
lack
intensivist
claim
legal
framework
practic
accord
subtyp
dflst
withhold
withdraw
subtyp
infect
sepsi
septic
shock
signif
statist
differ
hospit
mortalityfor
sepsi
patient
without
dflst
patient
withhold
patient
withdraw
p
septic
shock
patient
without
dflst
patient
withhold
patient
withdraw
p
figur
earli
predict
factor
dflst
multivari
analysisag
ic
p
metastat
cancer
ic
p
respiratori
ic
p
renal
ic
p
neurolog
ic
p
item
initi
sofa
score
fungal
infect
ic
p
conclus
dflst
independ
factor
mortal
patient
sepsi
septic
shock
icu
result
may
influenc
clinic
practic
show
necess
collect
dflst
studi
sinc
medic
decis
withhold
withdraw
treatment
patient
unabl
express
wish
legal
frame
leonetti
lawsuch
resolut
adopt
socal
collegi
reflect
procedur
regard
deliber
preced
decis
medic
societi
ethic
reflect
committe
issu
recommend
term
standard
train
transpar
studi
aim
evalu
delib
member
percept
collegi
procedur
implement
french
medic
intens
care
unit
main
object
survey
assess
role
collegi
procedur
within
decisionmak
process
core
issuei
deliber
perceiv
approv
decis
alreadi
taken
ethic
discuss
lie
heart
decisionmak
patient
method
percept
nurs
nurs
aid
resid
doctor
assess
use
fivesect
questionnair
openend
multipl
answer
question
characterist
patient
admit
icu
well
collegi
procedur
undertaken
period
collect
result
formal
collegi
procedur
patient
admit
regist
attend
least
resid
nurs
doctor
analysi
questionnair
fill
doctor
resid
nurs
nurs
aid
show
global
satisfact
regard
organ
durat
exchang
consider
particip
opinion
nurs
aid
often
absent
deliber
show
moder
implic
decis
make
contribut
specif
aspect
individu
care
desir
healthcar
profession
caregiv
also
deplor
limit
involv
extern
consult
whose
role
would
provid
neutral
expertis
patient
condit
base
examin
respons
openend
question
seem
necessari
reposit
collegi
procedur
within
complex
delib
process
gradual
lead
throughout
hospit
stay
conting
revoc
decis
forego
certain
treatment
deem
useless
disproportion
object
artifici
preserv
life
conclus
despit
limit
number
particip
singlecent
studi
suggest
sever
refin
improv
collegi
reflect
procedur
term
legal
ethic
knowledg
organ
attend
introduct
organ
donat
transplant
remain
requir
morocco
year
see
number
patient
need
organ
transplant
od
get
bigger
face
real
shortag
od
moroccan
student
repres
young
gener
could
key
futur
improv
organ
transplant
lead
studi
order
determin
knowledg
aspir
concern
life
save
therapi
patient
method
descript
prospect
studya
survey
lead
eight
higher
educ
institut
use
preestablish
questionnair
analyz
main
themesknowledg
assess
opinion
toward
od
caus
way
improv
countri
data
analyz
use
spss
softwar
question
alreadi
heard
od
awar
possibl
practic
morocco
idea
lethal
diseas
requir
use
transplant
abl
identifi
transplant
organ
tissu
underestim
number
peopl
wait
transplant
thought
act
organ
remov
transplant
done
privat
clinic
awar
law
govern
od
morocco
trust
law
ignor
registr
step
donat
accept
regist
convinc
perfect
compat
od
muslim
religion
major
student
favor
od
among
group
respond
refus
donat
organ
right
refus
religi
obstruct
top
list
determin
refus
respect
preval
student
express
opinion
rel
conclus
studi
show
young
moroccan
support
od
despit
limit
knowledg
subject
develop
therapi
must
go
inform
regular
motiv
peopl
gener
confer
seminar
repres
solut
spread
awar
among
gener
order
establish
strong
polici
organ
donat
earli
futur
hanan
ezzouin
speaker
introduct
encephal
death
organ
donat
wide
debatedth
promot
organ
donat
includ
brain
dead
donor
requir
us
explor
concept
among
populationw
aim
evalu
knowledg
attitud
consult
nonunivers
hospit
center
concern
organ
donat
concept
brain
death
patient
method
carri
descript
studi
one
year
moroccan
nonunivers
hospit
center
target
popul
consult
hospit
center
questionnair
fill
anonym
aim
evalu
organ
donat
knowledg
concept
brain
death
organ
transplant
braindead
patient
wear
voluntari
organ
donor
card
discuss
donat
famili
organ
famili
consent
case
cadaver
donor
receiv
organ
live
donor
donat
organ
religion
result
peopl
includ
averag
age
year
male
predomin
valu
associ
organ
donat
save
live
gestur
chariti
gestur
altruism
know
encephal
death
know
donat
organ
patient
state
brain
death
know
contraind
organ
donat
patient
state
encephal
death
agre
donat
one
organ
organ
donat
purpos
treat
patient
without
opinion
refus
carri
voluntari
organ
donor
card
agre
receiv
organ
live
donor
receiv
organ
deceas
donor
never
report
posit
love
one
favor
organ
donat
death
repli
muslim
religion
allow
live
organ
donat
live
repli
author
donat
organ
live
organ
patient
state
encephal
death
live
conclus
clear
dispar
found
concept
brain
death
organ
donat
despit
inform
campaign
media
coverag
popul
studi
sociodemograph
cultur
characterist
requir
adapt
inform
tool
cultur
approach
introduct
recreat
use
mdma
becom
common
sinc
end
number
poison
significantli
increas
last
year
mdma
respons
serotoninerg
toxic
lead
onset
hyperthermia
multiorgan
failur
object
describ
time
cours
bodi
temperatur
serotoninerg
sign
biolog
paramet
sever
mdmapoison
patient
order
understand
evolut
paramet
relat
plasma
concentr
mdma
main
metabolit
methylenedioxyamphetamin
mda
conduct
retrospect
singlecentr
observ
studi
includ
mdmapoison
patient
admit
intens
care
unit
icu
develop
fever
bodi
temperatur
symptom
sign
serotoninerg
syndrom
accord
sternbach
criteria
plasma
mdma
mda
concentr
determin
use
liquid
chromatographi
coupl
mass
spectrometri
result
sixteen
mdmapoison
patient
mdmaexpos
patient
admit
icu
period
present
serotoninerg
syndrom
fever
attribut
mdma
exposur
treat
support
care
extern
cool
cyproheptadin
nonspecif
serotonin
receptor
antagonist
includ
studi
patient
femal
et
male
old
median
percentil
use
recreat
mdma
found
nightclub
street
home
bodi
temperatur
reach
present
complic
cardiac
arrest
cardiovascular
failur
aspir
pneumonia
hospitalacquir
infect
fatal
four
patient
worsen
clinic
heart
rate
pyramid
syndrom
eeg
encephalopathi
biolog
paramet
transaminas
prothrombin
index
creatinin
phosphokinas
includ
serotoninerg
syndrom
surprisingli
observ
parallel
increas
bodi
temperatur
due
concomit
infecti
inflammatori
nontox
event
observ
worsen
occur
absenc
increas
plasma
mdma
mda
concentr
n
even
presenc
undetect
concentr
n
conclus
mdma
use
result
serotonin
syndrom
possibl
lead
onset
hyperthermia
organ
failur
death
despit
optim
care
worsen
serotonin
syndrom
icu
stay
sever
mdmapoison
patient
without
increas
plasma
mdma
concentr
observ
patient
exact
molecular
mechan
involv
serotoninerg
memori
remain
clarifi
prognost
factor
relat
co
induc
coma
primari
object
studi
determin
prognost
factor
icumort
follow
co
induc
coma
secondari
object
determin
prognost
factor
co
relat
cognit
sequela
time
intens
care
unit
icu
discharg
patient
method
retrospect
observ
studi
januari
decemb
comatos
patient
glasgow
coma
score
due
carbon
monoxid
poison
treat
hyperbar
oxygen
therapi
tertiari
hospit
greater
pari
area
includ
current
studi
clinic
biolog
iconograph
electrophysiolog
data
collect
medic
file
result
patient
includ
median
iqr
age
year
patient
male
caus
poison
mainli
co
exposur
n
smoke
inhal
n
patient
die
icu
stay
present
cognit
sequela
icu
discharg
multivari
analysi
found
cardiac
arrest
p
eeg
anomali
p
simplifi
acut
physiolog
score
sap
ii
p
associ
icumort
neuroimag
anomali
p
associ
cognit
sequela
icu
discharg
neither
lactat
carboxyhemoglobin
level
associ
cognit
sequela
mortal
cohort
conclus
studi
predict
factor
icumort
co
induc
comatos
patient
cardiac
arrest
eeg
anomali
sap
ii
score
neuroimag
anomali
predict
cognit
sequela
icu
discharg
introduct
recreat
use
popper
increas
franc
sinc
last
judgment
nation
council
june
reauthor
market
popper
contain
variou
alkyl
nitrit
highli
oxid
compound
abl
induc
methemoglobinemia
methb
deleteri
even
lifethreaten
consequ
human
object
describ
circumst
complic
outcom
patient
admit
intens
care
unit
icu
methb
onset
attribut
exposur
popper
investig
relationship
serum
lactat
concentr
methb
treatment
patient
method
conduct
retrospect
monocentr
observ
studi
includ
patient
admit
icu
increas
blood
methb
follow
exposur
popper
investig
relationship
serum
lactat
concentr
methb
icu
admiss
calcul
pearson
coeffici
use
bartlett
test
spheric
result
twentysix
patient
male
femal
age
year
median
percentil
includ
popper
snort
ingest
snort
ingest
recreat
multidrug
exposur
mostli
accompani
gammahydroxybutyr
use
admiss
methb
patient
receiv
methylen
blue
infus
mechan
ventil
catecholamin
infus
exsanguinotransfus
admiss
weakli
correl
methb
p
serum
lactat
concentr
mmoll
highli
correl
mehb
p
plasma
lactat
concentr
mmoll
highli
predict
methb
sensit
specif
posit
predict
valu
neg
predict
valu
conclus
use
popper
respons
lifethreaten
consequ
attribut
methb
data
clearli
support
recommend
intern
french
guidelin
administ
methylen
blue
patient
develop
methb
evidenc
tissu
hypoxia
almost
consist
present
threshold
introduct
cardiocirculatori
failur
one
lead
caus
death
acut
poison
aim
work
analyz
hemodynam
profil
intox
noncardiotrop
product
identifi
prognost
factor
patient
method
prospect
studi
includ
patient
age
year
primari
admiss
vital
emerg
room
noncardiotrop
drug
intox
also
nondrug
analyz
paramet
wereclin
examin
electr
abnorm
echocardiograph
data
troponin
level
evalu
perform
intak
statist
analysi
univari
p
result
patient
includ
averag
age
sex
ratio
toxic
product
found
organophosphoru
benzodiazepin
aluminum
phosphid
cocain
carbon
monoxid
tricycl
antidepress
cardiocirculatori
insuffici
observ
patient
electr
abnorm
patient
elev
troponin
patient
echocardiograph
abnorm
patient
incid
particularli
high
aluminum
phosphid
tricycl
antidepressantsth
overal
mortal
rate
death
depend
offend
aluminum
phosphid
tricycl
antidepress
cocain
organophosphoru
compound
benzodiazepin
figur
correl
clinic
paraclin
abnorm
occurr
death
shown
tabl
discuss
toxicolog
rang
cardiotox
product
much
wider
class
cardiotrop
drug
inde
mani
product
origin
cardiovascular
toxic
mechan
failur
variablemembran
stabil
effect
antidepress
betablock
calcium
channel
blocker
organophosphoru
diastol
dysfunct
rhythm
disord
toxic
myocard
myocardi
necrosi
phostoxin
cocain
co
vasodilat
antihypertens
conclus
difficulti
accur
assess
incid
preval
cardiocirculatori
failur
due
toxic
caus
due
among
thing
lack
valid
studi
propos
better
diagnost
therapeut
techniqu
studi
main
factor
poor
prognosi
cardiocirculatori
insuffici
echocardiograph
abnorm
cocain
poison
intens
care
unitar
differ
cocain
hydrochlorideand
crackrel
toxic
bruno
megarban
speaker
introduct
cocain
frequent
use
psychostimul
illicit
drug
worldwid
franc
use
significantli
increas
last
ten
year
two
main
modalitiesth
recreat
snort
cocain
hydrochlorid
inhal
smoke
crack
freebas
form
cocain
obtain
cocain
salif
use
common
bake
soda
ammoniac
highli
depend
dissoci
user
neurolog
cardiovascular
respiratori
metabol
complic
cocain
rel
wellknown
howev
differ
cocain
hydrochlorid
crackrel
toxic
poorli
investig
object
describ
compar
circumst
result
complic
cocain
use
patient
admit
intens
care
unit
icu
relat
rout
exposur
ie
snort
versu
inhal
patient
method
conduct
retrospect
singlecentr
observ
studi
includ
cocainepoison
patient
admit
intens
care
unit
period
comparison
two
rout
cocain
exposur
perform
use
univari
analysi
mannwhitney
test
request
n
present
significantli
sever
symptom
user
inhal
n
lower
glasgow
coma
score
p
intens
adrenerg
syndrom
p
tachycardia
elev
plasma
lactat
concentr
p
lower
platelet
count
p
mark
rhabdomyolysi
p
snort
cocain
less
frequent
associ
methadon
use
p
cocain
snort
patient
frequent
develop
cardiac
arrest
p
aspir
pneumonia
p
request
mechan
ventil
p
conclus
cocain
use
may
lead
sever
complic
requir
icu
admiss
find
suggest
complic
attribut
cocain
hydrochlorid
snort
sever
complic
attribut
crack
inhal
experiment
investig
may
interestingli
complement
studi
allow
better
understand
mechanist
reason
support
observ
differ
introduct
bromazepam
commonli
use
frequent
involv
benzodiazepin
acut
drug
poison
franc
object
report
complic
manag
bromazepampoison
patient
admit
icu
investig
bromazepam
pharmacokinet
overdos
relationship
coma
depth
plasma
bromazepam
concentr
admiss
patient
method
conduct
retrospect
singlecentr
observ
studi
includ
bromazepampoison
patient
admit
evidenc
least
one
plasma
bromazepam
concentr
toxic
rang
stay
studi
correl
presum
ingest
dose
bromazepam
plasma
concentr
bromazepam
coma
depth
determin
glasgow
coma
score
calcul
pearson
coeffici
use
bartlett
test
spheric
result
onehundr
sixtyfour
patient
femal
male
age
year
median
percentil
includ
toxic
result
multidrug
ingest
presum
bromazepam
ingest
dose
mg
plasma
bromazepam
concentr
admiss
mg
l
conscious
impair
mark
glasgow
coma
score
hypoton
coma
decreas
loss
tendon
reflex
complic
includ
aspir
pneumonia
increas
liver
enzym
cardiovascular
renal
failur
sinoand
atrioventricular
block
found
case
flumazenil
bolu
dose
mg
follow
infus
rate
mg
h
h
administ
patient
patient
intub
mechan
ventil
subgroup
monointox
bromazepam
signific
correl
coma
depth
plasma
bromazepam
concentr
observ
bartlett
test
p
factor
associ
requir
tracheal
intub
vs
flumazenil
use
includ
lower
glasgow
coma
score
p
elev
serum
lactat
concentr
p
signific
relationship
evidenc
ingest
dose
plasma
concentr
bromazepam
admiss
conclus
acut
bromazepam
poison
frequent
may
respons
lifethreaten
consequ
ingest
dose
plasma
concentr
bromazepam
correl
coma
depth
predict
necess
tracheal
intub
thu
suggest
high
interindividu
variabl
drug
toxic
optim
manag
ecstasi
unsaf
recreat
drugexperi
year
icu
practic
takoua
khzouri
speaker
hela
maamouri
meriem
fatnassi
rim
jemmali
nozha
brahmi
camu
tuni
tunisia
correspond
takoua
khzouri
yahoofr
annal
intens
care
suppl
introduct
mdma
also
known
ecstasi
recreat
drug
popular
among
youth
europ
america
sinc
last
decad
remarqu
increas
case
mdma
poison
admit
icu
present
studi
aim
better
know
epidemiolog
clinic
therapeut
characterist
poison
order
improv
prognosi
patient
method
observ
retrospect
studi
spread
nine
year
januari
septemb
toxicolog
icu
includ
patient
admit
acut
mdma
poison
result
studi
period
mdma
poison
account
n
acut
poison
requir
hospit
intens
care
unit
mean
age
year
sexratio
eight
patient
drugaddict
exposur
singledrug
case
case
ecstasi
coingest
alcohol
case
benzodiazepin
case
trihexyphenidyl
case
cannabi
heroin
one
case
suppos
ingest
dose
sid
unknown
case
one
median
sid
pill
half
consult
delay
h
ingest
main
symptom
mydriasi
agit
tachycardia
averag
bpm
hallucin
hypertens
five
coma
patient
intub
requir
sedat
midazolam
one
patient
requir
curar
malign
hyperthermia
eleven
patient
develop
rhabdomyolysi
averag
rate
creatin
phosphokinas
lactat
deshydrogenas
respect
ui
ui
two
patient
develop
dissemin
intravascular
coagul
fulmin
hepat
high
rate
alanin
aminotransferas
ui
ui
aspart
aminotransferas
ui
low
factorv
receiv
nacetylcystein
one
patient
receiv
cyproheptadin
antidot
mg
day
thirteen
patient
discharg
icu
mean
length
stay
three
day
one
patient
die
hepat
encephalopathi
cerebr
herniat
conclus
shown
mdma
poison
present
vital
risk
due
serotonin
syndrom
clinician
must
warn
recogn
better
symptom
sever
order
improv
manag
object
analyz
chang
clinic
present
outcom
sinc
artesun
becam
firstchoic
treatment
sm
retrospect
observ
singlecent
studi
medic
icu
referr
univers
hospit
conduct
patient
admit
sm
period
demograph
variabl
sever
score
who
sever
criteria
admiss
icu
hospit
length
stay
collect
patient
characterist
outcom
compar
two
period
name
artesun
becom
firstchoic
treatment
poor
outcom
defin
composit
endpoint
death
icu
length
stay
day
requir
vasopressor
invas
mechan
ventil
renal
replac
therapi
start
first
day
icu
univari
analysi
stepwis
multivari
logist
regress
stratifi
period
perform
identifi
factor
associ
poor
outcom
result
patient
includ
main
epidemiolog
clinic
characterist
tabl
even
number
criteria
sm
compar
group
sap
ii
sofa
icu
length
stay
significantli
higher
patient
visit
friend
rel
vfr
home
countri
live
endem
area
seem
frequent
p
poor
outcom
occur
case
case
p
risk
factor
poor
outcom
impair
conscious
adjor
ci
p
shock
adjor
ci
p
creatinin
l
adjor
ci
p
patient
vfr
live
endem
area
associ
better
outcom
adjor
ci
p
final
model
artesun
therapi
significantli
improv
outcom
compar
quininebas
therapi
adjor
ci
p
conclus
patient
sm
admit
icu
less
sever
trend
could
partial
explain
increas
proport
immun
patient
vfr
live
endem
area
adjust
sever
stratif
period
artesun
significantli
associ
better
outcom
iv
quinin
introduct
clostridium
speci
import
agent
anaerob
infect
may
associ
wide
rang
sever
clinic
diseas
requir
icu
admiss
data
focus
non
difficil
clostridium
speci
bacteriemia
icu
scarc
reli
mainli
case
report
sought
defin
clinic
biolog
characterist
risk
factor
acquisit
clostridium
ecolog
outcom
non
difficil
clostridium
speci
bacteriemia
critic
ill
patient
patient
method
multicentr
retrospect
cohort
studi
icu
includ
patient
diagnos
nondifficil
clostridium
bacteriemia
januari
june
result
fifti
patient
includ
median
age
year
old
patient
clostridium
bacteriemia
occur
day
icu
admiss
median
charlson
score
underli
condit
includedoncohaematolog
malign
chronic
alcohol
abus
diabet
chronic
cardiac
failur
obes
cirrhosi
chronic
kidney
injuri
first
symptom
start
day
icu
admiss
median
day
symptom
icu
admiss
patient
present
fever
case
hypothermia
shock
coma
acut
respiratori
failur
cardiac
arrest
digest
symptom
present
case
icu
admiss
median
sap
ii
score
median
sofa
score
overal
patient
requir
vasopressor
invas
mechan
ventil
renal
replac
therapi
twentyfour
percent
patient
experienc
massiv
hemolysi
median
serum
lactat
level
mm
infect
due
c
perfringen
follow
c
ramosum
c
septicum
c
tertium
digest
infect
diagnos
case
skin
infect
case
ga
gangren
present
patient
surgeri
necessari
speci
sensit
penicillin
two
third
patient
die
icu
hospit
mortal
non
survivor
median
time
icu
admiss
hospit
death
day
conclus
alcohol
consumpt
diabet
underli
malign
main
risk
factor
clostridium
bacteriemia
clinic
manifest
non
specif
digest
symptom
hemolysi
alert
physician
consid
risk
fulmin
cours
high
lethal
infect
adequ
antibiot
start
soon
diagnosi
suspect
laurenc
essolarerambiah
speaker
na
librevil
gabon
correspond
laurenc
essolarerambiah
laurenceessola
yahoofr
annal
intens
care
suppl
introduct
tetanu
infect
nonimmun
diseas
still
endem
mani
develop
countri
respons
high
mortal
aim
work
describ
manag
patient
admit
icu
tetanu
patient
method
descript
studi
base
retrospect
analysi
done
year
period
januari
decemb
intens
care
unit
includ
patient
admit
tetanu
studi
variabl
sociodemograph
characterist
clinic
therapeut
prognost
data
result
patient
admit
tetanu
mean
nage
patient
year
show
male
predomin
sex
ratio
trismu
associ
generalis
contractur
spasm
present
patient
port
entri
found
patient
mean
score
dakar
struggl
spasm
contractur
combin
magnesium
sulfat
diazepam
administ
patient
mechan
ventil
need
patient
mean
length
hospitalis
day
lethal
conclus
tetanu
patholog
still
met
unit
lethal
remain
high
intensif
vaccin
campaign
necessari
erad
diseas
introduct
candiduria
increasingli
frequent
among
patient
admit
intens
care
unit
clear
discrimin
threshold
predict
occurr
invas
candidiasi
purposeto
identifi
interest
yeast
numer
urin
earli
diagnosi
invas
candidiasi
patient
method
prospect
studi
carri
sfaxtunisia
intens
care
unit
period
month
marchjun
select
criteriapati
includ
least
one
major
risk
factor
two
minor
risk
factor
develop
ic
tabl
includ
studi
search
candida
urin
perform
day
hospit
week
patient
candiduria
carri
multipl
mycolog
sampl
bodi
site
blood
cultur
pittet
index
calcul
well
candida
score
diagnosi
invas
candidiasi
made
basi
presenc
candidemia
expert
advic
daili
visit
patient
least
one
follow
symptom
fever
hypothermia
unexplain
hypotens
absenc
respons
adequ
antibiot
treatment
suspect
bacteri
infect
heighti
height
patient
includ
candiduria
found
patient
patient
candiduria
densiti
cfuml
c
albican
found
patient
mean
interv
admiss
onset
candiduria
day
seven
patient
develop
candidemia
concomit
candiduria
diagnosi
invas
candidiasi
made
patient
risk
factor
develop
invas
candidiasi
patient
candiduria
wereren
failur
p
candida
score
point
p
pittet
index
p
logist
regress
renal
failur
independ
factor
associ
invas
candidiasi
patient
candiduria
p
ci
associ
candiduria
cfu
ml
pittet
index
significantli
associ
invas
candidiasi
p
mortal
rate
conclus
candiduria
cfu
ml
intens
care
patient
sever
risk
factor
predict
invas
candidiasi
perman
mycolog
surveil
wide
recommend
order
make
earli
diagnosi
start
appropri
antifung
therapi
data
epidemiolog
patient
signific
clinic
data
surgeri
mechan
ventil
dialysi
central
venou
cathet
urinari
cathet
arteri
cathet
total
parenter
nutrit
leucopenia
neutropenia
previou
antimicrobi
therapi
prophylaxi
collect
result
twentythre
per
cent
patient
enrol
studi
fungal
infect
case
fungal
colon
patient
median
score
candida
albican
isol
infect
case
colon
case
candiduria
detect
candidaemia
observ
patient
patient
develop
fungal
infect
central
line
insert
prolong
length
stay
prolong
antibiot
therapi
use
corticosteroid
neutropenia
fluconazol
first
line
use
antifung
treatment
n
amphotericin
b
use
three
patient
median
hospit
stay
day
multivari
analysi
reveal
catecholamin
use
associ
fungal
infect
colon
p
conclus
fungal
infect
colon
frequent
popul
use
catecholamin
appear
risk
factor
nouha
bouker
speaker
introduct
invas
fungal
infect
increasingli
observ
icu
concern
specif
nonneutropen
patient
absenc
simpl
access
techniqu
earli
microbiolog
diagnosi
use
antifung
steadili
increas
frequent
use
echinocandin
littl
known
extent
problem
typolog
antifung
prescript
tunisian
icu
bicentr
studi
describ
prescript
circumst
antifung
tunisian
icu
patient
method
studi
period
prescript
antifung
analys
analysi
concern
demograph
clinic
circumst
histori
acut
diseas
procedur
previou
drug
lifethreaten
condit
time
antifung
therapi
well
basi
antifung
prescrib
target
vs
preemptiv
empir
result
patient
enrol
studi
men
mean
year
admit
leuconeutropenia
present
steroid
administ
major
patient
mechan
ventil
central
venou
line
either
sever
sepsi
septic
shock
largespectrum
antibiotherapi
day
antifung
treatment
start
often
preemptiv
empir
basi
consist
often
echinocandin
prescript
azol
often
target
therapi
antifung
deescal
perform
infect
resolv
overal
mortal
conclus
antifung
prescript
except
tunisian
icu
preemptiv
empir
prescript
base
primarili
echinocandin
reflect
lack
effici
laboratori
support
prompt
physician
reli
clinic
inform
introduct
critic
ill
patient
type
diabet
increas
risk
infect
proinsulin
connect
peptid
cpeptid
protect
immunomodulatori
featur
level
may
affect
presenc
sepsi
exogen
insulin
treatment
aim
assess
sepsi
exogen
insulin
administr
affect
cpeptid
level
cpeptid
insulin
ratio
critic
ill
diabet
patient
patient
method
studi
critic
ill
adult
type
diabet
measur
serum
insulin
cpeptid
level
first
day
icu
stay
record
daili
exogen
insulin
dose
obtain
control
data
eight
volunt
patient
unexpos
exogen
insulin
therapi
first
compar
sepsi
without
compar
septic
patient
unexpos
insulin
therapi
sepsi
treat
insulin
determin
paramet
associ
cpeptid
level
cpeptid
insulin
ratio
use
multivari
linear
regress
result
sepsi
diagnos
patient
diabet
patient
sepsi
significantli
higher
cpeptid
level
compar
healthi
control
vs
nmoll
p
diabet
patient
sepsi
higher
cpeptid
insulin
ratio
compar
control
vs
p
increas
compar
nonsept
patient
p
expos
insulin
therapi
septic
patient
mark
decreas
cpeptid
insulin
ratio
compar
septic
patient
unexpos
insulin
p
multivari
analysi
cpeptid
level
significantli
neg
associ
exogen
insulin
therapi
posit
associ
serum
insulin
level
glucos
intak
cpeptid
insulin
ratio
significantli
posit
associ
sepsi
neg
exogen
insulin
therapi
p
p
respect
conclus
type
diabet
critic
ill
patient
sepsi
associ
mark
increas
cpeptid
cpeptid
insulin
ratio
impli
uncoupl
rel
secret
clearanc
uncoupl
howev
markedli
inhibit
administr
exogen
insulin
introduct
adjunct
corticosteroid
therapi
proven
effect
hivpati
pneumocysti
pneumonia
pcp
data
remain
unclear
controversi
concern
nonhiv
relatedpati
evalu
effect
mortal
earli
adjunct
corticosteroid
therapi
nonhiv
pcprelat
patient
calmett
cancer
referr
centr
compar
mortal
rate
chang
respiratori
item
sequenti
organ
failur
assess
score
delta
sofaresp
chang
global
sofa
score
sofaaggrav
use
intub
antipneumocysti
therapi
occurr
coinfect
earli
adjunct
corticosteroid
recipi
within
h
landmark
analysi
late
corticosteroid
recipi
use
invers
probabl
weight
surviv
analysi
ipw
result
hivneg
patient
pcp
includ
earli
corticosteroid
n
late
corticosteroid
n
main
underli
condit
haematolog
malign
n
solid
tumor
n
stem
cell
transplant
n
overal
mortal
respect
ipw
analysi
found
differ
hr
ci
p
hr
ci
p
mortal
rate
group
way
differ
deltasofaresp
sofaaggrav
use
intub
occurr
coinfect
found
group
conclus
addit
earli
adjunct
corticosteroid
antipneumocysti
therapi
nonhiv
patient
pcp
associ
improv
outcom
concern
mortal
respiratori
evolut
studi
need
evalu
therapeut
strategi
introduct
accuraci
test
depend
intrins
characterist
sensit
specif
diseas
preval
paramet
uncommonli
taken
account
assess
diagnost
accuraci
illustr
relationship
nonhiv
patient
pneumocysti
pneumonia
whose
preval
low
avail
diagnost
test
high
intrins
perform
studi
aim
assess
posttest
probabl
pneumocysti
pneumonia
accord
result
pcr
bdg
test
nonhiv
patient
arf
patient
method
systemat
review
perform
assess
diagnost
perform
pcr
betadglucan
bdg
preval
pneumocysti
pneumonia
assess
dataset
immunocompromis
patient
arf
use
supervis
classif
tree
preval
pneumocysti
pneumonia
simul
use
r
softwar
assum
normal
distribut
subject
basi
previous
observ
preval
posttest
probabl
assess
use
bay
theorem
analys
perform
use
r
softwar
result
preval
pneumocysti
pneumonia
arf
patient
ci
supervis
classif
identifi
subgroup
patient
without
ground
glass
opac
preval
ci
ground
glass
opac
prophylaxi
preval
ci
b
without
prophylaxi
preval
ci
c
without
prophylaxi
lymphoid
malign
stem
cell
transplant
preval
ci
overal
popul
posit
predict
valu
ppv
ci
ci
pcr
bdg
respect
neg
predict
valu
low
ci
ci
pcr
bdg
respect
highest
risk
subgroup
ppv
ci
ci
pcr
bdg
respect
conclus
although
pcr
bdg
yield
high
intrins
perform
low
incid
pneumocysti
pneumonia
translat
limit
ppv
even
highest
risk
group
result
underlin
need
adequ
pretest
probabl
assess
suggest
method
illustr
pre
posttest
probabl
relationship
may
improv
percept
diagnost
test
perform
patient
predefin
clinic
vignett
first
hour
hospit
emerg
evid
recent
suggest
artifici
intelligencederiv
method
could
effici
assist
medic
decis
process
wonder
mathemat
model
diagnost
predict
could
effici
evalu
made
experi
physician
object
studi
compar
abil
panel
expert
mathemat
model
predict
microbi
etiolog
scap
patient
method
conduct
prospect
nonintervent
studi
first
includ
patient
hospit
scap
icu
record
clinic
paraclin
data
avail
three
first
hour
care
final
microbi
diagnosi
establish
microbiolog
examin
includ
bacteri
cultur
multiplex
pcr
respiratori
fluid
scap
mix
etiolog
without
microbiolog
document
exclud
second
built
mathemat
model
predict
random
forest
method
loocv
use
data
initi
collect
final
independ
sampl
studi
popul
use
test
perform
pathogen
predict
panel
expert
ii
mathemat
algorithm
blind
regard
microbi
diagnosi
posit
likelihood
ratio
lr
neg
lr
consid
clinic
relev
result
includ
patient
scap
men
mean
age
year
mean
sapsii
respons
pathogen
viral
bacteri
mix
etiolog
unidentifi
datadriven
approach
defin
five
item
creat
final
mathemat
modelbmi
systol
blood
pressur
symptomtohospit
time
procalcitonin
neither
expert
algorithm
abl
predict
respons
pathogen
pneumonia
discrimin
abil
algorithm
moder
low
lr
viral
bacteri
pneumonia
discrimin
abil
expert
low
low
lr
viral
bacteri
pneumonia
conclus
studi
show
neither
expert
mathemat
algorithm
predict
microbi
etiolog
scap
within
first
hour
hospit
urg
defin
antiinfect
therapeut
strategi
result
highlight
need
develop
pointofcar
test
rapid
microbi
diagnosi
staphylococcu
aureu
communityacquir
bacteriuria
emerg
depart
warn
marker
infect
endocard
thoma
lafon
speaker
introduct
urinari
tract
ut
infect
frequent
diagnosi
emerg
depart
ed
staphylococcu
aureu
sa
uncommon
isol
urin
cultur
posit
urin
cultur
frequent
popul
risk
factor
ut
colon
absenc
urolog
invas
procedur
risk
factor
sa
colon
communityacquir
sa
bacteriuria
may
relat
deepseat
sa
infect
septic
embol
could
consid
trigger
symptom
cohort
studi
aim
assess
preval
infect
endocard
ie
patient
communityacquir
sa
bacteriuria
ed
patient
method
conduct
prospect
singlecent
studi
april
juli
patient
admit
ed
sa
bacteriuria
cfu
ml
sa
isol
singl
urin
sampl
without
risk
factor
ut
colon
ie
month
ut
surgeri
ut
catheter
includ
blood
cultur
collect
patient
clinic
symptom
infect
sir
criteria
concomit
bacteremia
h
case
transthorac
echocardiographi
tte
transesophag
echocardiographi
tee
perform
diagnosi
ie
base
duke
criteria
result
studi
period
patient
sa
bacteriuria
identifi
ed
exclud
patient
risk
factor
ut
colon
ut
catheter
n
ut
surgeri
n
patient
includ
men
yearsold
twentytwo
patient
clinic
symptom
infect
ut
infect
eleven
patient
concomit
sa
bacteremia
tte
tee
perform
patient
confirm
ie
patient
ie
affect
essenti
left
heart
mitral
aortic
valv
involv
sa
bacteriuria
identifi
significantli
earlier
ie
diagnosi
mean
differ
day
among
duke
minor
criteria
patient
septic
emboli
fever
predispos
heart
condit
mortal
conclus
absenc
risk
factor
communityacquir
sa
bacteriuria
interpret
isol
ut
infect
earli
warn
ie
requir
explor
accur
time
begin
antibiot
treatment
ulrich
clarac
speaker
result
studi
period
case
cabm
identifi
due
streptococcu
pneumonia
n
klebsiella
pneumonia
n
staphylococcu
aureu
n
escherichia
coli
n
neisseria
meningitidi
b
n
streptococcu
spp
n
pseudomona
aeruginosa
n
escherichia
coli
streptococcu
spp
n
strain
wildtyp
phenotyp
antibiot
resist
patient
febril
neurolog
sign
headach
stroke
nuchal
stiff
glasgow
coma
scale
alter
median
ig
score
hospit
mortal
rate
patient
stay
icu
day
requir
mechan
ventil
case
interestingli
staphylococcu
aureu
cabm
associ
endocard
whatev
bacteria
bacteraemia
occur
frequent
ie
case
associ
case
abscess
initi
therapeut
regimen
thirdgener
cephalosporin
n
alon
n
combin
aminoglycosid
n
aminopenicillin
n
aminopenicillin
alon
n
comparison
cabm
staphylococcu
aureu
endocard
exclud
klebsiella
pneumonia
cabm
n
specif
clinic
present
p
ns
introduct
spontan
bacteri
periton
sbp
seriou
complic
cirrhosi
despit
standard
treatment
mortal
remain
high
aim
evalu
predictor
mortal
patient
sbp
retrospect
work
carri
year
consecut
patient
approv
sbp
admit
depart
includ
clinic
biolog
data
collect
medic
record
univari
multivari
analysi
use
identifi
associ
factor
death
result
total
patient
diagnos
sbp
cirrhosi
enrol
studi
mean
age
sex
ratio
hcv
main
etiolog
cirrhosi
least
one
complic
occur
evolut
septic
shock
found
six
patient
die
sbp
signific
differ
sex
aetiolog
cirrhosi
ascit
abund
receiv
prophylact
antibiot
surviv
group
patient
die
howev
statist
signific
associ
mortal
onset
complic
p
low
systol
p
diastol
blood
p
pressur
tachycardia
p
admiss
empir
antibiot
therapi
static
prevent
factor
p
conclus
sbp
seriou
event
histori
cirrhot
diseas
particular
caution
must
exercis
regard
state
hemodynam
instabl
present
admiss
adequ
empir
treatment
would
improv
prognosi
perform
prospect
epidemiolog
multicent
studi
includ
consecut
hospit
adult
patient
iai
requir
hospit
icu
cultur
perform
blood
simpl
intraop
sampl
periton
fluid
purul
exud
discret
abscess
evalu
epidemiolog
factor
associ
isol
mdro
enrol
patient
result
among
patient
includ
studi
total
microorgan
isol
intraperiton
fluid
blood
sampl
cultur
two
pathogen
identifi
candida
spp
identifi
mdro
repres
total
isol
microorgan
among
patient
mdro
colon
found
surgeri
acquir
hospit
mdro
frequent
isol
patient
healthcareassoci
iai
uninomin
logist
regress
analysi
risk
factor
demonstr
statist
signific
risk
factor
independ
associ
occurr
mdro
iai
previou
know
carri
mdro
antimicrobi
therapi
administ
within
month
oper
studi
show
mdro
repres
tenth
iai
knowledg
previou
colon
mdro
previou
antibiotherapi
within
month
might
guid
identifi
patient
iai
caus
mdro
therefor
permit
introduc
adequ
empir
antimicrobi
therapi
determin
valu
mean
arteri
blood
pressur
lead
acut
kidney
failur
earli
septic
shock
factor
associ
mortal
patient
method
conduct
prospect
studi
month
januari
august
includ
patient
present
septic
shock
patient
cardiogen
hypovolem
shock
exclud
analyz
demograph
characterist
comorbid
sapsii
score
respiratori
hemodynam
neurolog
paramet
use
noninvas
invas
ventil
impact
hemodynam
statu
kidney
function
length
stay
mortal
result
includ
patient
sex
ratio
sapsii
admiss
averag
point
thirtyseven
percent
case
admit
respiratori
distress
aki
develop
multivari
logist
regress
analysi
reveal
develop
septic
aki
associ
older
age
preexist
chronic
kidney
diseas
low
mean
arteri
pressur
map
septic
shock
day
h
later
roc
curv
show
aki
develop
patient
map
septicshockday
mmhg
mmhg
h
later
studi
incid
aki
higher
patient
nt
receiv
fluid
resuscit
vs
p
mortal
rate
higher
aki
group
p
coexist
aki
septic
myocard
septic
cholestasi
associ
low
outcom
conclus
develop
septic
aki
associ
poor
clinic
outcom
prevent
attenu
septic
aki
need
good
fluid
manag
hemodynam
statu
adjust
despit
larg
research
incid
mortal
septic
aki
high
extens
studi
best
histopatholog
inform
may
need
better
manag
kidney
dysfunct
patient
septic
shock
introduct
acut
kidney
injuri
aki
requir
renal
replac
therapi
rrt
occur
critic
ill
patient
associ
high
mortal
higher
sodium
na
dialys
concentr
mmoll
recommend
order
improv
intradialyt
hemodynam
toler
may
lead
sodium
load
patient
fluid
overload
associ
advers
icu
outcom
aim
therefor
evalu
flux
sodium
accord
na
dialysat
concentr
mmoll
hemodialysi
hd
hemodiafiltr
hdf
session
icu
aki
patient
patient
method
aki
patient
requir
rrt
includ
prospect
studi
patient
underw
consecut
hd
hdf
session
na
dialys
concentr
mmoll
sodium
concentr
measur
plasma
session
affluent
effluent
fluid
flux
sodium
rrt
session
estim
use
mean
sodium
logarithm
concentr
includ
diffus
convect
influx
compar
flux
sodium
hd
hdf
mmoll
na
concentr
dialys
result
fourteen
patient
enter
studi
aki
mostli
septic
origin
almost
patient
requir
need
vasopressor
drug
mechan
ventil
underw
rrt
session
hdf
neg
na
gradient
dialys
replac
fluid
patient
observ
techniqu
dialys
sodium
concentr
induc
fluid
overload
comparison
hd
hd
hdf
hdf
show
higher
na
dialysat
induc
signific
higher
flux
na
patient
consequ
fluid
overload
tabl
icu
mortal
rate
around
surviv
patient
mean
creatinin
clairanc
icu
discharg
studi
show
rrt
substanti
na
load
occur
na
load
increas
significantli
elev
na
dialys
concentr
mmoll
clinic
intradialyt
hemodynam
toler
increas
na
dialys
need
howev
studi
analyz
cardiomyopathi
case
pulmonari
arteri
hypertens
found
patient
cr
mean
systol
pap
mmhg
patient
cr
septicemia
univari
analysi
show
signific
associ
cr
acut
circulatori
failur
admiss
p
occurr
cr
associ
increas
risk
mortal
p
conclus
cr
frequent
patient
admit
ae
copd
significantli
associ
circulatori
failur
admiss
well
signific
risk
death
introduct
advers
event
ae
common
recogn
report
ae
crucial
step
caregiv
implement
adequ
strategi
improv
patient
safeti
aim
evalu
rate
risk
factor
ae
impact
patient
method
prospect
studi
conduct
octob
june
medic
icu
includ
patient
monitor
ae
variabl
found
statist
signific
univari
analysi
introduc
multivari
regress
model
identifi
factor
independ
associ
ae
remov
bladder
cathet
accident
extub
fall
cathet
relat
bloodstream
infect
acut
renal
failur
venou
thromboembol
event
patient
present
ae
significantli
longer
durat
imv
vs
day
p
longer
lo
vs
day
p
higher
mortal
rate
vs
p
univari
analysi
reveal
follow
factor
associ
ae
respect
age
year
vs
p
sapsii
vs
p
imv
use
vs
p
vasopressor
use
vs
p
corticosteroid
use
vs
p
sed
agent
use
vs
p
delirium
vs
p
multivari
regress
model
identifi
two
factor
independ
associ
ae
delirium
ci
introduct
earli
icu
admiss
propos
mean
limit
risk
clinic
worsen
improv
outcom
icu
patient
aim
review
investig
impact
earli
icu
admiss
gener
icu
popul
criticallyil
cancer
patient
cicp
patient
method
systemat
review
perform
accord
prisma
statement
protocol
regist
prospero
databas
studi
report
impact
delay
icu
outcom
search
pubm
adult
patient
without
cancer
differ
term
mortal
report
risk
ratio
ci
public
bia
assess
visual
inspect
funnel
plot
summari
estim
rel
risk
confid
interv
calcul
use
fix
randomeffect
model
result
overal
icu
popul
among
citat
identifi
gener
icu
popul
studi
report
patient
includ
includ
patient
earli
admiss
group
earli
icu
admiss
associ
decreas
mortal
use
random
effect
model
rr
confid
interv
figur
cicp
among
citat
identifi
studi
report
patient
includ
earli
icu
admiss
includ
earli
icu
admiss
associ
decreas
mortal
use
random
effect
model
rr
confid
interv
explor
heterogen
metaregress
perform
characterist
trial
prospect
vs
retrospect
monocent
vs
multicent
impact
find
public
median
public
period
associ
lower
treatment
effect
estim
ci
p
gener
icu
popul
signific
public
bia
observ
sever
sensit
analys
perform
use
trim
fill
method
copa
method
take
account
outcom
report
bia
confirm
find
robust
gener
icu
popul
cicp
conclus
result
suggest
earli
icu
admiss
associ
decreas
mortal
gener
icu
popul
cicp
result
howev
obtain
high
risk
bia
studi
high
heterogen
note
addit
studi
requir
confirm
potenti
benefit
earli
icu
admiss
along
costbenefit
ratio
introduct
icu
heath
care
worker
icu
hcw
use
expens
devic
care
patient
unfortun
lifetim
multi
user
devic
often
shorter
could
wait
singl
user
util
aim
survey
evalu
icu
hcw
knowledg
cost
devic
regularli
use
icu
patient
care
patient
method
hcw
three
icusmed
medico
surgic
univers
affili
propos
answer
anonym
questionnair
aim
measur
estim
cost
devic
system
use
daili
patient
care
includ
cathet
ultrasound
devic
renal
replac
therapi
devic
cost
estim
express
percentag
real
cost
cost
estim
compar
use
median
quartil
accord
hcw
statu
magnitud
cost
devic
correct
estim
defin
estim
cost
equival
real
cost
result
hcw
accept
take
part
survey
provid
cost
estim
median
global
cost
estim
devic
decreas
real
cost
devic
real
cost
real
cost
real
cost
devic
cost
accuraci
cost
estim
real
cost
estim
cost
estim
cost
senior
physician
perform
better
junior
physician
conclus
hcw
unawar
real
cost
devic
use
icu
patient
care
case
introduct
clinic
assess
sever
ill
essenti
compon
medic
practic
especi
intens
care
unit
icu
multipl
score
system
develop
icu
risk
stratifi
patient
predict
outcom
help
care
provid
decis
make
guid
alloc
resourc
aim
studi
compar
perform
local
valid
clinic
sever
score
css
sever
score
systemsphysiolog
chronic
health
evalu
apach
system
ii
simplifi
acut
physiolog
score
ii
sap
ii
sequenti
organ
failur
assess
score
sofa
patient
method
retrospect
studi
perform
micu
januari
decemb
data
collect
review
medic
patient
chart
score
system
calcul
base
worst
valu
record
first
h
admiss
discrimin
evalu
use
receiv
oper
characterist
roc
curv
result
total
patient
enrol
studi
mean
age
n
male
common
reason
admiss
acut
respiratori
failur
patient
neurolog
cardiovascular
disord
respect
patient
patient
intub
need
vasopressor
mean
length
icu
stay
day
mean
sapsii
apach
ii
sofa
css
respect
overal
mortal
rate
best
perform
icu
score
system
studi
css
area
roc
curv
auc
p
sofa
sapsii
apach
ii
respect
auc
p
p
p
figur
find
present
studi
show
sofa
sap
ii
apach
ii
good
accuraci
predict
mortal
icu
howev
partial
perfect
emphas
import
repeat
valid
score
css
interest
timeconsum
costless
minim
invas
tool
predict
mortal
icu
introduct
elimin
unnecessari
health
care
may
reduc
cost
improv
qualiti
healthcar
studi
aim
measur
appropri
hospit
identifi
patient
hospit
characterist
associ
appropri
hospit
acut
medic
unit
univers
hospit
patient
method
prospect
data
includ
patient
admit
acut
medic
unit
collect
month
appropri
hospit
day
contribut
patient
assess
mean
appropri
evalu
protocol
assess
equiti
distribut
hospit
resourc
among
patient
cumul
appropri
hospit
mean
gini
coeffici
gini
index
rang
zero
repres
perfect
equal
distribut
predictor
variabl
includ
patient
anthropometr
characterist
hospit
characterist
associ
patientrel
variabl
inappropri
hospit
day
relat
variabl
studi
use
gener
estim
equat
univari
multivari
logist
regress
analysi
result
overal
hospit
admiss
hospit
day
rate
inappropri
univari
analysi
inapproprit
hospit
day
frequent
among
patient
whose
admiss
inappropri
factor
significantli
relat
inappropri
stayshospit
singl
room
absenc
previou
hospit
p
transfer
request
anoth
depart
p
transfer
done
anoth
depart
p
diagnosi
hematolog
diseas
p
multivari
analysi
diagnosi
hematolog
diseas
remain
significantli
relat
inappropri
stay
p
day
inappropri
hospit
less
evenli
distribut
appropri
day
gini
coeffici
respect
conclus
studi
show
inappropri
hospit
acut
medic
unit
frequent
admiss
one
bed
ten
could
free
one
patient
twenti
could
shorter
stay
consid
emerg
depart
chronic
satur
limit
fund
inadequ
hospit
result
unnecessari
cost
less
effici
qualiti
care
acut
medic
unit
introduct
mani
studi
focus
work
hospit
doctor
littl
known
work
intens
care
unit
icu
physician
especi
concern
medic
time
spent
outsid
unit
workload
never
evalu
date
main
object
studi
evalu
time
spent
icu
doctor
outsid
unit
manag
patient
intrahospit
transport
iht
care
patient
depart
vital
emerg
advic
medic
care
ethic
discuss
secondari
object
describ
organ
distribut
medic
time
outsid
icu
patient
method
prospect
observ
studi
took
place
year
januari
decemb
two
academ
medic
icu
strasbourg
dijon
intervent
outsid
icu
intensivist
doctor
time
intervent
everi
day
morn
medic
staff
anonym
data
collect
regist
result
five
year
studi
h
spent
intensivist
outsid
icu
strasbourg
dijon
correspond
averag
h
min
per
year
min
per
day
strasbourg
averag
h
per
year
min
per
day
dijon
five
year
shift
correspond
averag
shift
per
year
strasbourg
shift
dijon
correspond
averag
shift
per
year
one
third
time
spent
emerg
depart
one
third
intrahospit
medic
ward
last
third
iht
icu
patient
requir
computer
tomographi
scan
cardiac
catheter
discuss
better
understand
differ
activ
respect
part
occupi
daili
life
intensivist
essenti
order
optim
care
hospit
patient
conclus
prospect
french
bicentr
studi
highlight
fact
intensivist
medic
activ
outsid
unit
timeconsum
part
intensivist
activ
often
unrecogn
hospit
administr
taken
account
concern
routin
activ
icu
well
care
given
patient
bedsid
time
devot
recept
famili
time
devot
meet
introduct
bacteraemia
induc
high
rate
morbimort
blood
cultur
bc
standard
method
diagnosi
bacteraemia
franc
practic
recommend
exist
concern
bc
updat
avoid
inadequ
sampl
result
fals
diagnosi
inadequ
antibiotherapi
prolong
hospit
length
stay
appropri
train
nurs
student
could
promot
good
clinic
practic
sinc
franc
bc
mainli
taken
nurs
aim
studi
evalu
theoret
practic
train
receiv
french
nurs
student
school
hospit
bc
execut
well
relat
hygien
practic
patient
method
perform
crosssect
studi
evalu
theoret
practic
train
receiv
french
nurs
student
hygien
practic
concern
bc
studi
base
electron
survey
use
questionnair
sent
french
nurs
student
octob
januari
survey
encompass
short
answer
multiplechoic
question
result
one
thousand
thirtysix
nurs
student
fill
femal
mean
age
year
nurs
school
nurs
student
declar
receiv
theoret
train
bc
execut
receiv
practic
train
theoret
practic
train
internship
declar
receiv
practic
train
theoret
train
declar
train
among
bc
execut
recommend
peripher
stick
first
aerob
well
known
among
nurs
student
respect
similarli
practic
wash
hand
clean
venepunctur
site
prior
bc
execut
known
among
student
contrast
practic
wear
glove
facial
mask
rel
lower
conclus
discrep
knowledg
base
nurs
student
good
practic
recommend
blood
cultur
execut
relat
hygien
practic
strengthen
teach
practic
like
improv
student
knowledg
base
reduc
blood
cultur
contamin
improv
qualiti
care
introduct
inhospit
admiss
elderli
patient
resuscit
outofhospit
cardiac
arrest
ohca
increas
author
report
favour
outcom
other
report
increas
risk
death
surviv
loss
autonomi
addit
benefit
intervent
ie
transport
percutan
coronari
intervent
pci
time
resourc
associ
evalu
consequ
conduct
studi
evalu
prognosi
elderli
ohca
patient
region
one
pci
center
retrospect
includ
patient
age
older
admit
intens
care
unit
universityand
non
univers
hospit
ohca
januari
decemb
cardiac
arrest
patient
characterist
collect
cardiac
arrest
hospit
prognosi
cahp
score
calcul
primari
outcom
neurocognit
function
assess
cerebr
perform
categori
hospit
discharg
result
studi
period
patient
includ
median
age
male
patient
present
signific
comorbid
condit
median
charlson
index
sixtyeight
patient
initi
shockabl
rhythm
hundr
sixtysix
patient
present
without
obviou
extracardiac
caus
pci
perform
patient
number
nonneurolog
organ
failur
admiss
lower
patient
favor
outcom
patient
receiv
renal
replac
therapi
unfavour
outcom
rate
favor
neurolog
outcom
hospit
discharg
patient
includ
patient
initi
first
shockabl
rhythm
month
rate
decreas
patient
includ
patient
initi
first
shockabl
rhythm
accord
cahp
score
patient
low
risk
poor
neurolog
outcom
intermedi
risk
high
risk
base
cahp
score
stratif
patient
low
risk
group
patient
intermedi
risk
group
patient
highrisk
group
underw
earli
pci
conclus
surviv
elderli
patient
low
ohca
especi
patient
first
non
shockabl
rhythm
howev
patient
first
shockabl
rhythm
low
risk
death
may
favor
long
term
outcom
level
organ
failur
seem
strongli
associ
prognosi
stratif
cahp
score
suggest
use
pci
coud
improv
better
select
patient
like
benefit
healthcar
cost
resourc
util
associ
treatment
outofhospit
cardiac
arrest
guillaum
geri
speaker
perform
analysi
merg
databas
toronto
region
rescunet
epistri
databas
prehospit
data
administr
populationbas
databas
ontario
nontraumat
ohca
patient
year
age
treat
em
januari
march
includ
studi
primari
outcom
per
patient
longitudin
cumul
healthcar
cost
time
collaps
maximum
follow
death
day
event
includ
avail
cost
sector
perspect
health
system
payer
use
multivari
gener
linear
model
logarithm
link
gamma
distribut
determin
predictor
healthcar
cost
inhospit
cost
account
total
cost
adjust
age
gender
rate
patient
surviv
main
driver
total
coststh
rate
ratio
confid
interv
patient
die
ed
patient
die
ed
within
day
patient
still
aliv
compar
patient
pronounc
dead
scene
respect
factor
independ
associ
cost
number
prehospit
team
need
hospit
transfer
coronari
angiographi
target
temperatur
manag
conclus
clinic
outcom
main
driver
total
cost
treat
ohca
patient
larg
canadian
health
system
potenti
modifi
factor
includ
number
prehospit
team
arriv
scene
arrest
need
betweenhospit
transfer
success
resuscit
hyperkalemia
relat
hypercapnia
acidemia
lactat
accumul
cardiac
arrest
impact
clinic
manag
matthieu
jamm
speaker
introduct
low
ph
acidemia
histor
describ
one
major
factor
associ
hyperkalemia
older
studi
suggest
context
elev
anion
gap
metabol
acidosi
acidemia
link
hyperkalemia
consequ
administr
sodium
bicarbon
long
consid
firstlin
therapi
acut
hyperkalemia
recent
reassess
treatment
either
hyperkalemia
regard
high
preval
hyperkalemia
acidemia
resuscit
outofhospit
cardiac
arrest
ohca
patient
share
experi
sever
acut
type
lactic
acidosi
frequent
caus
metabol
acidosi
set
patient
method
retrospect
analyz
first
arteri
blood
ga
result
success
resuscit
ohca
patient
admit
tertiari
parisian
intens
care
unit
baselin
characterist
compar
accord
presenc
hyperkalemia
factor
associ
kalemia
identifi
use
multivari
linear
regress
sensit
analysi
repeat
subgroup
patient
without
chronic
respiratori
diseas
crd
without
acut
kidney
injuri
aki
admiss
blood
lactat
mmoll
patient
potassium
level
mmoll
patient
hyperkalemia
present
frequent
initi
nonshock
rhythm
experienc
longer
collaps
resuscit
icu
admiss
patient
hyperkalemia
present
deeper
acidemia
vs
p
higher
lactatemia
vs
p
higher
serum
creatinin
level
vs
p
follow
multivari
linear
regress
kalemia
associ
initi
nonshock
rhythm
ci
higher
creatininemia
ci
elev
ci
elev
lactat
level
inde
statist
neg
trend
potassium
blood
level
lactatemia
observ
p
sensit
analys
perform
patient
without
aki
crd
show
similar
result
conclus
studi
demonstr
absenc
associ
blood
lactat
potassium
level
acidosi
sever
acidemia
success
resuscit
ohca
patient
set
phenomenon
appear
independ
aki
result
suggest
kaliemia
fact
strongli
link
arteri
introduct
mitral
veloc
e
wave
veloc
wave
veloc
earli
diastol
mitral
annulu
veloc
e
assess
transthorac
echocardiographi
tte
tissu
doppler
imag
tdi
correl
pulmonari
arteri
occlus
pressur
paop
cardiolog
patient
paramet
depend
load
condit
modifi
mechan
ventil
use
catecholamin
icu
ventil
patient
receiv
catecholamin
e
ratio
e
veloc
evalu
patient
method
observ
prospect
studi
includ
consecut
patient
mean
age
year
septic
shock
ard
patient
treat
catecholamin
mean
dose
mg
h
ventil
mean
mean
tidal
volum
ml
kg
volum
expans
perform
ringer
lactat
solut
discret
clinician
echocardiograph
doppler
examin
hemodynam
measur
repeat
volum
expans
obtain
measur
doppler
mitral
inflow
tdi
mitral
annulu
veloc
determin
compar
paop
measur
swanganz
cathet
tte
paramet
analyz
offlin
independ
oper
blind
clinic
histori
paop
valu
result
fluid
challeng
increas
paop
mmhg
howev
differ
cardiac
index
l
min
signific
correl
paop
e
wave
beta
ic
introduct
central
venou
cathet
cvc
allow
infus
sever
drug
simultan
intens
care
unit
thank
use
yset
infus
line
mani
constraint
encount
manag
pediatr
populationslimit
infus
rate
accord
age
children
maximum
infus
volum
relat
weight
inde
limit
water
suppli
perform
hyperpermeabil
vessel
popul
optim
infus
set
therefor
essenti
improv
secur
support
main
object
evalu
infus
practic
identifi
optim
suggest
patient
method
observ
infus
line
cvc
conduct
month
decemb
march
pediatr
resuscit
depart
restitut
observ
carri
unit
form
work
group
optim
infus
setup
sever
propos
perfus
set
discuss
result
conduct
interview
nurs
last
approxim
min
accord
grid
compos
multiplechoic
question
openend
question
infus
line
observ
nurs
interview
nurs
staff
observ
concern
children
year
old
children
year
old
children
year
old
cvc
place
jugular
vein
femor
subclavian
trilumen
bilumen
monolumen
cvc
avail
port
use
infus
line
cvc
dress
chang
everi
day
soil
unstuck
nurs
declar
problem
dressingdress
big
younger
inadapt
burn
children
yet
sticki
drool
nurs
encount
drug
incompat
infus
cvc
survey
nurs
knew
exist
unit
drug
incompat
tabl
conclus
evalu
nurs
practic
highlight
good
knowledg
type
infus
line
compar
recommend
howev
effort
must
made
ration
number
line
avail
infus
set
integr
infus
devic
optim
geometri
limit
drug
incompat
discuss
medic
team
size
cathet
accord
child
weight
engag
smaller
dress
referenc
unit
modif
dess
chang
frequenc
consid
day
introduct
malnutrit
preval
children
admit
pediatr
intens
care
unit
picu
inadequaci
energi
intak
known
risk
factor
morbid
mortal
critic
children
sfar
et
de
publish
european
nutrit
guidelin
studi
aim
evalu
nutrit
practic
french
picu
compar
energi
protein
intak
use
sfar
recommend
american
recommend
identifi
risk
factor
inadequ
energi
intak
use
sfar
recommend
patient
method
studi
retrospect
one
picu
univers
hospit
children
age
one
month
eighteen
year
old
receiv
exclus
enter
nutrit
en
includ
patient
hospit
less
h
patient
fed
exclus
oral
parenter
rout
exclud
individu
energi
protein
intak
calcul
day
compar
sfar
recommend
satisfactori
energi
intak
consid
follow
equal
greater
sfar
recommend
intak
two
group
constitut
compar
identifi
risk
factor
patient
follow
sfar
recommend
optim
en
group
children
receiv
energi
recommend
maintain
least
half
icu
stay
optim
en
children
nt
result
patient
involv
studi
malnutrit
admiss
occur
patient
averag
energi
intak
kcal
kg
day
repres
energi
estim
intak
sfar
recommend
schofield
equat
respect
energi
intak
receiv
closer
intak
estim
use
schofield
equat
recommend
sfar
figur
sfar
recommend
respect
patient
american
recommend
taken
board
patient
averag
protein
intak
g
kg
day
repres
intak
recommend
sfar
patient
optim
en
median
time
initi
en
longer
optim
en
group
vasopressor
identifi
risk
factor
meet
sfar
recommend
p
conclus
patient
respect
sfar
recommend
vasopressor
risk
factor
meet
sfar
recommend
american
recommend
use
schofield
equat
respect
patient
enter
feed
protocol
could
reduc
median
time
initi
en
support
intoler
hi
deplet
children
nt
exist
knowledg
anoth
studi
show
calibr
abdomin
compress
cac
abl
predict
fluid
respons
children
acut
circulatori
failur
patient
method
primari
object
studi
determin
variat
stroke
volum
index
svi
cac
test
indexcan
predict
hi
deplet
defin
decreas
cardiac
output
deplet
least
ml
kg
children
fo
conduct
prospect
nonintervent
studi
french
teach
hospit
cardiolog
icu
patient
eight
year
old
might
suffer
fo
need
deplet
diuret
select
includ
urin
ml
kg
less
two
hour
assess
svi
aortic
flow
veloc
integr
transthorac
echocardiographi
deplet
cac
deplet
record
hemodynam
paramet
consid
secondari
outcom
result
patient
includ
cardiac
surgeri
six
decreas
cardiac
output
deplet
introduct
intern
task
forc
chang
definit
sepsi
septic
shock
adult
use
organ
failur
score
name
sequenti
organ
failur
assess
sofa
concept
new
progress
multipl
organ
dysfunct
syndrom
npmod
correspond
organ
dysfunct
aggrav
propos
proxi
mortal
critic
diseas
mani
criteria
exist
defin
organ
dysfunctionsth
proulx
criteria
goldstein
criteria
pediatr
logist
organ
score
pediatr
sofa
score
aim
studi
compar
four
definit
find
best
definit
npmod
could
use
surrog
outcom
pediatr
septic
shock
therapeut
trial
patient
method
retrospect
observ
studi
januari
decemb
singl
picu
inclus
criteria
age
year
hospit
picu
septic
shock
definit
primari
outcom
measur
picu
mortal
secondari
outcom
evalu
morbiditymort
use
evolut
pediatr
overal
perform
categori
popc
result
patient
includ
mean
age
year
year
patient
less
day
old
patient
die
fatal
rate
patient
signific
worsen
deltapopc
common
caus
septic
shock
mening
meningoenceph
purpura
fulminan
intraabdomin
infect
patient
develop
npmod
accord
proulx
criteria
accord
goldstein
criteria
psofa
four
definit
use
defin
npmod
significantli
associ
mortal
deltapopc
p
deceas
patient
score
worsen
first
five
day
score
improv
contrari
score
survivor
improv
within
first
day
whatev
definit
use
conclus
npmod
definit
could
surrog
outcom
mortal
usabl
pediatr
septic
shock
therapeut
trial
whether
use
proulx
goldstein
psofa
criteria
howev
definit
consid
onset
aggrav
organ
dysfunct
studi
would
need
creat
valid
altern
definit
incorpor
notion
nonimprov
organ
dysfunct
time
would
better
reflect
natur
cours
sever
patient
pediatr
septic
shock
introduct
electr
velocimetri
ev
noninvas
method
continu
left
cardiac
output
monitor
main
object
valid
ev
investig
agreement
cardiac
output
measur
perform
ev
transthorac
echocardiographi
patient
method
conduct
prospect
singlecent
pilot
studi
bed
pediatr
intens
care
unit
picu
includ
children
day
year
hemodynam
instabl
circulatori
failur
exclud
children
congenit
heart
diseas
imposs
chest
access
imposs
simultan
measur
cardiac
output
ev
echocardiographi
agreement
bia
precis
measur
analyz
blandaltman
method
bia
percentag
error
consid
clinic
accept
paramet
contractil
icon
ev
left
ventricular
eject
fraction
preload
depend
stroke
volum
variat
svv
ev
variat
aortic
blood
flow
veloc
echocardiographi
compar
result
patient
includ
median
age
year
median
weight
kg
measur
perform
analyz
bia
percentag
error
cardiac
output
measur
respect
correl
paramet
assess
contractil
left
ventricular
eject
fraction
echocardiographi
contractil
index
ev
r
p
evalu
preload
depend
variat
aortic
blood
flow
veloc
echocardiographi
svv
ev
r
p
conclus
ev
appear
reliabl
method
continu
co
monitor
compar
transthorac
echocardiographi
limit
contractil
preload
depend
paramet
cardioreap
studi
follow
pilot
studi
start
novemb
focu
children
introduct
kawasaki
diseas
kd
rare
acut
system
vascul
occur
mainli
children
year
age
major
challeng
cardiac
involv
may
requir
admiss
intens
care
unit
icu
lifethreaten
common
patient
requier
icu
nt
meet
american
heart
associ
aha
criteria
vascular
damag
often
begin
complic
differenti
diagnosi
especi
infecti
challeng
risk
delay
treatment
case
intraven
immunoglobulin
ivig
patient
method
aim
studi
specifi
caracterist
outcom
patient
admit
icu
potenti
kd
complic
compar
patient
met
aha
criteria
aha
patient
aha
end
collect
nation
retrospect
case
et
follow
call
scholarli
associ
sofremip
gfup
collect
clinic
biolog
echocardiographi
data
comparison
base
fisher
exact
test
categor
variabl
student
ttest
continu
variabl
statist
analys
perform
use
prism
medcalc
test
twotail
p
consid
signific
result
patient
yet
kd
diagnos
admiss
icu
present
either
sepsi
includ
toxic
shock
syndrom
acut
abdomen
nearli
half
patient
receiv
vasoact
drug
patient
except
two
receiv
broadspectrum
antibiot
patient
receiv
least
one
ivig
infus
resist
first
ivig
infus
observ
patient
second
ivig
infus
chosen
third
treatment
line
need
iv
corticoid
infus
chosen
associ
antiinterleukin
anakinra
patient
kdicu
present
aha
criteria
compar
nt
patient
ahawer
younger
lower
heamoglobin
concentr
intub
mechan
ventil
conclus
kdicu
patient
initi
evolut
differ
whether
complet
incomplet
aha
criteria
strong
suspicion
kd
icu
therefor
enough
initi
specif
therapeut
ivig
analysi
defin
phenotyp
patient
kdicu
target
earlier
compar
kd
need
icu
transfer
via
kawanet
french
databas
introduct
bronchiol
first
caus
hospit
infant
six
admit
pediatr
intens
care
unit
picu
develop
complic
relat
respiratori
distress
like
seizur
hyponatremia
aim
studi
describ
occurr
hyponatremia
bronchiol
infant
age
three
month
admit
picu
associ
morbid
patient
method
conduct
retrospect
studi
includ
infant
younger
month
admit
lyonfranc
picu
diagnosi
bronchiol
januari
april
children
previou
histori
signific
heart
diseas
neurolog
impair
exclud
studi
approv
ethic
committe
french
societi
intens
care
hyponatremia
defin
plasma
sodium
level
mmoll
time
picu
stay
test
use
compar
hyponatremia
group
nohyponatremia
group
pvalu
consid
signific
result
total
infant
includ
among
least
one
avail
natremia
valu
hyponatremia
occur
n
children
n
natremia
mmoll
age
vs
day
hyponatremia
group
p
weight
g
vs
g
p
similar
two
group
comparison
sever
factor
group
present
tabl
conclus
hyponatremia
occur
one
third
infant
younger
month
year
old
admit
picu
bronchiol
hyponatremia
associ
sever
factor
bronchiol
frequent
seizur
longer
length
picu
stay
hyponatremia
need
monitor
prevent
treat
accur
infant
sever
bronchiol
samia
benouaz
speaker
faiza
nadia
benatta
setti
aouicha
zelmat
djahida
djamila
batouch
ibtissem
bouanani
de
algeria
de
oran
algeria
correspond
samia
benouaz
drbenouaz
hotmailfr
annal
intens
care
suppl
introduct
hyponatremia
common
fluid
electrolyt
disord
incid
estim
oper
children
hyponatraemia
occur
postop
period
objectiveto
determin
circumst
occurr
hyponatremia
patient
method
retrospect
studi
carri
pediatr
surgeri
multipurpos
resuscit
depart
chu
includ
acut
hyponatraemia
without
neurolog
symptomatolog
follow
control
surgeri
healthi
children
patholog
lead
fluid
electrolyt
disturb
result
hyponatraemia
identifi
studi
regardless
mechan
children
present
iatrogen
acut
hyponatremia
children
oper
circumcis
fractur
reduct
orthoped
surgeri
clubfoot
lch
thyrogloss
cyst
serum
sodium
rang
mmoll
mmo
l
patient
present
vomit
three
children
gener
seizur
brain
ct
found
diffus
cerebr
edema
evolut
favor
case
one
death
addit
anticonvuls
therapi
patient
treatment
hyponatremia
involv
administr
sodium
salt
rate
mmol
hour
pe
h
control
clinic
statu
ionogram
discuss
children
present
iatrogen
acut
hyponatremia
underw
simpl
surgeri
one
except
children
class
perfus
periop
period
hypoton
highthroughput
fluid
blood
glucos
moder
high
children
hypovolem
arriv
circumst
occurr
explain
bya
dilut
relat
infus
hypoton
solut
abund
flow
monitor
nurs
due
lack
personnel
prolong
preoper
fast
h
seri
may
accompani
hypovolemia
respons
secret
adh
compon
ad
iatrogen
factor
conclus
followup
good
practic
periop
pediatr
perfus
use
adapt
equip
precis
infus
pump
volumetr
pump
strict
control
infus
rate
educ
nurs
staff
perman
abandon
pseudo
prescript
type
keep
vein
fundament
avoid
type
ionic
disord
children
postop
introduct
traumatolog
triag
dynam
process
start
trauma
scene
includ
prehospit
care
continu
trauma
team
activ
trauma
center
requir
end
patient
admiss
adequ
unit
hospit
referr
sever
injur
children
level
pediatr
trauma
center
ptc
like
femm
enfant
hfme
lyon
franc
reduc
mortal
hfme
local
guidelin
establish
trauma
team
activ
prehospit
carrier
trauma
scene
emerg
physician
emerg
depart
level
criteriavit
distress
level
criteriavit
distress
stabil
prehospit
care
level
criteriano
vital
distress
mechan
injuri
criteria
patient
method
conduct
retrospect
studi
patient
admit
hfme
trauma
team
activ
criteria
accord
local
guidelin
level
patient
level
patient
present
injuri
sever
score
iss
consid
sever
injur
four
type
undertriag
defin
differ
stage
supportprehospit
undertriag
transport
prehospit
undertriag
orient
emerg
depart
undertriag
final
undertriag
consid
main
undertriag
figur
rate
undertriag
ptc
recommend
less
prehospit
triag
seem
strongli
impact
cours
patient
care
evalu
traumat
child
complic
even
profession
firstaid
high
rate
emerg
depart
undertriag
show
triag
also
need
improv
emerg
depart
introduct
diaphragm
dysfunct
wean
induc
pulmonari
edema
wipe
two
main
caus
wean
failur
sinc
spontan
breathingincreas
venou
return
key
determin
wipe
hypothes
diaphragm
dysfunct
could
provid
thorac
depress
enabl
occurr
wipe
therefor
object
studi
determin
preval
wipe
diaphragm
dysfunct
coexist
patient
method
patient
intub
sinc
h
elig
fail
first
spontan
breath
trial
sbt
follow
sbt
diaphragm
function
evalu
refer
method
drop
tracheal
pressur
induc
bilater
phrenic
nerv
stimul
cardiac
echo
earli
e
late
peak
diastol
veloc
ratio
tissu
doppler
imag
mitral
annulu
veloc
includ
earli
ea
peak
diastol
veloc
wave
ratio
biolog
hemoconcentr
marker
wipe
search
diaphragm
dysfunct
defin
ptr
stim
wipe
defin
fail
sbt
associ
either
combin
e
e
ea
end
sbt
increas
plasma
protein
concentr
hemoglobin
sbt
result
among
patient
includ
twentyon
fail
sbt
wipe
present
patient
fail
diaphragm
dysfunct
found
patient
fail
mechan
present
patient
except
one
patient
patient
wipe
occur
diaphragm
dysfunct
found
figur
conclus
coexist
diaphragm
dysfunct
wipe
frequent
time
liber
mechan
ventil
difficult
wean
patient
presenc
diaphragm
dysfunct
nt
reduc
risk
wipe
extracorpor
membran
oxygen
adult
cancer
patient
sever
acut
respiratori
failureview
cancer
center
afef
hammami
speaker
introduct
use
extracorpor
membran
oxygen
ecmo
adult
cancer
patient
controversi
studi
design
report
outcom
adult
cancer
patient
treat
ecmo
sever
acut
respiratori
distress
syndrom
ard
failur
optim
convent
therapi
also
identifi
preecmo
predictor
icu
mortal
patient
method
chart
cancer
patient
admit
oncolog
icu
receiv
ecmo
support
ard
retrospect
review
case
record
use
pmsi
data
analysi
computer
record
keyword
systemat
detect
placement
cannula
patient
transfer
hospit
special
icu
ecmo
therapi
result
fourteen
patient
receiv
ecmo
studi
period
tabl
one
patient
receiv
venoarterialven
ecmo
acut
circulatori
failur
addit
ard
patient
receiv
venoven
ecmo
ecmorel
major
bleed
ventilatorassoci
pneumonia
frequent
respect
respect
median
ecmo
durat
icu
stay
day
icu
surviv
four
survivor
significantli
shorter
time
interv
icu
admiss
start
ecmo
therapi
vs
day
lower
baselin
vs
mmhg
ecmo
initi
lower
health
careassoci
infect
vs
episod
shorter
ecmo
durat
vs
day
discuss
limit
studi
retrospect
design
small
number
case
involv
obviou
select
bia
induc
patient
treat
ecmo
includ
systemat
computer
analysi
ensur
lack
miss
data
despit
high
rate
icu
mortal
studi
show
survivor
still
aliv
month
later
earli
begin
ecmo
avoid
ventilatorinduc
lung
injuri
associ
better
prognosi
find
encourag
identifi
soon
possibl
patient
favor
prognosi
malign
isol
respiratori
failur
order
optim
chanc
recoveri
ard
close
cooper
intensivist
oncologist
warrant
conclus
ecmo
therapi
may
benefici
select
cancer
patient
ongo
investig
need
better
select
patient
like
benefit
determin
optim
time
initi
ecmo
introduct
system
lupu
erythematosu
chronic
autoimmun
diseas
characteris
frequent
skin
joint
haematolog
renal
involv
acut
interstiti
pneumonia
aip
infrequ
poorli
investig
diseas
aim
studi
describ
clinic
characterist
cours
outcom
aip
sle
conduct
monocentr
retrospect
observ
cohort
studi
novemb
septemb
includ
patient
sle
defin
use
american
colleg
rheumatolog
criterion
aip
defin
acut
respiratori
manifest
diffus
pulmonari
opac
chest
radiographi
lung
tomographi
exclus
altern
diagnosi
includ
acut
respiratori
infect
result
fourteen
patient
male
femal
sex
ratio
mean
sd
age
year
present
episod
includ
aip
present
diseas
onset
first
year
sle
diagnosi
respect
patient
eleven
episod
requir
icu
admiss
respiratori
failur
episod
requir
mechan
ventil
vvecmo
median
introduct
sever
pneumonia
frequent
associ
acut
respiratori
distress
syndrom
ard
uncontrol
inflammatori
respons
lung
key
factor
transit
pneumonia
ard
howev
underli
mechan
still
poorli
understood
assess
heterogen
popul
lymphocyt
call
unconvent
cell
utc
deserv
greater
attent
cell
compris
natur
killer
nkt
cell
mucosalassoci
invari
cell
mait
gamma
delta
cell
preclin
studi
shown
versatil
properti
key
role
immun
respons
invad
pathogen
thu
hypothes
tight
regul
function
mandatori
finetun
host
inflammatori
respons
infect
lung
subsequ
prevent
emerg
aberr
respons
lead
tissu
damag
despit
strong
rational
human
data
howev
lack
patient
method
singlecent
prospect
studi
patient
hospit
intens
care
sever
pneumonia
blood
respiratori
sampl
perform
flow
cytometrybas
analysi
cell
order
determin
frequenc
differ
timepoint
hospit
presenc
activ
regul
marker
abil
produc
cytokin
involv
ard
pathogenesi
cytotox
capac
result
patient
includ
date
compar
healthi
control
half
patient
present
ard
median
sapsii
patient
sever
pneumonia
observ
strike
decreas
circul
mait
cell
compar
healthi
control
fig
nkt
gamma
delta
cell
observ
may
suggest
recruit
cell
inflammatori
site
sinc
high
proport
mait
cell
detect
respiratori
fluid
patient
ard
addit
circul
mait
cell
patient
express
high
level
fig
interestingli
proport
mait
cell
decreas
clinic
improv
proport
remain
stabl
upon
ex
vivo
stimul
proport
ifngammaproduc
mait
cell
significantli
decreas
patient
compar
healthi
control
fig
proport
tnfalphaproduc
mait
cell
similar
conclus
mait
cell
recruit
activ
alter
cytokin
profil
secret
sever
pneumonia
preliminari
data
justifi
pursu
indepth
analysi
mait
cell
function
patient
correl
clinic
condit
introduct
venoarteri
ecmotr
patient
present
mani
risk
factor
breath
failur
associ
heart
failur
seem
essenti
optim
ventilatori
paramet
order
limit
lung
injuri
aim
studi
evalu
abil
electr
imped
tomographi
set
optim
level
posit
end
expiratori
pressur
peep
perform
alveolar
recruit
maneuv
follow
decrement
peep
trial
decrement
thank
clinic
ultrasonograph
paramet
heart
lung
defin
optim
pep
accord
respiratori
criteria
peeplung
adjust
accord
hemodynam
cardiac
toler
defin
pepheart
lung
eit
data
region
distribut
ventil
zcomplianc
overdistens
collapsu
odcl
global
inhomogen
index
gi
record
procedur
analyz
retrospect
defin
optim
peepspeepcomp
peepodcl
peepgi
friedman
test
compar
differ
optim
peep
well
region
ventil
distribut
pep
level
agreement
peeplung
measur
peep
analyz
cohen
kappa
coeffici
result
patient
includ
analyz
month
period
peep
decreas
increment
ventil
ventral
region
correspond
overdistens
decreas
dorsal
region
reflect
collaps
collaps
cl
maximum
distens
maximum
signific
differ
differ
optim
peep
agreement
averag
peeplung
optim
peep
calcul
eit
paramet
kappa
choic
peeplung
question
base
global
static
respiratori
complianc
paramet
measur
singl
respiratori
cycl
measur
transpulmonari
pressur
could
precis
measur
peplung
statist
higher
pepheart
lung
p
reflect
bad
hemodynam
toler
high
level
peep
due
complex
phenomenon
heartlung
interact
conclus
eit
help
find
best
compromis
overdistens
lung
collaps
detect
region
distribut
mechan
ventil
effect
howev
evalu
chosen
peep
hemodynam
toler
necessari
associ
eitechocardiographi
seem
effici
tool
provid
monitor
peep
effect
conclus
chang
cvp
plr
use
bedsid
predict
preload
unrespons
critic
ill
patient
howev
crucial
distinguish
patient
respond
fluid
challeng
improv
cardiac
output
inferior
vena
cava
ivc
diamet
variat
one
sever
indic
propos
predict
fluid
respons
howev
efficaci
indic
remain
controversi
studi
test
hypothesi
respiratori
variat
ivc
crosssect
surfac
could
better
predictor
fluid
respons
ivc
diamet
variat
patient
method
prospect
studi
mechan
ventil
patient
cardiac
surgeri
crystalloid
fluid
challeng
administ
period
time
collect
data
includ
puls
pressur
variat
respiratori
variat
ivc
diamet
respiratori
variat
ivc
crosssect
surfac
ivc
studi
subxyphoid
view
fluid
respons
defin
increas
cardiac
output
obtain
swanganz
cathet
continu
thermodilut
analys
perform
use
parametr
nonparametr
test
accord
variabl
distribut
abil
paramet
predict
fluid
respons
assess
use
roc
curv
result
popul
studi
consist
consecut
patient
age
male
main
type
surgeri
coronari
arteri
bypass
graft
valvular
surgeri
statist
differ
respond
nonrespond
static
paramet
includ
heart
rate
central
venou
pressur
minim
maxim
ivc
diamet
respiratori
variat
ivc
diamet
ivc
distens
index
unabl
predict
fluid
respons
show
area
roc
curv
auc
indic
discrimin
power
puls
pressur
variat
fair
studi
best
predictor
fluid
respons
respiratori
variat
ivc
crosssect
surfac
auc
figur
novel
dynam
index
obtain
cyclic
variat
ivc
crosssect
surfac
could
candid
predict
fluid
respons
consist
previou
studi
ivc
diamet
fail
distinguish
fluid
respond
nonrespond
studi
fair
abil
puls
pressur
variat
predict
fluid
respons
could
explain
rapid
chang
patient
hemodynam
shown
signific
drop
system
vascular
resist
observ
fluid
challeng
introduct
valproic
acid
vpa
overdos
caus
lifethreaten
disord
includ
hyperammonemia
hyperlactatemia
lcarnitin
use
sever
year
antidot
revers
vpa
toxic
without
evid
effect
aim
describ
featur
outcom
vpapoison
patient
admit
icu
investig
effect
lcarnitin
treatment
vpa
pharmacokinet
pk
contribut
patient
prognosi
patient
method
conduct
retrospect
singlecent
cohort
studi
consecut
patient
admit
icu
acut
vpa
intox
defin
presenc
compat
symptom
plasma
vpa
concentr
mg
l
februari
decemb
includ
lcarnithin
administ
accord
physician
charg
vpa
elimin
halfliv
determin
use
noncompartment
approach
populationbas
model
vpa
pk
individu
pharmacodynam
pd
obtain
effect
lcarnitin
investig
use
multivari
analysi
propens
score
match
studi
result
sixtynin
patient
includ
frequent
present
conscious
impair
multiorgan
failur
sofa
score
median
percentil
frequent
biolog
impair
increas
lactat
concentr
mmoll
patient
treat
lcarnithin
present
significantli
higher
peak
lactat
concentr
mmoll
vs
p
sever
neurolog
disord
vs
p
significantli
differ
vpa
concentr
howev
base
propens
score
approach
differ
associ
lcarnithin
administr
plasma
lactat
admiss
p
compar
match
lcarnithinetr
nontreat
patient
signific
benefit
lcarnithin
demonstr
use
differ
wors
admiss
valu
sofa
score
delay
plasma
lactat
normal
vpa
halflif
pharmacokinet
paramet
wellfit
populationbas
model
vpa
pk
overdos
ka
ke
halfliv
h
conclus
vpa
poison
respons
lifethreaten
featur
includ
hyperlactatemia
treatment
use
lcarnithin
alter
neither
vpa
elimin
patient
outcom
icu
pk
pd
model
appear
help
improv
manag
vpapoison
patient
allow
identif
condit
interindividu
variabl
introduct
acut
intox
common
reason
admiss
emerg
care
resuscit
servic
object
studi
determin
prognost
factor
relat
acut
intox
young
popul
patient
method
retrospect
studi
includ
acut
intox
admiss
intens
care
unit
year
epidemiolog
biolog
therapeut
paramet
collect
uni
follow
multivari
analysi
perform
determin
independ
factor
mortal
result
studi
period
patient
admit
intens
care
acut
intox
averag
age
year
old
intox
voluntari
order
commit
suicid
incrimin
toxic
drug
n
especi
psychotrop
drug
n
pesticid
n
chloralos
leader
n
accident
poison
carbon
monoxid
co
rank
first
n
clinic
pictur
domin
coma
n
digest
disord
n
igsii
apach
ii
admiss
sever
score
respect
stay
main
complic
inhal
pneumonia
case
rodenticid
poison
shock
case
drug
poison
rhabdomyolysi
case
co
poison
nosocomi
infect
observ
patient
therapeut
manag
mainli
symptomat
use
mechan
ventil
case
antibiot
case
vasoact
amin
case
overal
mortal
acut
poison
n
independ
mortal
factor
werea
greater
score
p
apach
ii
occurr
hepat
cytolysi
p
acut
renal
failur
p
recov
cardiorespiratori
arrest
p
length
stay
day
p
conclus
although
mortal
acut
intox
low
essenti
rais
awar
danger
poison
certain
cardiotox
drug
also
legisl
sale
insecticid
product
minoxidilfrom
hair
lotion
toxic
shock
intens
care
unit
takoua
khzouri
speaker
hela
maamouri
nasreddin
foudhaili
ikram
benjaberi
nozha
brahmi
camu
tuni
tunisia
correspond
takoua
khzouri
yahoofr
annal
intens
care
suppl
introduct
minoxidil
commonli
use
treatment
androgen
alopecia
wrongli
consid
safe
sever
poison
case
mainli
pediatr
prove
ingest
millilit
lead
signific
intox
perspect
carri
illustr
differ
characterist
poison
order
introduct
terrorist
threat
franc
real
differ
form
attack
challeng
train
numer
nonspeci
caregiv
differ
background
damag
control
dc
strategi
purpos
work
propos
specif
train
program
provid
standard
care
ambiti
goal
zero
avoid
death
patient
method
task
forc
civilian
militari
physician
expert
tactic
medicin
medic
train
met
h
session
propos
construct
dc
train
program
nonspeci
caregiv
result
dc
train
program
exist
alreadi
heterogen
mainli
theoret
almost
physician
task
forc
identifi
hole
exist
train
program
name
damag
control
terrorist
attack
victim
dctav
propos
identifi
train
target
caregiv
physician
nurs
nurs
assist
prehospit
hospit
staff
trauma
experi
train
object
improv
individu
collect
skill
dc
strategi
manag
terrorist
attack
casualti
tool
select
train
concern
elearn
dedic
digit
teach
platform
includ
core
section
modul
type
mechan
injuri
basic
dc
techniqu
triag
organ
emerg
medic
respons
complementari
modul
doctor
dc
resuscit
dc
surgeri
handson
workshop
procedur
simul
full
scale
simul
exercis
technic
tourniquet
hemostat
gauz
needl
thoracostomi
chest
tube
drainag
manag
airway
coniotomi
nontechn
leadership
commun
coordin
triag
decisionmak
appropri
use
resourc
skill
feasibl
pilot
studi
propos
rural
area
trauma
center
univers
hospit
final
evalu
dctav
plan
use
tool
use
train
dctav
program
ambiti
civilianmilitari
nation
longterm
program
base
harmon
standard
care
includ
multidimension
train
introduct
despit
increas
organ
donat
hundr
patient
die
wait
list
everi
year
one
solut
suggest
agenc
de
la
abm
develop
organ
donat
nonheart
beat
donor
nhbd
particularli
nhbd
categori
iii
maastricht
classif
nhbd
allow
sinc
chang
french
law
program
launch
abm
want
initi
organ
donat
nhbd
miii
hospit
chu
besancon
order
increas
graft
pool
patient
die
brain
death
patient
organ
donor
dbd
hospit
perform
retrospect
analysi
death
follow
withdraw
life
sustain
support
treatment
wlst
intens
care
unit
icu
use
data
medic
record
primari
endpoint
identifi
mani
patient
could
nhbd
elig
criteria
weredeath
icu
wlst
age
year
major
brain
damag
hope
recoveri
exclud
patient
present
contraind
organ
donat
result
patient
die
wlst
year
old
less
exclud
patient
cancer
patient
multipl
organ
failur
patient
die
wlst
patient
brain
injur
patient
could
nhbd
median
age
men
caus
brain
damag
patient
post
anox
encephalopathi
subarachnoid
hemorrhag
patient
brain
trauma
examin
medic
record
suggest
patient
could
donat
kidney
patient
could
donat
liver
base
data
day
death
patient
die
h
wlst
patient
uncontrol
infect
left
potenti
kidney
donor
potenti
liver
donor
conclus
patient
identifi
potenti
nhbd
chu
besancon
addit
dbd
data
show
patient
young
good
health
suggest
great
qualiti
graft
despit
potenti
warm
ischem
injuri
due
nhbd
posit
experi
hospit
sinc
encourag
us
initi
program
introduct
transcrani
doppler
tcd
noninvas
examin
allow
velocimetr
studi
intracrani
vessel
via
ultrasound
beam
author
propos
studi
statist
therapeut
impact
tcd
trauma
coma
databank
tcdb
data
coupl
moder
cranial
trauma
ed
prospect
studi
includ
patient
year
old
moder
head
injuri
gc
initi
admit
vital
emerg
room
immedi
benefit
craniocerebr
ct
dtc
within
h
postadmiss
without
respiratori
hemodynam
distress
without
gasometr
anomali
normal
absenc
anemia
tdm
allow
distinguish
class
trauma
coma
databank
measur
dtp
consid
stabl
pattern
ten
cardiac
cycl
paramet
measur
weresystol
velocimetri
sv
mean
velocimetri
mv
diastol
velocimetri
dv
well
pulsatil
index
pi
cerebr
perfus
pressur
deduc
equationmap
x
dv
mv
data
collect
concern
demograph
data
vital
paramet
neurolog
deterior
statist
analysi
univari
p
result
patient
includ
studi
divid
two
groupsgroup
n
without
neurolog
deterior
group
n
neurolog
deterior
mean
age
two
group
year
sex
ratio
group
group
averag
initi
gc
group
group
patient
group
tcdb
tcdb
group
patient
tcdb
patient
tcdb
pi
group
pi
group
statist
perform
dtc
ctdb
dtc
ctdb
coupl
occurr
neurolog
worsen
illustr
follow
tabl
coupl
dtc
tcdb
data
would
increas
statist
predict
perform
earli
neurolog
deterior
high
sensit
specif
vpn
would
also
guid
intens
neuroresuscit
result
confirm
larger
cohort
introduct
immun
system
play
central
role
surveil
neoplasm
develop
develop
research
project
investig
impact
sepsisinduc
immun
dysfunct
malign
tumor
growth
sepsisthencanc
model
like
sepsisinduc
immun
suppress
promot
tumor
growth
cancerthensepsi
model
sepsi
may
rather
inhibit
tumor
growth
herein
investig
sepsi
tolllik
receptor
tlr
signal
may
promot
antitumor
function
cytotox
natur
killer
nk
cell
lymphocyt
patient
method
use
j
wildtyp
wt
mice
mice
first
subcutan
inocul
fibrosarcoma
cell
fourteen
day
later
mice
subject
septic
challeng
polymicrobi
sepsi
induc
cecal
ligat
punctur
clp
endotoxin
shock
induc
intraperiton
lipopolysaccharid
lp
inject
main
function
tumorassoci
cytotox
nk
cell
assess
flow
cytometri
intracellular
express
interferongamma
ifn
cytotox
molecul
perforin
granzym
well
outer
membran
express
degranul
marker
order
address
cytotox
function
vitro
nk
cell
isol
septic
control
mice
expos
tumor
cell
result
polymicrobi
sepsi
dampen
tumor
growth
wt
mice
neither
counterpart
similar
tumor
growth
inhibit
observ
follow
lp
challeng
wt
mice
distribut
tumorinfiltr
nk
cell
weakli
affect
sepsi
undergo
signific
function
chang
among
nk
cell
lp
induc
expans
cytotox
along
increas
express
activ
marker
tumorinfiltr
nk
cell
obtain
septic
mice
exhibit
enhanc
antitumor
properti
nk
cell
obtain
clpoper
mice
display
increas
express
ifn
behaviour
nk
cell
obtain
lpschalleng
mice
consist
activ
degranul
process
suggest
increas
membran
express
along
decreas
intracellular
express
perforin
granzym
express
low
cell
similar
cell
antitumor
properti
nk
cell
obtain
septic
mice
exacerb
cultur
cell
introduct
date
maintain
fibrinogen
level
g
l
recommend
therapeut
target
postpartum
hemorrhag
howev
time
fibrinogen
supplement
still
controversi
purpos
retrospect
studi
describ
experi
earli
administr
fibrinogen
concentr
sever
pph
patient
method
analyz
databas
patient
need
fibrinogen
concentr
transfus
treatment
sever
postpartum
hemorrhag
cesarean
deliveri
treat
coagulopathi
plasmat
fibrinogen
gl
massiv
transfus
earlier
result
plasmat
concentr
fibrinogen
patient
divid
two
group
group
e
earli
receiv
fibrinogen
concentr
within
first
hour
deliveri
group
l
late
receiv
fibrinogen
transfus
later
h
assess
blood
loss
transfus
requir
result
demograph
paramet
age
weight
patient
height
gestiti
pariti
preoper
hemostat
statu
compar
group
blood
loss
correl
delay
fibrinogen
administr
fig
pearson
correl
coeffici
mean
blood
loss
ml
group
e
n
versu
ml
group
l
n
p
red
blood
cell
transfus
requir
unit
patient
group
e
versu
group
l
p
need
fresh
frozen
plasma
unit
patient
group
e
versu
group
l
p
discuss
fidel
studi
prospect
multi
centric
french
studi
whose
result
yet
publish
may
give
answer
best
time
fibrinogen
concentr
infus
sever
pph
conclus
earli
administr
fibrinogen
within
first
hour
follow
deliveri
may
reduc
bleed
sever
postpartum
hemorrhag
transfus
requir
optim
daili
dose
enoxaparinin
acut
burn
patient
amel
moklin
speaker
result
confirm
adjust
confound
use
multivari
logist
regress
compar
calibr
varianc
explain
model
conclus
cohort
sever
tma
patient
requir
icu
admiss
plasmic
score
limit
perform
diagnosi
ttp
perform
coppo
score
good
similar
singl
highli
discrimin
itemplatelet
count
new
definit
sepsi
septic
shock
usabl
cancer
patient
nathan
neveux
speaker
mariann
paesman
lievek
amey
jeanpaul
sculier
annepascal
meert
institut
jule
bordet
bruxel
belgium
correspond
nathan
neveux
nathanneveux
ulbacb
annal
intens
care
suppl
introduct
new
definit
sepsi
septic
shock
base
sofa
score
qsofa
score
emerg
studi
conduct
gener
popul
demonstr
sofa
score
accur
sir
score
predict
hospit
mortal
infect
patient
requir
intens
care
howev
nowaday
oncolog
popul
one
studi
shown
new
definit
predict
hospit
mortal
reliabl
gener
popul
analyz
record
cancer
patient
admit
infect
oncolog
icu
calcul
sofa
qsofa
sir
score
tri
determin
accur
score
predict
hospit
mortal
also
compar
new
old
definit
septic
shock
final
analyz
prognost
factor
hospit
mortal
result
studi
includ
solid
tumor
metastasi
hematolog
malign
allograft
hospit
mortal
rate
patient
septic
shock
accord
new
definit
accord
old
definit
patient
sofa
score
increas
point
sinc
admiss
icu
qsofa
sir
score
sofa
score
reach
best
diagnost
perform
predict
hospit
mortal
area
roc
curv
auc
compar
auc
qsofa
sir
score
multivari
analysi
higher
sofa
score
higher
qsofa
score
predict
poor
prognosisodd
ratio
per
onepoint
increas
ci
ci
respect
complet
remiss
cancer
good
prognost
factor
hospit
mortalityor
ci
new
definit
sepsi
septic
shock
usabl
icu
oncolog
popul
reliabl
similar
report
gener
popul
oncolog
patient
admit
icu
suspect
infect
sofa
score
accur
qsofa
sir
score
predict
hospit
mortal
intervent
splenic
pancreat
surgeri
n
hepat
surgeri
n
urolog
surgeri
n
gynecolog
surgeri
n
gastric
surgeri
n
median
durat
followup
month
ci
mortal
observ
period
n
ci
univari
analysi
risk
factor
associ
mortal
werea
score
asa
p
preoper
malnutrit
p
preoper
cognit
disord
p
emerg
surgeri
p
intraop
vasopressor
p
cur
surgeri
associ
better
longterm
surviv
p
type
cancer
type
surgeri
metastat
diseas
influenc
longterm
mortal
use
multivari
analysi
five
factor
associ
prognosishistori
diabet
p
cognit
disord
p
preoper
malnutrit
p
intraop
vasopressor
p
cur
natur
surgeri
associ
better
surviv
p
longterm
surviv
major
oncolog
surgeri
may
consid
patient
year
even
though
cur
natur
surgeri
remain
determin
factor
work
strongli
highlight
import
comorbid
context
view
data
preoper
optim
within
framework
specif
prehabilit
protocol
must
evalu
prospect
preoper
optim
within
framework
specif
prehabilit
protocol
must
prospect
evalu
introduct
incid
cancer
constantli
increas
surviv
critic
ill
cancer
patient
improv
past
decad
data
scarc
regard
biliari
sepsi
septic
shock
ohp
bssohp
main
object
studi
evalu
hospit
mortal
well
associ
factor
context
bssohp
patient
method
observ
retrospect
monocentr
studi
includ
patient
novemb
octob
describ
two
group
patientsa
group
consist
ohp
control
group
noncanc
patient
present
bssohp
icu
admiss
periop
paramet
collect
well
performan
statu
ps
karnofski
score
stage
malign
hospit
discharg
year
statisticunivari
multivari
analysi
use
logist
regress
p
consid
signific
result
ohp
hospit
mortal
n
mortal
n
control
group
n
n
respect
ohp
use
multivari
analysi
factor
independ
associ
hospit
mortal
weresapsii
introduct
acut
respiratori
failur
arf
sever
lifethreaten
complic
oncohematolog
patient
arf
frequent
mix
associ
lesion
cardiogen
edema
surviv
benefit
niv
could
harder
demonstr
may
balanc
chang
ventil
strategi
select
strategi
differ
accord
arf
etiolog
sever
niv
valid
acut
cardiac
pulmonari
edema
acut
exacerb
chronic
obstruct
pulmonari
diseas
decreas
intub
mortal
rate
opposit
highflow
oxygen
nasal
cannula
hfnc
valid
context
de
novo
arf
data
niv
cancer
patient
mix
arf
lack
aim
studi
assess
prognost
factor
includ
ventil
strategi
associ
intens
care
unit
icu
mortal
conduct
observ
retrospect
studi
institut
paolicalmett
cancerreferr
center
critic
ill
cancer
patient
mix
arf
analyz
factor
associ
icu
mortal
use
univari
multivari
match
propens
score
analysi
evalu
result
icu
hospit
mortal
initi
ventil
strategi
icu
admiss
consist
mechan
ventil
mv
other
patient
receiv
noninvas
ventil
niv
associ
oxygen
high
flow
nasal
oxygen
hfno
hfno
alon
standard
oxygen
icu
stay
patient
requir
intub
multivari
analysi
identifi
independ
factor
associ
icu
mortalitysapsii
admiss
point
ci
p
invas
fungal
infect
ci
p
initi
ventil
strategi
p
compar
niv
hfno
alon
standard
oxygen
alon
associ
increas
icu
mortal
respect
p
p
subsequ
realiz
propens
score
analysi
includ
match
patient
niv
arm
receiv
ventil
strategi
exclud
initi
mv
patient
icu
mortal
rate
significantli
lower
patient
treat
niv
versu
patient
receiv
ventil
strategi
p
conclus
oncohematolog
patient
present
mix
arf
sever
icu
admiss
invas
fungal
infect
initi
ventil
strategi
independ
associ
icu
mortal
niv
protect
factor
icu
mortal
niv
evalu
mix
arf
cancer
patient
result
one
hundr
two
patient
includ
among
medic
intens
care
surgic
intens
care
unit
respect
overal
mortal
deceas
patient
pancreat
classifi
sever
sofa
score
admiss
significantli
lower
survivor
nonsurvivor
respect
iq
p
ig
ii
score
also
significantli
lower
among
survivor
among
nonsurvivor
mortal
rate
similar
patient
without
necrosi
infect
univari
analysi
sofa
score
admiss
multipl
organ
failur
renal
dysfunct
metabol
acidosi
hypoxemia
haemoconcentr
associ
death
well
need
renal
replac
therapi
mesenter
ischemia
icu
stay
differ
model
multivari
analysi
sofa
score
icu
acquir
liver
dysfunct
occur
median
delay
one
day
thirtyeight
patient
hepat
cytolysi
ggt
elev
bilirubin
elev
nine
alp
elev
twelv
patient
hepatobiliari
imag
diagnosi
cholecyst
retain
one
case
patient
serolog
hepat
virus
allneg
except
one
fiftynin
episod
collect
median
number
hepat
dysfunct
episod
per
patient
one
ten
patient
two
episod
retain
etiolog
weremultifactori
forti
case
sepsi
hypoxia
drug
toxic
sepsi
seven
case
drug
toxic
two
case
compar
group
control
patient
mortal
higher
vs
p
length
stay
prolong
vs
day
p
differ
signific
conclus
liver
abnorm
common
intens
care
multifactori
liver
dysfunct
frequent
popul
drug
toxic
commonli
suspect
difficult
retain
incrimin
factor
introduct
encephalopathi
common
complic
liver
diseas
andor
portosystem
shunt
pathophysiolog
complet
understood
mechan
includ
role
elev
ammonia
level
associ
system
inflamm
impair
bloodbrain
barrier
bbb
permeabl
also
hypothetis
metabolom
enabl
detect
wide
rang
metabolit
without
priori
recent
metabolom
studi
includ
patient
underw
cerebrospin
fluid
csf
collect
group
outlin
xenobioticsdrug
usual
nt
cross
bbb
retriev
csf
suggest
potenti
neurolog
toxic
drug
csf
collect
invas
henc
aim
describ
xenobiot
present
plasma
cirrhot
patient
use
metabolom
approach
conduct
retrospect
studi
plasma
sampl
hepatolog
icu
plasma
sampl
cirrhot
patient
display
encephalopathi
compar
plasma
cirrhot
patient
without
neurolog
symptom
plasma
healthi
control
liquid
chromatographi
coupl
highresolut
mass
spectrometri
perform
metabol
fingerprint
compar
databas
differ
group
alcohol
healthi
control
among
identifi
metabolit
correspond
xenobiot
deriv
fluoxetin
detect
fold
increas
aminosalicyl
acid
fold
increas
benzyl
alcohol
present
cough
pill
antisept
fold
increas
cirrhot
patient
encephalopathi
compar
cirrhot
patient
cirrhot
patient
without
encephalopathi
propranolol
detect
fold
increas
acetaminophen
fold
increas
penicillamin
ampicillin
fold
increas
compar
healthi
control
interestingli
sever
substanc
expect
system
diffus
detect
cirrhot
patient
healthi
controlseugenol
isoeugenol
use
mouth
bath
solut
triethanolamin
trolamin
use
cutan
cream
resorcinol
monoacet
use
mouth
bath
solut
cutan
cream
conclus
cirrhot
patient
especi
neurolog
symptom
display
dramat
increas
level
sever
xenobiot
plasma
result
confirm
pk
pd
paramet
commonli
use
drug
highli
modifi
patient
suggest
potenti
role
xenobiot
pathophysiolog
encephalopathi
patient
liver
diseas
neutrophillymphocyt
ratioprognost
valu
cirrhosi
ameni
khale
speaker
introduct
differ
score
model
use
predict
sever
acuteonchron
liver
failur
aoclf
childpugh
differ
score
model
use
predict
sever
acut
chronic
liver
failur
aoclf
childpugh
model
endstag
liver
diseas
meld
clif
sofa
previou
studi
shown
neutrophillymphocytr
ratio
nlr
plateletlymphocyt
plr
use
prognost
marker
variou
diseas
process
aim
evalu
role
nlr
predict
mortal
patient
aoclf
patient
method
retrospect
follow
studi
includ
patient
decompens
cirrhosi
januari
decemb
result
total
case
decompens
cirrhosi
aoclf
enrol
present
studi
mean
age
year
sex
ratio
mean
child
meld
respect
chronic
hepat
c
infect
remain
major
case
cirrhosi
studi
lead
caus
hospit
oedematoascit
decompens
diagnosi
sepsi
identifi
case
find
indic
month
mortal
interset
patient
univari
logist
regress
analys
show
signific
posit
correl
nlr
mortal
p
also
high
meld
score
p
child
score
p
clif
sofa
p
multivari
logist
regress
analys
prove
high
nlr
addit
independ
risk
factor
mortal
p
well
child
score
p
evalu
abil
nlr
child
score
predict
mortal
roc
curv
obtainedth
auc
valu
child
score
nlr
p
conclus
studi
nlr
seem
good
marker
easili
achiev
assess
prognosi
immedi
admiss
decompens
cirrhosi
introduct
combin
increas
antibiot
resist
decreas
discoveri
new
antibiot
molecul
seriou
concern
intens
care
unit
howev
link
bacteri
resist
prognosi
remain
controversi
predomin
pathogen
caus
ventilatorassoci
pneumonia
vap
pseudomona
aeruginosa
pa
increasingli
becom
multidrug
resist
mdr
aim
studi
therefor
evalu
relationship
mdr
vap
pa
episod
mortal
patient
method
longitudin
prospect
french
multicent
databas
pavap
onset
physiolog
data
record
mdr
defin
nonsuscept
least
one
agent
three
antimicrobi
categori
analyz
mdr
episod
associ
higher
inhospit
mortal
perform
multivari
surviv
analysi
use
multivari
nonlinear
frailti
model
result
total
patient
present
pavap
maximum
episod
per
patient
observ
episod
mdr
suscept
multivari
model
factor
independ
associ
mortal
includ
age
hr
ci
p
hospit
month
preced
first
episod
hr
ci
p
chronic
renal
failur
hr
ci
p
vap
pa
recurr
hr
ci
p
final
mdr
pavap
associ
death
hr
ci
p
conclus
studi
identifi
relationship
resist
profil
pseudomona
aeruginosa
mortal
introduct
octob
march
nosocomi
outbreak
corynebacterium
striatum
occur
icu
tertiari
hospit
aim
character
popul
affect
defin
risk
factor
match
equival
control
help
avoid
futur
outbreak
patient
method
retrospect
identifi
patient
posit
cultur
corynebaterium
striatum
regardless
infecti
sign
includ
control
posit
patient
match
icu
length
stay
unit
hospit
presenc
mechan
ventil
tri
identifi
risk
factor
c
striatum
acquisit
result
wherea
respect
patient
c
striatum
posit
specimen
first
month
identifi
patient
c
striatum
cultur
oct
march
isol
identifi
use
malditof
share
suscept
resist
antibiomicrobi
except
vancomycin
genotyp
perform
cohort
includ
male
mean
age
year
median
icu
stay
day
iqr
main
comorbid
cancer
diabet
patient
follow
immunodepress
copd
cirrhosi
chronic
kidney
diseas
n
medic
admiss
one
case
elect
postop
admiss
surviv
rate
patient
one
intub
median
ventil
length
day
patient
one
posit
respiratori
specimen
either
tracheobronchi
aspir
bronchoalveolar
lavag
c
striatum
one
patient
periton
liquid
first
posit
cultur
one
soft
tissu
colon
case
consid
actual
infect
accordingli
treat
vancomycin
case
show
clinic
recoveri
despit
microbiolog
failur
niv
high
flow
oxygen
therapi
patient
infect
treat
antibiot
corynebacterium
posit
cultur
among
treat
broad
spectrum
antibiot
characterist
control
patient
current
record
data
comparison
case
control
shown
congress
conclus
c
striatum
caus
microepidem
icu
mechan
ventil
comorbid
patient
high
lo
virul
seem
low
infect
patient
infectionrel
mortal
intestin
rich
divers
relat
rel
abund
multidrugresist
gramneg
bacilli
relat
enterococci
abund
digest
microbiota
intens
care
unit
patient
candic
fontain
speaker
besid
alter
intestin
microbiota
relat
antibiot
intak
could
associ
nosocomi
infect
includ
involv
mdrgnb
poor
outcom
main
object
assess
link
intestin
colon
mdrgnb
composit
microbiota
rich
divers
patient
method
perform
prospect
monocentr
cohort
studi
medic
icu
bichat
hospit
pari
patient
ventil
day
spontan
pass
fece
includ
patient
fecal
sampl
collect
day
inclus
twice
week
mdrgnb
defin
third
gener
cephalosporin
resist
enterobacteriacea
also
enterococcu
faecium
search
cultur
method
mdrgnb
rel
abund
ra
calcul
defin
concentr
mdrgnb
concentr
total
enterobacteriacea
composit
intestin
microbiota
assess
profil
calcul
rich
number
oper
taxonom
unit
divers
shannon
index
result
collect
stool
sampl
patient
includ
fece
mdrgnb
includ
extendedspectrum
betalactamaseproduc
enterobacteriacea
cephalosporinas
overproduc
enterobacteriacea
differ
patient
averag
ra
mdrgnb
twentytwo
stool
sampl
posit
e
faecium
observ
link
divers
rich
intestin
microbiota
mdrgnb
intestin
ra
convers
intestin
divers
rich
decreas
along
rel
abund
read
assign
enterococcu
sp
p
figur
enterococcu
faecium
intestin
carriag
detect
p
detect
mdrgnb
nosocomi
infect
includ
ventil
associ
pneumonia
within
day
posit
mdrgnb
stool
sampl
mdrgnb
intestin
ra
associ
occurr
infect
caus
mdrgnb
conclus
intestin
mdrgnb
rel
abund
associ
divers
rich
intestin
microbiota
enterococcu
sp
rel
abund
enterococcu
faecium
intestin
carriag
introduct
pneumonia
usual
present
forgotten
killer
ventilatorassoci
pneumonia
repres
frequent
nosocomi
infect
intens
care
unit
diagnosi
remain
problemat
earli
diagnosi
could
larg
improv
prognost
outcom
sever
clinic
radiolog
biolog
tool
develop
impov
speed
diagnost
perform
recent
lung
ultrasound
becam
tool
allow
estim
lung
morpholog
bedsid
purpos
studi
determin
sensibl
specif
perform
diagnosi
lung
ultrasound
alon
associ
bronchoalveolar
lavag
patient
method
monocent
prospect
studi
patient
suspect
ventilatorassoci
pneumonia
investig
diagnost
perform
lung
ultrasound
sensibl
specif
sign
ultrasound
pneumonia
subpleur
consolid
lobar
consolid
arboresc
linear
air
bronchogram
also
evalu
combin
lung
ultrasound
direct
examin
bronchoalveolar
lavag
result
preval
ventilatorassoci
pneumonia
two
group
patient
without
ventilatorassoci
pneumonia
similar
term
gener
characterist
signific
differ
two
group
occur
purul
secret
lobar
hemilobar
consolid
specif
subpleur
consolid
arboresc
linear
air
bronchogram
specif
posit
predict
valu
associ
lung
ultrasound
bronchoalveolar
lavag
specif
posit
predict
valu
conclus
lung
ultrasound
vailabl
tool
practic
bedhead
among
critic
patient
intens
care
unit
valid
altern
earli
reliabl
diagnosi
ventilatorassoci
pneumonia
could
also
allow
follow
evolut
treatment
ann
cost
speaker
matthieu
guillaum
desland
ronan
bellouard
laurenc
jalin
clair
roger
brest
hospit
brest
franc
servic
de
pharmacologi
cliniqu
dieu
nant
franc
hopit
dieu
servic
de
pharmacologi
cliniqu
nant
franc
de
pari
franc
servic
de
chirurgical
franc
servic
de
nant
nant
correspond
ann
cost
gmailcom
annal
intens
care
suppl
introduct
french
guidelin
recommend
reach
amikacin
concentr
h
begin
infus
h
time
minim
inhibitori
concentr
mic
respons
bacterium
probabilist
therapi
mic
consid
mg
l
target
rare
achiev
icu
despit
mg
kg
recommend
dosag
aim
elabor
nomogram
guid
clinician
choos
right
first
amikacin
dose
icu
patient
septic
shock
patient
method
data
two
prospect
french
cohort
icu
patient
treat
amikacin
sepsi
analyz
two
pharmacokinet
model
one
parametr
one
nonparametr
built
use
popul
approach
monolix
pmetric
softwar
respect
use
nonparametr
model
produc
dose
nomogram
montecarlo
simul
amikacin
amount
need
achiev
h
mic
h
x
mic
accord
model
covari
depict
result
analyz
observ
patient
median
simplifi
acut
physiolog
score
ii
ninetyfour
patient
requir
invas
mechan
ventil
patient
need
vasopressor
twocompart
pharmacokinet
model
total
bodi
weight
tbw
influenc
central
compart
volum
creatinin
clearanc
accord
chronic
kidney
diseas
epidemiolog
collabor
ckdepi
formula
chosen
nonparametr
parametr
model
adequ
describ
h
similar
perform
coeffici
correl
dose
nomogram
elabor
accord
patient
tbw
creatinin
clearanc
recommend
amikacin
dose
achiev
h
mg
l
rang
mg
mg
mg
kg
mg
kg
conclus
first
amikacin
dose
depend
patient
tbw
creatinin
clearanc
result
frequent
dose
mg
kg
extern
valid
nomogram
evalu
amikacin
toxic
high
dose
necessari
use
nomogram
clinic
practic
infect
frequent
complic
stroke
pneumonia
frequent
site
infect
associ
lower
surviv
impair
neurolog
outcom
studi
focus
intens
care
patient
show
highest
incid
pneumonia
heterogen
sever
select
patient
date
studi
focus
exclus
epidemiolog
prognost
impact
pneumonia
mechan
ventil
stroke
patient
furthermor
previou
studi
lack
adjust
earli
decis
forgo
lifesustain
treatment
dflst
signific
confound
patient
patient
method
conduct
retrospect
analysi
larg
prospect
multicent
databas
period
includ
adult
ischem
stroke
patient
admit
icu
requir
invas
mechan
ventil
icu
admiss
relat
occurr
pneumonia
icu
stay
mortal
investig
use
cox
proport
hazard
model
adjust
dflst
data
present
median
interquartil
rang
number
percentag
result
identifi
patient
age
year
male
gender
patient
icu
icu
admiss
glasgow
coma
scale
score
gc
simplifi
acut
physiolog
score
sap
score
patient
requir
vasopressor
case
renal
replac
therapi
case
dflst
occur
day
icu
admiss
patient
withhold
care
withdraw
care
observ
case
respect
surviv
day
month
one
year
respect
icu
stay
pneumonia
episod
occur
least
patient
pneumonia
caus
sepsi
septic
shock
definit
case
respect
adjust
occurr
pneumonia
icu
stay
associ
mortal
figur
conclus
cohort
mechan
ventil
patient
acut
ischem
stroke
pneumonia
frequent
complic
associ
mortal
impact
pneumonia
function
outcom
survivor
investig
studi
pilot
studi
cerebrovascular
accid
univers
hospit
risk
factor
assumpt
respons
propos
adopt
samia
benouaz
speaker
introduct
stroke
common
neurolog
condit
manag
progress
recent
year
morbid
mortal
remain
high
stroke
second
lead
caus
death
world
develop
countri
behind
cardiovascular
diseas
accord
new
case
regist
year
algeria
death
first
caus
acquir
mental
physic
disabl
objectiveto
analyz
risk
factor
relat
stroke
evalu
manag
patient
method
retrospect
studi
cover
period
month
octob
januari
includ
patient
acut
neurolog
impair
admit
emerg
depart
evalu
criterianihss
score
glasgow
score
blood
pressur
reason
orient
result
collect
file
patient
admit
acut
neurolog
deficit
stroke
ischem
patient
admit
intens
note
predomin
male
averag
age
patient
arriv
sever
hour
onset
symptom
nihss
score
nihss
analysi
risk
factor
showshta
ara
ii
diabet
atrial
fibril
arrhythmia
case
dyslipidemia
cardiovascular
histori
case
relationship
hta
nihss
scorepres
arteri
hypertensionnihss
nihss
nihss
atrial
fibril
arrhythmia
relationship
nihss
scorepres
atrial
fibril
nihss
score
nihss
nihss
score
discuss
frequenc
risk
factor
occurr
stroke
similar
found
literatur
howev
manag
optim
need
minim
vasopressor
hemoglobin
gdl
demograph
clinic
outcom
data
patient
analys
result
period
studi
patient
admit
patient
intub
includ
mean
age
year
sexratio
averag
tbsa
includ
face
neck
patient
averag
durat
sedat
day
studi
patient
simpl
wean
trial
difficult
wean
trial
prolong
wean
trial
wean
mv
success
ca
fail
case
caus
extub
failur
esenti
nosocomi
pneumonia
n
icu
acquir
weak
n
studi
total
bodi
burn
surfac
area
associ
extub
failur
tbsa
success
wean
group
vs
fail
wean
group
p
conclus
result
suggest
incid
extub
failur
high
patient
due
essenti
extent
burn
includ
neck
face
region
